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Abstract 
 
              Genomic imprinting is an epigenetic process in which the instructions for gene 
activation or gene silencing are initiated in the germline by DNA methylation. Many 
imprinted genes play key roles regulating fetal growth and placental development. In addition 
to their prenatal roles, several imprinted genes have been shown to play significant roles post-
natally in particularly with respect to regulating behaviour and metabolism.  
               Cdkn1c, a maternally expressed imprinted gene, codes for the p57Kip2 protein which 
is a cyclin dependent kinase inhibitor, belonging to the same CIP/KIP family as p21 and p27. 
Cdkn1c was shown to be expressed and imprinted in a small population of cells within post 
natal iBAT and rWAT. Using both loss-of-function and gain-in-expression models, a critical 
and dosage-related function for Cdkn1c in brown adipogenesis was identified, through 
Prdm16 and C/ebpβ. 
              Consistent with an increase in mitochondrial uncoupling, mice that over-expressed 
Cdkn1c were found to be protected against diet- and age-induced obesity, in a dosage 
dependent manner. Cdkn1c may therefore represent a novel route towards obesity therapy and 
corroborates the hypothesis that the brown adipose tissue may represent a key area of 
genomic conflict in mammals. 
 
 
Abbreviations 
iBAT- interscapular brown adipose tissue 
rWAT- retroperitoneal white adipose tissue 
mWAT- mesenteric white adipose tissue 
scWAT- inguinal subcutaneous white adipose 
tissue 
cDNA- complimentary Deoxyribonucleic acid 
gDNA- genomic Deoxyribonucleic acid 
mRNA- messenger Ribonucleic acid 
DMR- Differentially methylated region 
sDMR- somatic differentially methylated 
region 
gDMR- gametic differentially methylated 
region 
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IC- Imprinting Centre 
IC1- Imprinting Centre 1 
IC2- Imprinting Centre 2 
BWS- Beckwith Wiedemann Syndrome 
SWS- Silver-Russell Syndrome 
C57J/Bl6- Black 6 mouse line 
129S2/SvHsd - 129 mouse line 
TEM- Transmission Electron Microscopy 
H+E- Haematoxylin and Eosin  
ATP- Adenosine TriPhosphate 
PET- Positron Emission Tomography  
 qPCR- quantitative polymerase chain reaction 
WT- Wild type. 
P7- post natal day 7 
RFLP- restriction fragment length 
polymorphism 
E-embryonic day 
(Q) PCR- (quantitative) polymerase  
chain reaction 
 
Gene Abbreviations 
Igf2- Insulin like grown factor 2 
Igf2r- Insulin like growth factor receptor 2 
Cdkn1c- Cyclin dependent kinase inhibitor 1c 
Phlda2- Pleckstrin homology-like domain 
family A member 2 
Slc22a18- Solute carrier family 22 member 18 
Ucp-1- Uncoupling protein 1 
PGC-1α- Peroxisome proliferator-activated 
receptor gamma coactivator-1 alpha 
Prdm16- PR domain containing 16 
Elovl3- elongation of very long chain fatty 
acids-like 3 
Fsp-27- fat specific protein family member 27 
Perilipin- lipid droplet-associated protein 
aP2- adipocyte fatty  
acid binding protein 
Cox II- cyclooxygenase-2 
MyoD- myogenic differentiation 1 
Myf5- myogenic factor 5 
pRb- retinoblastoma protein 
PPARγ- Peroxisome proliferator-activated 
receptor γ 
C/ebpβ- Ccaat-enhancer binding protein β 
C/ebpα- Ccaat-enhancer binding protein α 
Cidea- cell death-inducing DFFA 
-like effector a  
RIP140- receptor-interacting protein 140 
PPARα- Peroxisome proliferator-activated 
receptor α
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Genomic Imprinting 
                          Genomic imprinting is an epigenetic process in which the instructions for gene 
activation or gene silencing are initiated in the germline by DNA methylation 1. Genomic imprinting 
has so far been described in mammals and in some plants which have independently utilised DNA 
methylation to generate allele-specific gene expression 2. Currently around 100 protein coding genes 
have been demonstrated to have their expression regulated by imprinting in mice, representing around 
0.1% of the genome (Catalogued: MRC Harwell). The majority of these genes are also imprinted in 
the human genome with some notable exceptions 3; 4. Evidence for an imprinting system was implied 
from work performed in the 1980s on parthogenetic embryos, which possess two maternally inherited 
copies of the genome from the same mother, gynogenetic embryos which possess two maternally 
inherited copies from different mothers and androgenetic embryos which possess two paternal copies 
from the same father. These embryos, while possessing a diploid chromosomal content, failed to reach 
term 5; 6; 7; 8. It was concluded from these elegant experiments that there must be a difference in the 
genetic inheritance from either parent that was complimented only by the combination of both the 
maternal and paternal genomes. It had earlier been shown such an imbalance was unlikely to be found 
in other vertebrate species 9. 
              Fig 1.1 illustrates the expression pattern of imprinted genes, where one of the parentally 
inherited genes is silenced while the other remains active. In (a), a classical Mendelian gene is 
displayed with active expression for the maternally (green) and paternally (blue) inherited alleles. 
Genes (b) and (c) represent maternally and paternally expressed imprinted genes respectively, with 
the other parentally inherited copy of the gene silenced. In most cases, this pattern is conserved across 
members of the same species, where all individuals will display a similar expression pattern. 
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Figure 1.1 Basic Principle of Genomic Imprinting: (a) Bi-allelically expressed gene following a Mendelian 
pattern of inheritance, (b) Maternally expressed imprinted gene, (c) Paternally expressed Imprinted gene. Mono-
allelic expression from the imprinted genes accounts for the majority of expression of that gene, as opposed to 
(a), where both alleles contribute equally.  
    
              This pattern of silencing and expression is controlled by DNA methylation 10; 11; 12; 13. All 
imprinted loci to date contain regions of DNA methylation present on one allele but absent on the 
other allele 14. These Differentially Methylated Regions (DMRs) are CpG-rich regions of DNA that 
undergo methylation as a result of the action of the DNA methyltransferase (DNMT) enzymes 15; 16; 17; 
18. An example of methylation controlling the expression of imprinted genes can be seen below (Fig 
1.2). Methylation of the DMR on the maternal allele, often called the Imprinting Centre (IC), is 
sufficient to control the imprint status of the entire domain 19; 20; 21. 
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Figure 1.2 Map of IC2 imprinted domain on mouse distal chromosome, a larger cluster of imprinted genes that 
is located next to, but otherwise functions distinctly, from the IC1. The IC2 is only found to be imprinted in 
eutherian mammals. White boxes represent bi-allelically expressed genes, green boxes represent maternally 
expressed imprinted genes and blue box represents paternally expressed imprinted gene. Grey boxes represent 
the silenced allele. Arrow displays direction of transcription. 3 black lollipops highlight the differentially 
methylated region (DMR) that controls imprinted expression of the cluster. A differentially methylated region is 
also found in the promoter region of Cdkn1c gene, referred to as a somatic DMR that functions to maintain 
imprinted expression once it is established.      
             
 
Gametic differentially methylated region (gDMR) vs. Somatic differentially methylated region 
(sDMR) 
 
           Two types of DMR have been described within imprinted domains (recently reviewed in 22). 
DMRs which are initiated in the germline have variously been termed primary DMRs, germline 
DMRs and gametic DMRs. A number of studies have identified these gDMRs as imprinting centres. 
This is based on targeted deletion of these discrete regions which has been found to result in loss of 
imprinting after passage through one parental germline 22. A second type of DMR exists, which is 
acquired on one parental allele after fertilisation. These are termed secondary or somatic DMRs. An 
example of a somatic DMR is one spanning the promoter of the Cdkn1c gene, where methylation is 
acquired after monoallelic expression of Cdkn1c is established between approximately embryonic day 
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(E) 6.5 and E8.5 23. These somatic DMRs appear to be important in the maintenance of gene silencing 
22; 24; 25                   
Imprinting in clusters 
 
              Imprinted genes are predominantly found in imprinting clusters 24; 26; 27; 28; 29. This 
phenomenon will be described in greater detail later on when exploring the imprinting clusters on 
mouse distal chromosome 7, including the cluster containing Cdkn1c 29.  
 
 
Dangers of monoallelic gene expression 
 
                  While the parent specific nature of imprinted genes represents a clearly deliberate method 
of gene dosage regulation, it is also apparent that this method opens the individual to unique dangers 
from mutation to the single active copy (Fig 1.1). Any changes in this active allele are likely to have 
an immediate consequence, in contrast to mutations that occur in a single copy of a bi-allelically 
active gene where the undamaged allele can provide some protection. There is also the possibility that 
silent mutations can take place in the inactive copy which will manifest only after transmission 
through one parental germline.  
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Appearance and Expansion of Genomic Imprinting 
 
               As has already been drawn attention to, the genomic imprinting system is believed to be 
restricted to the mammalian order within vertebrates. Genomic imprinting has also been described in 
plants. While the two phenomena share mechanistic similarities, there are examples of co-evolution 
which may have occurred in response to the same evolutionary pressure 2; 30; 31.  
              Much speculation exists with respect to what these evolutionary selective pressures might be. 
Extant mammals are divided into eutherians, marsupials and monotremes. Monotremes are considered 
to be the more primitive mammal as they are egg laying mammals and so far imprinting has not been 
found in the limited examples analysed 32. Only three extant species of monotreme remain, located 
exclusively in Australasia. Unlike the other orders of mammals where offspring begin life within the 
womb and are nurtured through supplies from the placenta, monotremes instead lay eggs. However, 
these eggs are not like those laid by birds. Instead they are surrounded by a porous membrane and, as 
such, some nutrient transfer in the womb does take place 33.  
               Marsupials, which are now only found in the wild in Australasia and the Americas, have 
acquired a limited system of genomic imprinting. Of those so far studied, only a subset of genes 
imprinted in eutherians, such as Igf2, are imprinted in marsupials 34; 35; 36. This difference in the extent 
of imprinting has been attributed to differences in reproductive strategies. Although marsupials and 
eutherians both share the characteristic of giving birth to live young, the marsupial young is born at a 
less well developed stage and remains dependent on the mother for longer 37. Another striking 
difference between eutherians and marsupials is the structure and invasiveness of the extra embryonic 
tissues. In marsupials, nutrient transport primarily takes place via membranous extra embryonic 
tissues (chorio-vitelline placenta). In contrast eutherians switch from this simpler structure at 
approximately mid gestation to a more complex structure, the chorio-allantoic placenta, which is 
invasive and, in many mammalian species also in direct contact with maternal blood 38. This more 
complex placenta acts to provide high turnover of supplies supporting extended gestation and the 
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development of the more mature fetus 39. The difference between the mammalian orders in this 
context is annotated below (Fig 1.3). 
 
Figure 1.3 Comparison of extant mammalian orders with respect to childbirth and genomic imprinting. MYA: 
Million Years Ago. 
                     
 
Parental Conflict Hypothesis: 
 
                  The most popular and enduring hypothesis to explain the presence of the imprinting 
system in eutherian and marsupials is the parental conflict hypothesis. This theory states that 
YesLimitedXImprinting
YesXXInvasive 
Placenta
YesYesXEmbryogenesis/ 
Live Young
YesYes(Limited)Pregnancy
125 MYA160 MYADivergence
EutherianMarsupialMonotremeOrder
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differences in the reproductive contribution made by the two sexes acted as the driving forces for 
commencement of imprinting. From the point of view of the father, the survival of offspring remains 
of the utmost importance, so as to continue the genetic line. While this is also the case from the 
maternal side, allocation of resources to offspring during pregnancy are a factor, as these primarily 
come from the mother and it is also necessary to ensure her personal wellbeing 40. Consequently it is 
thought that there is a selection advantage for the paternal genome to silence genes that limit fetal 
growth while the maternal genome has responded by silencing genes that act to promote fetal growth 
(Fig 1.4) 40; 41; 42. 
 
 
Figure 1.4 Depiction of Parental Conflict Hypothesis. Silencing of genes on the paternally inherited genome 
result in larger offspring that have improved survival chances. In contrast, silencing of maternally inherited 
genes will prevent excess nutrient depletion during pregnancy by limiting embryonic growth. 
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                    Parental Conflict was based on the observed roles of two of the earliest imprinted genes 
identified, Igf2 and the Igf2r. In therian mammals studied, Igf2 is exclusively expressed from the 
paternally inherited allele in almost all tissue types, while the maternal copy remains silent 43; 44; 45; 46. 
In contrast, Igf2r was exclusively found to be expressed from the maternally inherited allele 3; 44.  
Analysis of mouse models and human disease have clearly demonstrated that reduced Igf2 expression 
impairs growth, while elevated expression produces overgrowth 47; 48; 49; 50. As a reciprocal phenotype 
to this, loss of Igf2r expression presents with, amongst others, perinatal overgrowth in mice 47. Since 
this time, a number of imprinted genes have been identified that fit with this pattern. However, not all 
imprinted genes fit this pattern. For example loss of function of Nesp55 does not overtly alter fetal 
growth but instead results in behavioural changes 51. The rational for adopting the imprinting system 
may therefore be more complex and several alternative explanations have been put forward 52; 53; 54. 
Parental conflict, however, remains a principle hypothesis associated with the imprinting system and 
will therefore be utilised in discussing the results of this project.   
 
 
Mouse Distal Chromosome 7 
 
               One of the largest domains of imprinted genes observed in the mouse genome is found on 
mouse distal chromosome 7, homologous to human chromosome 11p15. Although initially thought to 
represent a single large domain, it is now known that there are two mechanistically distinct imprinted 
domains in this region, named IC1 and IC2 24; 55; 56. 
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IC1 
 
                 The IC1 cluster, which spans Igf2, is illustrated below (Fig 1.5). The genes in the IC1 
domain were in fact some of the earliest discovered genes that displayed mono-allelic expression, in 
both mice and humans 43; 57; 58. The IC1 domain is thought to be a  more ancient imprint since 
imprinting of Igf2 occurs in both eutherian and marsupial species 34; 35; 43; 45. No such parent specific 
expression was observed in monotremes 32. The presence of imprinting within this cluster of genes 
prior to the divergence of eutherians and marsupials would suggest that this was one of the earliest 
imprinting events. The mechanism of imprinting and functions of these imprinted genes will not be 
discussed in this thesis, as no work has been performed on this cluster. 
 
 
Figure 1.5 Map of IC1 imprinted domain on mouse distal chromosome 7. This cluster represents an evolutionary 
ancient imprint, with monoallelic expression conserved in marsupials. Blue boxes represent paternally expressed 
genes, while green are maternally expressed. White box represents a bi-allelically expressed gene. Arrow 
displays direction of transcription. Black lollipops highlight the differentially methylated region (DMR) that 
controls imprinted expression of the cluster.                  
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IC2 
 
                         Located next to the IC1 domain is the larger IC2 imprinted domain, which was 
previously illustrated (Fig 1.2). In contrast to the IC1 domain, genes within the IC2 domain have been 
shown to be bi-allelically expressed in marsupials 34; 36, implying that imprinted status of this domain 
was acquired after the divergence of marsupials and eutherians. Imprinted status for the IC2 domain is 
controlled by a DMR found within the non-coding region of the Kcnq1 gene. Unlike the enhancer 
interactions model that has been suggested for the IC1 domain, the IC2 domain appears to work via a 
non-coding RNA mechanism. The DMR within the IC2 domain, termed KvDMR, contains the 
promoter of a long non-coding RNA which has been called Kcnq1ot1 or Lit1 20; 59; 60. This non protein 
coding RNA has been demonstrated to be critical for imprinting of the entire cluster, and in its 
absence, bi-allelic expression is restored in all imprinted genes 20; 21; 61; 62. 
              There is a second DMR within the IC2 domain, depicted in Fig 1.2, which is located over the 
promoter and gene body of Cdkn1c 63.  Differential methylation at this region is acquired after 
fertilisation in the mouse 23; 60 and this DMR is therefore a somatic DMR. Continued methylation at 
this region is required to maintain the established mono-allelic expression of Cdkn1c 20; 22; 24; 25; 64; 65  
 
 
Imprinting Disorders of IC1 and 2    
 
               Beckwith-Wiedemann (BWS) and Silver-Russell Syndrome (SRS) are two human 
imprinting disorders that are believed to primarily arise due to altered imprinting status of the genes 
on chromosome 11p15 66; 67; 68; 69; 70. The syndromes are rare with prevalence of around 1/13,700 and 
1/100,000, respectively. 
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                 BWS is a childhood overgrowth disorder with additional features including macroglossia, 
neonatal hypoglycaemia and abdominal wall defects 71; 72. The heterogeneous presentation of 
symptoms in patients has been attributed to different gene alterations. Familial cases of BWS often 
possess maternally inherited inactivating mutations of the CDKN1C gene 73; 74; 75. Sporadic cases, 
which make up the vast majority of BWS patients, show far fewer CDKN1C mutations 70. Instead loss 
of methylation in the IC2 gametic DMR (Fig 1.2), which would be predicted to result in loss of 
expression of the IC2 genes including CDKN1C, has been found to account for >60% of cases 76; 77; 78. 
In addition, some patients have maternal uniparental disomy and some show loss of imprinting in the 
Igf2 79. Loss of function of CDKN1C expression and loss of imprinting of IGF2 either alone or in 
combination are likely to be the cause of many of the defects observed in BWS.  
                    SRS is considered to be a reciprocal growth disorder to BWS with many patients showing 
alterations involving the 11p15 region 68; 80; 81; 82. The major clinical feature associated with the disease 
is severe growth retardation 83; 84. As with BWS, SRS may originate from mutations in CDKN1C 
and/or IGF2. Most recently, micro-duplications in the region that maps to CDKN1C have been 
reported, implicating over expression of CDKN1C as a cause of SRS imprinting 68; 80; 81; 82; 85. Similar 
to BWS, SRS cases display a heterogenous phenotype implying multiple underlying defects. Overall, 
it appears that loss of function of CDKN1C is present in the majority of cases of BWS while gain-in-
expression of CDKN1C is present in at least some cases of SRS 
 
 
Cyclin Dependent Kinase Inhibitor 1c (Cdkn1c) 
                 Cdkn1c codes for the p57Kip2 protein which is a cyclin dependent kinase inhibitor, 
belonging to the same CIP/KIP family as p21 and p27 86; 87; 88. Cdkn1c is located in the IC2 imprinted 
domain of mouse distal chromosome 7, homologous to human chromosome 11p15. It has been shown 
to be imprinted in both humans and mice 86; 89, with exclusive expression from the maternally 
inherited allele in mice and majority expression from the maternal allele in humans. While highly 
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expressed in the developing embryo and placenta in a specific set of tissues as they exit proliferation 
87; 88; 90, expression of Cdkn1c is down-regulated after birth 91.  
                  The primary function of Cdkn1c is to induce growth arrest, through the inhibition of G1/S 
phase progression in the cell cycle 87; 88. However, aside from a general function in attenuating cell 
cycle progression, Cdkn1c has been shown to play roles in directing the differentiation of several cell 
types, influencing cell migration 92; 93 and modifying the Actin cytoskeleton 94; 95. Regarding a role in 
differentiation, Cdkn1c has been shown to regulate the differentiation of amacrine cells in the retina 
96. In addition, the gene is a positive regulator of dopamine cell differentiation 97; 98. Finally, a direct 
binding interaction between the protein and MyoD protein has been established, and Cdkn1c knockout 
mice display signs of poorly differentiated skeletal muscle 99; 100; 101. Included within this role was a 
positive feedback loop with MyoD, that involved the promotion of Cdkn1c expression 70. 
                  Three independent Cdkn1c loss of expression mouse models have been reported 101; 102; 103. 
While some features relevant to BWS were present such as abdominal wall defects, fetal overgrowth, 
the cardinal feature of the syndrome, was not present. Our more recent studies have revisited the 
model and demonstrated that, while loss of function results in an increased potential for overgrowth, 
there is a failure of the Cdkn1c-deficient fetuses to maintain their growth trajectory later in 
development. We attributed this loss of growth potential to severe placental defects. We also noted 
that Cdkn1c-deficient pups in larger litters were not overgrown while those in smaller litter were 
overgrown by as much as 20%. We suggested that intrauterine competition might account for the 
difference in overgrowth observed in the mouse model versus the human scenario, rather than the 
gene functioning differently between the species 104. Adult studies on Cdkn1c-deficiency are impaired 
by the neonatal lethality observed on the C57BL/6 (BL6) strain background 101; 102; 103 and also, as we 
reported, on the 129S2/SvHsd (129) background 104. More than 90% of knockout mice die within 24 
hours of birth which may be due to a cleft palate that prevents feeding and/or abdominal wall defects. 
                   Using bacterial artificial chromosome-based transgenes (BACs), mouse lines have been 
generated to study over-expression of Cdkn1c. BACs are useful in the studies of over expression 
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phenotypes since they encompass discrete region of genomic DNA and include both the endogenous 
promoters and enhancers for the gene of interest. This means that entopic over-expression rather than 
ectopic mis-expression can be studied 105. The BAC transgene spanning the Cdkn1c locus is 85 kb in 
size and contains the coding regions for two additional imprinted genes, Phlda2 and Slc22a18 106. 
Previous studies on mice carrying one or more copies of this transgene identified a growth restriction 
phenotype 107. These mice were studied on a mixed genetic background because on a pure 129 
background, the transgene was found to be lethal with no survivors identified after birth 107. The 
background for most of the early studies was 75% 129 and 25% BL6. Embryos carrying the transgene 
were found to be growth restricted during embryogenesis as early as E13.5 and growth restriction was 
maintained through to birth and into adult life. This growth restriction was found to be dosage 
dependent, with increased Cdkn1c linked to further decreases in body weight 107. While three genes 
were present on the transgene, the growth restriction phenotype was attributable to Cdkn1c through 
the use of a modified version of the BAC transgene in which expression of transgenic Cdkn1c was 
interrupted by insertion of  β-galactosidase, described in more detail in the material and methods. The 
conclusion from this study was that Cdkn1c represented the major negative regulator of embryonic 
growth with the IC2 domain.  
 
Phlda2 
  
              Located next to Cdkn1c on the IC2 domain, Phlda2 (formerly Ipl) encodes a Pleckstrin 
homology-like domain containing protein that is heavily associated with placental development. As 
was the case for Cdkn1c, Phlda2 has been shown to exhibit imprinting in eutherians, but not 
marsupials 36; 108. Expression of Phlda2 is primarily within the placenta and extra-embryonic 
membranes 109. Phlda2 has been shown to be a potent negative regulator of placental growth in mice, 
acting on the spongiotrophoblast lineage 109; 110; 111. This role in placental development has been 
narrowed towards glycogen storage within the placenta that is thought to support later growth of the 
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fetus 112. Imprinting of Phlda2 results in increased glycogen storage, coinciding with enhanced growth 
capabilities of the offspring as a result of Cdkn1c imprinting. 
              In humans multiple studies have implicated abnormal expression levels of PHLDA2 in low 
birth weight 94; 113; 114; 115. The over-expression mouse model was used to demonstrate a direct causal 
link between elevated Phlda2 and growth restriction 97; 110; 111.  
 
 
Slc22a18 
                 Slc22a18 is a maternally expressed imprinted gene that displays high expression in the 
placenta 116. The gene encodes a organic cation transporter (solute carrier family 22 (organic cation 
transporter), member 18), expressed in the placenta, the yolk sac, fetal kidney, liver and intestine 116. 
In the limited work that has been performed on the gene, a change in expression level of the gene was 
detected in the kidneys of Aprt-deficient mice 98. 
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Adipose Tissue     
 
Interscapular Brown Adipose Tissue (iBAT) 
 
                 Brown Adipose tissue was initially described over 400 years ago 117. In rodents, brown 
adipocytes are primarily located in a distinct depot located between the shoulder blades referred to as 
interscapular brown adipose tissue (iBAT). Brown adipose is competent to store lipid (Fig 1.6). These 
stores are multi-locular droplets within the cell. The brown colour, by which this type of adipose 
tissue is described and which is observable in haematoxylin and eosin (H+E) section, arises from the 
large mitochondrial count, which can be individually seen in the transmission electron microscope 
(TEM) images (Fig 1.7).  
             
 
Figure 1.6 H+E stained brown adipocytes from interscapular pad of 10 week old female BL6 mouse. Lipid 
stores (white) and nucleus (dark purple) are observable in cells. The brown colour results from high 
mitochondrial population. Photographed under standard light microscopy at 40X magnification. 
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                   Clues as to the biological function of the tissue came from studies in the late sixties and 
seventies and based on the high mitochondrial population of the cell and the unusual membrane 
potential properties they exhibited. Through a series of experiments it was determined that free fatty 
acids were providing the major source of metabolic fuel in these adipocytes 118; 119; 120. Furthermore, a 
large proton leak was present within this mitochondrial population 121; 122; 123; 124. It was believed that 
this leak was a determined effort to bypass ATP-synthesis, with free energy given off as a result. 
Essentially, the free fatty acid stores were being burnt off to provide free energy in the form of heat.  
 
 
Figure 1.7 Transmission Electron Microscope image of a single brown adipocyte, photographed at X8700 
magnification. The nucleus could be seen surrounded by many large mitochondria containing a complex internal 
membrane structure. Also observable were the multiple lipid droplets (white) within the cell. Reproduced from 
125. 
 
                        The characterisation of the uncoupling protein 1 (Ucp-1) from brown adipose tissue 
eventually provided an explanation for these phenomena 126; 127; 128; 129; 130.  Ucp-1 is a protein that acts 
to uncouple the electron transport chain through dissipation of the H+ gradient that spans the inner 
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mitochondrial membrane. ATP synthase are thus bypassed and the resulting free energy is released in 
the form of heat. This method of heat generation is termed non-shivering thermogenesis. Winkler and 
Klingenberg proposed that Ucp-1 spans the mitochondrial membrane, acting as a carrier protein 
(reviewed 131; 132). 
              Brown adipose tissue was for an extended period believed to only exist in eutherian 
mammals. Within mammals, this form of thermoregulation was thought to be absent in monotremes 
and re-warming rates of echidna hint towards a lack of non-shivering thermogenesis 133. Non-
shivering thermogenesis and the occurrence of brown adipose tissue in marsupials remains a highly 
contentious issue, with multiple reports presenting with conflicting data 134; 135; 136; 137. Consensus now 
believes that an archaic brown adipocyte-like cell is found in the smallest marsupials, which retain the 
system of non-shivering thermogenesis throughout life 134. Larger marsupials most likely do possess 
the tissue, though in small quantities and potentially only during immaturity 135; 136. More recent 
studies on Ucp-1 conservation across species suggest that, although the gene has been present in 
vertebra since fish, an acceleration of adaptive evolution occurred in eutherians 138.  
               The detection of brown adipose tissue in adult humans a few years ago was a huge surprise, 
as it was thought that BAT was lost soon after birth. However, PET scanning of individuals showed 
all to possess varying amounts of the cell type 139.  UCP1 positivity confirms the role of these human 
depots in non-shivering thermogenesis 140. Prior to these discoveries, brown adipose tissue had largely 
been viewed as an interesting but otherwise unimportant cell type that was only to be found in small 
mammals. In light of these discoveries, a host of research avenues has opened up, with a majority 
focussing on the potential to combat obesity with mitochondrial uncoupling.  
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White Adipose Tissue (WAT)                   
                      While BAT primarily utilises cellular lipid for mitochondrial uncoupling and heat 
generation, white adipose tissue provides a lipid store. In fact the cell is so specialised at doing this 
that the vast majority of cellular volume is occupied by a single uni-locular lipid droplet (Fig 1.8). 
This lipid droplet is so intrusive to the rest of the cellular contents that the nucleus will generally 
adopt a flattened shape. The full extent of the content can be more easily observed in the TEM image 
(Fig 1.9), where almost no sub-cellular organelles could be observed.  
                Due to intermittent restrictions in available food sources, the ability to store energy supplies 
provides an advantage. From an evolutionary perspective, white adipose tissue is significantly more 
historic than its brown adipocyte family member that is only observed in the placental mammals. 
Lipid storage to some degree has been described throughout the eukaryotic family, with most 
vertebrate organisms found to possess the white adipocyte (reviewed 141).  
 
 
Figure 1.8 H+E image of white adipocytes in epididymal depots from 10 week old C57J/Bl6 female mouse, 
image under standard light microscopy at 40X magnification. Scale bar represent 200 μm. 
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Figure 1.9 TEM image of white adipocytes in epididymal depots from P.7 C57J/Bl6 female, at 5000X 
magnification. Uni-locular lipid droplets (white) can be seen with minimal surrounding cytosolic region. Dark 
organelles are mitochondria.  
 
               White adipose tissue is almost exclusively located in the sub cutaneous deposits in reptiles, 
amphibians and fish. Meanwhile, mammals and many birds share this feature, in addition to 
possessing significant stores in the visceral areas (reviewed 141. Both groups are the only forms of 
endotherms, meaning they generate heat through their bodily processes, as opposed to relying on the 
environment. Clearly generating your own heat will significantly increase the energy intake one must 
achieve, and these extra lipid stores would help to reduce any strain that would otherwise be put on 
food gathering. Regarding heat generation, general consensus held that white adipose stores provided 
insulation to the environment, in a bid to reduce heat loss. Findings that showed little variation 
between adipose mass of animals from polar regions and the tropics threw doubt on this theory 142. 
The picture remains largely unclear as to the true extent that the cell type does play in 
thermoregulation. 
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                  Until quite recently, beyond lipid storage and possible roles in maintaining body 
temperature, the white adipocyte was not believed to harbour many more biologically significant 
functions. Perhaps the greatest discovery in dispelling this myth was the cloning of the obese gene, 
which codes for leptin protein 143. Since confirmation that the gene was expressed and subsequently 
secreted from the adipocytes 14, many other secretory factors have been identified. The result is that 
the adipose organ, comprising both white and brown forms of the adipocyte, has been recognised as 
an endocrine organ (reviewed 72). 
 
 
(Brown) Adipogenesis  
 
                 The interscapular brown adipose pad is first identifiable around E15.5 of embryogenesis 
144. At birth, iBAT plays a critical role in maintaining body temperature before the development of fur 
and the insulating layer of subcutaneous white fat (reviewed 69). In order for correct differentiation of 
iBAT to occur, a complex signalling cascade must first be achieved, that begins with C/ebpβ 
induction. In fact, it is likely that this signalling cascade is required for both white and brown adipose 
differentiation. C/ebpβ phosphorylation occurs at three separate sites on the protein in two separate 
events, enabling it to dimerise and attain DNA binding ability 145; 146; 147 (Fig 1.9).  
                 It has previously been shown that mice lacking C/ebpβ display heavily impaired 
development of adipose pads, resulting in lean and cold sensitive mice 148; 149. Given the role of 
inducing the two major adipogenic transcription factors C/ebpα and PPARγ, this dependence on 
C/ebpβ expression is not unexpected. Aside from a function in thermogenic program induction that 
shall be discussed in greater detail later on, there remains a key function for the liver-enriched 
transcriptional inhibitory (LIP) isoform of C/ebpβ. While the activating LAP isoform promotes 
adipogenesis, the LIP isoform acts to suppress Ucp-1 expression through direct interaction with its’ 
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promoter 149. These additional functions highlight the dependency of both forms on adipose tissue on 
C/ebpβ expression. 
  
 
Figure 1.9 Depiction of C/ebpβ phosphorylation in differentiating adipocytes. Initial phosphorylation of Thr188 
performed by MAPK/ERK, and maintained by Cdk2-cyclin A complexes. Secondary phosphorylation of Ser184 
induces di-merisation, activating DNA binding capability and driving cell through S phase. Positive regulators 
of C/EBP β phosphorylation are shown in purple, while inhibitors are in green. 
 
                Downstream of C/ebpβ as has already been mentioned are PPARγ and C/ebpα. These two, 
as was the case for C/ebpβ, are critical for adipogenesis. PPARγ, often regarded as the master 
adipogenic regulator is an absolute requirement for differentiation of both white and brown cell types 
150; 151, while C/ebpα is indispensable to white adipogenesis 152. These two work in tandem to activate 
the expression of all genes required for the formation of mature adipocytes 153.  
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Thermogenic Program Induction 
            In addition to inducing genes that enable lipid storage and turnover amongst other roles, brown 
adipocytes must successfully acquire the ability to uncouple oxidative phosphorylation in their 
mitochondria. This function is dependent on Prdm16 and C/ebpβ 148; 154, with Prdm16 acting to both 
promote the expression of thermogenic genes, and to inhibit white adipogenic genes through direct 
binding with the CtBP proteins 155. 
                 Recently it has been shown that Prdm16 and C/ebpβ are direct binding partners, inducing 
expression of downstream genes only when in complex 156. Due to this complex only forming with the 
active LAP isoform of C/ebpβ, activation of gene expression appears to be its’ exclusive function. 
Loss of this complex revert the cell towards a skeletal muscle phenotype 157.  
 
Adipocyte lineages  
            The proposed pathways leading to formation of mature adipocytes is visualised below (Fig 
1.10). The number of question marks within the diagram draws attention to how much work remains 
to be done before these pathways have been fully elucidated. Furthermore, the adipoblast, which gives 
rise to the white adipose population, has yet to be identified.  
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Figure 1.10 Theoretical pathway for differentiation of adipose tissues in vivo. Many of the key factors involved 
in the respective pathways remain unclear, and are therefore highlighted by question marks. Transcription 
factors in blue represent only the most important factors that promote each following cell type. Nucleus is 
depicted by black, while lipid droplets are shaded blue. Adapted from 158.  
 
 
                     Strikingly from the image, there are two proposed types of brown adipocyte. It is 
believed that brown adipocytes, in the classic interscapular depot, come from a Myf5+ lineage. A 
study involving loss of expression of Prdm16, a brown adipose determinant, was expected to result in 
reversion to a white adipocyte-like state. Instead, skeletal muscle characteristics were established 157. 
Furthermore, forced expression of Prdm16 within skeletal muscle cells prompted lipid accumulation 
and mitochondrial uncoupling 156; 158. The gene was acting as a switch between the myogenic-brown 
adipogenic lineages.  
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                     White adipose depots have been shown to contain brown adipocyte-like cells. In contrast 
to the iBAT, white adipose tissue arises from a Myf5- lineage (reviewed 85; 125). Differences between 
these two types of brown adipocyte, if there are any, have not yet been elucidated. Difficulty in 
studying the adipocyte lineages stems from the lack of known pre-adipocyte markers. Currently, only 
Pref-1 has been demonstrated as a marker of pre-adipocytes, which is down-regulated upon 
differentiation 159; 160. It will therefore require the discovery of more markers and identify precursor 
populations within the adipose depots before the whole nature of both brown and white adipocytes 
can be confirmed. 
                   A final point is that under multiple separate conditions, a brown adipose phenotype can be 
enhanced in white adipose tissue, in response to a number of different conditions. This will include 
the induction of Ucp-1 and non-shivering thermogenesis 161; 162; 163; 164.  
 
 
Imprinted genes and brown fat 
 
                 Many imprinted genes play key roles regulating fetal growth and placental development 111; 
165; 166; 167; 168.  In addition to their prenatal roles, several imprinted genes have been shown to play 
significant roles post-natally in particularly with respect to regulating behaviour and metabolism 169; 
170; 171; 172. The association between imprinted genes and brown fat development was first suggested by 
David Haig, where he noted that body warmth might be an area on which genomic conflict might act 
173; 174; 175. A number of imprinted genes have been reported that play a direct or indirect role in 
regulating thermogenesis 176; 177; 178; 179. Due to the limited number of imprinted genes within the 
genome, it is surprising to find such a clustering of expression away from the role of embryogenesis.  
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Preliminary Work  
            The aim of this project was to investigate the consequence of loss and gain-in-expression of 
Cdkn1c in adipose tissue. Constitutive loss of expression of the gene has been widely studied 
particularly with respect to modeling BWS 74; 102; 103; 104. The consequences of over-expressing Cdkn1c 
on embryonic growth have also been described 107. Preliminary studies on the over-expression model 
noted that adults were lean and did not gain weight as they aged. In a preliminary study, one year old 
mice that carried an single extra copy of Cdkn1c (5D3) on a BAC transgene were found to have a 
reduced weight of several visceral white adipose depots relative to their total body weight, possessing 
around 40% less visceral fat (white) than wild types (data not shown). By Magnetic Resonance 
Imaging (MRI) there was a clear loss of both visceral and subcutaneous adipose (Fig 1.11). No 
previous role for Cdkn1c had been described in adipogenesis, and therefore the project was devised to 
explore a potential role for Cdkn1c in regulating adipogenesis.  
 
Figure 1.11 MRI scans of 1 year old Wild type and 5D3 129:BL6 female mice. Images were taken around 
midsection of the mouse body, and revealed less visceral and subcutaneous adipose tissue (white) in 5D3 
subject. Through software analysis, signal of the adipose pads were suppressed in the right hand images, leaving 
only the non-adipose tissue visible.  
5D3
WT
Fat Suppressed Unmodified
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Experimental Design 
               As has been previously stated, >90% of Cdkn1c-m/+p mice die within 24 hours of birth 
hampering any study on adult mice. In one study it was reported that surviving Cdkn1c-deficient mice 
(N=5) were all severely growth retarded with severe skeletal abnormalities but their adipose was not 
investigated 101. However, studies on iBAT can be performed since this depot develops during 
embryogenesis, as opposed to after birth as is the case for white adipose. Therefore experiments were 
performed at E18.5 of embryogenesis, a time at which Cdkn1c-deficient fetuses were still viable.       
                To study the effects of over-expression of Cdkn1c in the adipose tissue, two of the Cdkn1c 
BAC transgenic lines were used. Lines 5D3 and line 5A4 have been previously described 106; 180. 5D3 
and 5A4 carry one or two copies, respectively, of an unmodified 85kb BAC transgene, described in 
greater detail in methods section. The BAC transgene spans two additional genes, Phlda2 and 
Slc22a18, but the existence of the reporter line, 10-15, allows the attribution of Cdkn1c-specific 
phenotypes.  
                    As a first step in the analysis, the 5D3 and 5A4 lines were bred into the BL6 background. 
As observed when these lines studied on the mixed 129:BL6 background 107, both lines were found to 
be growth restricted at E18.5. In contrast, 10-15 mice, which possess a modified BAC which does not 
elevated expression of Cdkn1c, were not growth restricted (Fig 1.12). At P7, a similar degree of 
growth restriction was apparent (Fig 1.13).  
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Figure 1.12 Whole body weights of E18.5 transgenic embryos on a pure Bl6 genetic background, compared to 
wild type (white) littermates. 5D3 (light green) and 5A4 (dark green) embryos were significantly growth 
restricted, while 10-15 (blue) were not.  Error bars represent standard deviation. Statistical analysis was 
performed by Student’s t-test. 
 
Figure 1.13 Whole body weights of P7 5D3 (light green) and 5A4 (dark green) mice on a pure BL6 background, 
compared to wild type littermates (white). Error bars represent standard deviation. Statistical analysis was 
performed by Student’s t-test. Both 5D3 and 5A4 pups were smaller, but data for 5D3 did not reach 
significance. 
n.s. (P = 0.161) 
P = 0.00426 
91% 
74%
n = 18 n = 11 n = 6
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 The aims of the work were: 
1. To characterise the cellular and molecular consequences of loss-of-function and gain-in-
expression of Cdkn1c in iBAT 
2. To characterise the cellular and molecular consequences of gain-in-expression of Cdkn1c in 
WAT 
3. To determine whether the identified phenotypes occur through the intrinsic action of Cdkn1c 
using mouse embryonic fibroblasts 
4. To explore the mechanism by which Cdkn1c regulates iBAT and WAT development 
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Chapter 2: Materials and Methods 
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Mouse Lines           
                      Three transgenic mouse lines were used for experiments to study the effects of 
Cdkn1c over-expression. The two experimental line 5D3 and 5A4 possess one and two 
copies, respectively, of a bacterial artificial chromosome (BAC; Genome Systems 144D14) 
that spans the Cdkn1c gene and two other genes, Phlda2 and Slc22a18. This BAC is 
illustrated in Fig 2.1 (c). These lines were initially generated by electroporating the linearised 
BAC in mouse 129 RI ES cells, making chimeras and then identifying transgenic offspring 
106. These lines were initially bred into an MF1 background as no survivors were found on a 
pure 129 background. For the purposes of this study, the lines were bred for ≥8 generations in 
the BL6 background. The reporter line 10-15 possesses a modified version of BAC 144D14, 
illustrated below in Table (b). For creation of this reporter line, the BAC 144D14 clone was 
modified by homologous recombination of a β-galactosidase reporter construct (p57Kip2-
IRESβgeoloxPalkP) into the Cdkn1c locus. Transgenic mice were generated by pronuclear 
injection of the construct into F1 C57BL/6 x CBA embryos. The line can be used as a reporter 
(LacZ staining) to observe where Cdkn1c is expressed from the transgene. This line also acted 
as a control for the experimental lines to ensure that experimental results on the adipose tissue 
are due exclusively to Cdkn1c over-expression (present in line 5D3 and 5A4, absent in line 
10-15) and not the other two genes. In all cases transgenic material was obtained by mating 
male transgenics with wild type females. The majority of the experiments were performed on 
the BL6 background but some limited analysis was performed on a mixed background of 75% 
129 and 25% BL6. 
                  In order to study the consequences of loss of expression of Cdkn1c, we utilised the 
Elledge mutation (Cdkn1ctm1Sje) 103, which had been bred into the 129 genetic background for 
+8 generation. As Cdkn1c is a maternally expressed imprinted gene, effect of the mutation 
can only be observed upon maternal transmission. Paternal transmission of the same mutation 
is silent, as this copy of the gene is not naturally expressed. Therefore to generate litters 
where a phenotype could be observed, females were first generated, which inherited the 
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mutation by paternal transmission. These Cdkn1c+m-p mothers were phenotypically wild type.  
Cdkn1c+m-p females were paired with 129 studs and plug checked each morning. Cdkn1c-m+p 
embryos generated were used to study the effect of loss of Cdkn1c expression. 
 
 
Figure 2.1 IC2 domain and position of transgenes. (a) Representation of five of the imprinted genes 
found in the IC2 region of Mouse Distal Chromosome 7, which is homologous to Human Chromosome 
11p15.5. The five pictured genes are maternally expressed imprinted genes, while the non-coding 
Kcnp1ot1 transcript is paternally expressed. (b) Representation of modified BAC transgenes. Line 10-
15 carried 3 copies of this modified BAC in which a β-galactosidase insert interrupts expression of 
Cdkn1c expression from the BAC. Phlda2 and Slc22a18 expression are the only genes expressed from 
this modified BAC (Andrews 2007, Tunster 2010). (c) Representation of the unmodified BAC144D14.  
Line 5D3 contains one copy and line 5A4 contains two copies of the BAC and all three genes are 
expressed from the transgenic at level similar to the endogenous loci (Andrews 2007, Tunster 2010). 
   
Animal Maintenance 
            Mice were housed in cages in cohorts not greater than five individuals per cage in 
non-barrier conditions as per Home Office regulations. Environment was kept at 20°C ± 1°C 
on a 12 hour light-dark cycle with standard chow (Harlan, Oxfordshire) and water freely 
accessible. Mice were weaned at four weeks and caged separately from parents in single sex 
cages. 
 40
Genotyping 
               Tail biopsy from 4 week old animals was digested overnight in lysis buffer (0.05 M 
Tris.HCl pH 8, 0.025 M EDTA, 0.031% SDS, 0.02 M NaCl, 80 μg/ml Proteinase K 
(Promega)) at 50ºC with rocking. The following morning, samples were vigorously shaken to 
ensure total lysis, followed by being left for at least 30 minutes to allow undigested material 
to settle. 
       10 μl sample was diluted in 190 μl 10mM Tris.HCl pH 8 and boiled at 95ºC for 30 
minutes. During this time, a PCR master mix was prepared, as given below. 
 
 
 
 
 
 
 
 
 
 
 
                
 
Reagent Volume (per reaction, μl) 
TrueStart 10X Buffer  1.5 
MgCl2 1.2 
dNTP’s (25 mM) 0.6 
Primers F + R (25 μM) 0.3 
TrueStart Taq (Fermentas) 0.1 
Boiled Sample 1 
ddH20 to 15 
 41
                   Once boiling had been completed, samples were shaken and allowed briefly to 
cool. PCR reactions were then set up, and underwent the following PCR: 1. 94ºC 15 minutes, 
2. 94ºC 30 secs, 3. 60ºC 30 secs, 4. 72ºC 30 secs, 5. 75ºC 30 secs, repeat cycle 2-5 35 times, 
6. 72ºC 5 minutes. The 75ºC anti-dimer step was found to be a requirement for successful 
product generation when the hot start Taq was implemented.  PCR products were separated 
on a 1.5% agarose gel and viewed under U.V light. A H20 negative and a positive control 
were used for every reaction. 
 
LacZ staining  
           Adipose pads were dissected and placed in LacZ fix (2% formaldehyde, 0.2% 
glutaraldehyde, 0.02% NP-40, 1mM MgCl2, 0.1mg/ml Sodium Deoxycholate in 1X PBS). 
Fixation was performed for 1 hour at 4ºC with rocking. Tissue was briefly washed in 1X PBS 
(Gibco) to remove LacZ fix, before being placed in LacZ stain (0.4mg/ml XGal, 4mM 
Potassium Ferrocyanide, 4mM Potassium Ferricyanide, 1mM MgCl2, 0.02% NP-40 in 1X 
PBS). Staining was performed overnight at 4ºC with rocking. The following morning, adipose 
pads were washed 2X five mins in 1X PBS, before transfer to 70% EtOH for storage. 
Photography of tissue was performed under standard light field conditions. 
 
Feeding Studies 
                   Two separate long-term high fat diet studies were performed on transgenic lines. 
10 week old 5D3 BL6 females were subjected to 12 week insult of high fat diet, while 5D3 
and 5A4 129:BL6 females underwent a shorter 8 week study. High fat diet (TestDiet 58V8, 
45% calories from fat) and water were available ad libitum.  Mice were weighed weekly, 
while glucose and insulin tolerance testing was performed post-diet. 
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                When measuring food consumption, one week was allowed after dietary or housing 
change, as initially during this time it had been noted that large variation in consumption 
existed. Consumption was calculated by subtraction from the previous days’ total. Any mice 
that had previously demonstrated shredding of food were not utilised in these studies. Tests 
were performed blind. 
              For the low protein studies, wild type 129 matings were set up and plug checked 
each morning. Upon plug discovery, females were removed to a clean cage, either with 
standard chow, or the low protein diet (4400, 8% casein chow, Abdiets). Pregnant females 
were exposed to the low protein diet until 18.5 days after plug discovery, when they were 
returned to standard chow. 
 
Glucose Tolerance Testing (GTT) 
                   Both glucose and insulin tolerance testing were performed in order to provide a 
view of any changes that may have occurred to the glucose management of 5D3 and 5A4 
individuals, under both natural ageing and altered diet. For the ageing cohorts, both GTT and 
ITT were performed at six months and one year of age, while HFD cohorts were subjected to 
testing both pre- and post-diet. 
                Mice were fasted overnight prior to testing, but still had access to water. All 
subjects were individually housed for the duration of the test, with sufficient and comparable 
environmental enrichment to reduce any undue stress, and were weighed before testing began. 
A minimum part (≤5mm) of the tail end was cut off by a clean scalpel and blood was 
squeezed out. This blood was collected in cuvettes (HemoCue) and blood glucose 
concentration was measured by Glucose 201+ meter (HemoCue). After samples were taken, 
mice were injected intraperitoneally with 10 mM/ kg glucose (Sigma Aldrich) and further 
readings were taken at 30, 60, 90 and 120 mins post-injection.  
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                Once the final sample had been taken, mice were returned to their original cages, 
and we allowed access to chow again. All experiments were performed blind and not more 
than twelve individuals were tested in a single test. 
  
Insulin Tolerance Testing (ITT) 
                       Normal practice for insulin tolerance testing involves a short fasting of the mice 
prior to test commencement, in order to ensure a fair baseline reading. After the initial 
attempt, it was discovered that 5A4 mice produced a sufficiently extreme response to insulin 
challenge that this would not be possible. As a result, mice had access to chow ad libitum for 
the entirety of the procedure. In order to provide some control of baseline readings, it was 
determined that an early afternoon start provided significantly better grouping of the readings, 
than one started in the morning. Therefore, all tests were begun at 2pm. 
                 As in the GTT, mice were individually housed with access to water, and in this 
case chow, ad libitum. A minimum part (≤5mm) of the tail end was cut off by a clean scalpel 
and blood was squeezed out. This blood was collected in cuvettes (HemoCue) and blood 
glucose concentration was measured by Glucose 201+ meter (HemoCue). After samples were 
taken, mice were injected intraperitoneally with 0.75 U/ kg insulin (Novo Nordisk) and 
further readings were taken at 15, 30, 45 and 60 mins post-injection.  
                 Once the final sample had been taken, mice were returned to their original cages. 
All experiments were performed blind and not more than twelve individuals were tested in a 
single test. A supply of 2M glucose solution was required at all tests as a precautionary 
measure to combat any cases of hypoglycaemia. Any tests subjects that were seen to have 
blood glucose readings dipping below 3 mMol/ L were removed from the test and injected 
with 100 μl glucose initially. These mice were then monitored periodically for the rest of the 
day, to ensure their well being. 
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Core Body Temperature + Cold Challenge 
                         In order to determine if 5D3 and 5A4 mice displayed any variations in core 
body temperature, rectal temperatures were measured, which was immediately followed by 
cold challenge and re-measurement. 10 week old 5D3 and 5A4 BL6 litters had their core 
body temperature measured by a rectal probe (IN005A, Vet Tech solution). Mice were firmly 
scruffed for the procedure, and any signs of greater than mild discomfort caused the test on 
that subject to be halted. Once measured mice were singly housed in cages in a fridge for 30 
mins, with food and water ad libitum. The cages had been pre-cooled for a minimum of five 
hours before starting. Upon completion of the test, rectal temperatures were measured again. 
Testing was started as close to 2pm as possible and only four mice were tested at any given 
time, to ensure that warming of the fridge did not occur due to the door having been opened to 
frequently.    
 
 
Dissection and Weighing 
                                   Mice were culled via cervical dislocation and their abdomen was 
disinfected with 70% EtOH. Organs and fat pads were dissected out and snap frozen on dry 
ice prior to being stored at -80ºC. Tissues were only weighed once fully frozen to ensure that 
no loss of material occurred. This was of particular importance for the white adipose tissue, 
which was found to be more fragile than any other tissue type.  
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Embryo Dissection 
                 Pregnant females were culled via cervical dislocation and their abdomen was 
disinfected with 70% EtOH. The uterus was dissected out and transferred to cold 1X PBS 
(Gibco). Embryos were removed from uterus and separated from placenta. They were then 
culled by decapitation and brown adipose tissue was removed from between the shoulder 
blades. Samples were either flash frozen on dry ice and stored at -80ºC, or fixed as has 
already been described. Tail tips were used for genotyping. 
 
 
Mouse Embryonic Fibroblast Culture (performed by Dr. Rosalind John) 
                     Primary cultures of mouse embryonic fibroblasts (MEF) from E12.5 embryos 
were maintained and differentiated as described 181 with minor modifications. Briefly, 
embryos were removed from the uterine horn into PBS with the yolk sac, head, and internal 
organs discarded. Remaining tissue was sheared through the barrel of an 18-gauge needle 
attached to a 2 ml syringe into cell culture medium, a total of three times. These cell 
suspensions from each individual embryo were plated into separate wells on 6 well tissue 
culture plates (Nunclon), incubated for 24 hours (37oC, 5% CO2) and split (using 0.05% 
trypsin/EDTA) onto 10 cm plates. Cells were maintained in Dulbecco's modified Eagle's 
medium (DMEM) and F12 (1:1) containing: 
Fetal bovine serum (FBS)    10% 
L-glutamine      1.8 mM 
Penicillin G      100 units/ml 
Streptomycin       100 μg/ml 
(all Gibco) 
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At confluence cells were split onto 6 well tissue culture plates or poly-L-lysine coated 13 mm 
coverslips. Two days post-confluence, media was changed to a pro-differentiation media 
containing: 
 
Insulin      170 ηM 
Dexamethasone                 250 ηM 
Isobutylmethylxanthine (IBMX)   0.5 mM 
(all Sigma)  
Rosiglitazone  (Axxora)   2.5 ηM 
 
After 2 days, this media was removed and cells were fed media containing only insulin and 
rosiglitazone for a further 6 days. Cells were fixed, or harvested for RNA on day 0, 2, 5 and 8 
respective to addition of the first differentiation regimen.  
 
 
Confocal microscopy 
                           MEF’s were grown up and underwent differentiation as described in the 
previous section, however for the purposes of confocal microscopy, separate 5cm glass 
bottom plates (Mat Tek) were utilised. These allowed higher resolution images to be taken, 
due to the reduced scattering effect of glass over plastic, which allowed clearer visualisation 
of cellular mitochondrial population. 
               After 8 days of differentiation, cells were stained with 5 μg/ ml Hoechst 33342 
(Invitrogen) and Rhodimine-123 (Sigma Aldrich) in 2nd differentiation media for 30 minutes 
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at 37ºC. Dyes were removed, and cells were washed for 5 minutes in media. Further staining 
with 7.5 μg/ ml HCS CellMask Red (Invitrogen) for 10 mins was performed. 3 X 5 mins 
washes in ddH20 were performed. Samples were imaged using Leica TCS SP2 AOBS laser 
confocal microscope, and Leica Confocal software.  
 
 
Tissue fixation + Sectioning 
                  Samples for H+E staining and In situ hybridisation were dissected and 
immediately immersed in cold 4% PFA fixative. Fixation occurred overnight at 4ºC on 
rotation. The following morning, samples were washed twice in 1X PBS for 5 mins, before 
storage in 70% EtOH. Paraffin embedding and 10 μm sectioning was performed by Derek 
Scarborough.  
                   For Oil Red O staining of adipocytes, frozen adipose pads were embedded on 
aluminium chucks in OCT mounting medium (RA Lamb), using dry ice. 10 μm thick sections 
were cut using a Bright Microtome 3050 cryostat at -20ºC onto TESPA (0.2% TESPA in 
100% Acetone (Sigma Aldrich)) coated slides. Samples were immediately sent for fixation 
and staining.  
               For immunofluorescence of iBAT, P7 pads were dissected and immediately 
immersed in cold 4% PFA fixative. Fixation occurred overnight at 4ºC on rotation. The 
following morning, samples were washed twice in 1X PBS for 5 mins, before immersion in 
30% sucrose for 24 hours at 4°C for cryopreservation. Upon completion, samples were dried 
on paper towel and embedded on aluminium chucks in OCT mounting medium (RA Lamb), 
using dry ice. 7 μm thick sections were cut using a Bright Microtome 3050 cryostat at -20ºC 
onto TESPA coated slides. 
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Oil Red O (ORO) staining  
                  A stock solution of Oil Red O (ORO) lipid stain was prepared by mixing 1g Oil 
Red O (Sigma Aldrich) in 500ml Isopropanol. The solution was left to dissolve for 24 hours 
with mixing to aid. In order to prevent any issues with precipitation of the dye, a working 
solution was only prepared directly prior to being needed. 24ml of ORO stock solution was 
mixed with 16ml ddH20. After 10 mins, the working solution was filtered through double 
Whatman paper, where upon passing through was ready for use. 
            Freshly cut adipose sections were fixed in paraformaldehyde vapour. This was to 
ensure that formalin liquid did not come into direct contact with the lipid, which hinders the 
stain. An enclosed incubator was preheated to 50ºC containing 10ml paraformaldehyde placed 
in a beaker. After 15 mins, slides containing the sections were rapidly placed inside the 
incubator, whilst more paraformaldehyde in the beaker was added if all had vaporised. 
Samples were fixed for 20 mins in this environment. 
             Post-fixation, slides were briefly washed in ddH20 prior to haematoxylin (Sigma 
Aldrich) staining for 30 secs. It was necessary to perform the nuclear stain first as little signal 
was generated when performed after lipid staining, whereas this way round, lipid staining 
performed second was not found to significantly alter results. Slides were washed in running 
tap water for five mins after nuclear staining and finally rinsed in ddH20. Filtered Oil Red O 
working solution was then applied to slides and left to stain for 15 mins. Upon completion, 
slides were washed with ddH20 and mounted using cover slip and Vectamount AQ aqueous 
mounting medium (Vector). Slides were photographed under standard light microscopy 
within 24 hours. 
              ORO staining of day 8 MEF plates was performed in an identical way, however this 
was performed in 6 well plates, as opposed to slides. 
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H+E staining  
                        Paraffin embedded 10 μm sections were stained with haematoxylin and eosin 
(H+E) by Derek Scarborough via standard protocol. Sections were then photographed under 
standard light microscopy at 20X magnification.  
 
 
 
In situ hybridisation and Cell Counting 
                 In situ hybridisation was performed so as to gain insight into Cdkn1c expression 
within the adipose tissue. A probe for Cdkn1c had previously been designed by Dr. Simon 
Tunster. An approximately 500 bp sequence was amplified from mouse placenta cDNA using 
primers designed by Primer 3. mRNA and genomic Cdkn1c had already been aligned to 
ensure an intron/ exon boundary was the target of amplification. PCR product was purified 
using PCR purification kit (Qiagen) and resuspended in 30 μl 10mM Tris (pH8). 
            25 ηg DNA was ligated into pGEM-T Easy vector per reaction as follows: 
Reagent Volume (μl) 
H2O  to 10 
2X Buffer 5 
pGEM-T Easy vector 1 
T4 DNA ligase 1 
DNA (25 ηg) 
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Reactions were left at 4°C overnight. 
           The follow day, LB/Carbenicillin plates were prepared by spreading 100 µl IPTG 
(0.1M) and 20 µl X-Gal (50mg/ml) onto agar and drying at 37 °C for thirty mins.  
            2 µl of the ligation was added to 50 µl JM109 cells (Promega) on ice and incubated 
for 20 mins. Cells were heat-shocked for 45 secs at 42°C and then immediately returned to ice 
for 2 mins. 950 µl SOC medium was added to each reaction and incubated for ninety mins at 
37°C on rotation. On separate LB/Carbenicillin/IPTG/X-Gal plates, 100 µl and 900 µl of 
reaction was plated and incubated overnight at 37°C. 
                The following day, six white colonies were selected and transferred to 5ml of LB 
medium containing Carbenicillin using a clean tip, which was then incubated overnight at 
37°C on rotation. Plasmid DNA was purified from 4.5 ml of each culture using a mini prep kit 
(Qiagen), according to the manufacturer’s instructions, with DNA eluted in 50 μl ddH2O. 
Analytical digest and sequencing was performed to confirm product, orientation and 
sequence. 0.5 ml of each culture was used to generate a “glycerol stock” by mixing with an 
equal volume of 50% glycerol in a sterile screw cap tube, labelled appropriately and stored at 
-80oC. 
                  Agar plates containing the appropriate antibiotic were inoculated using the 
glycerol stock of the required construct and incubated overnight at 37oC. A single, well-
isolated colony was used to inoculate a second agar plate, and incubated overnight at 37oC. A 
single colony from the second agar plate was used to inoculate 5 ml of LB medium containing 
antibiotic and grown for 8 hours at 37oC in a shaking incubator at 200 rpm. 100 μl of this 
culture was used to inoculate 200 ml LB medium, from which plasmid DNA was purified 
using a midi prep kit (Qiagen) following the manufacturer’s instructions, with DNA 
resuspended in 200 μl 10 mM Tris (pH 8.0), and stored at -20oC. Analytical digests were 
performed on plasmid DNA preps to confirm product. 
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             Two separate reactions were set up using the restriction enzymes SacI (NEB) and 
KpnI (Promega) to linearise each construct either side of the insert thus allowing the 
independent transcription of sense and anti-sense probes. A total of 30 μg of DNA was 
linearised in each reaction, with constituents as shown below 
  
Reagent Volume (μl) 
H2O  to 200 
10X Buffer (NEB) 20 
BSA 100X (NEB) 2 
Enzyme 10 
DNA (30 µg) 
 
             Restriction digests were incubated overnight at the appropriate temperature, and 5 μl 
of reaction was run on a 1 % agarose gel alongside undigested vector to confirm complete 
linearisation. 
               Linearised plasmid DNA was phenol/chloroform extracted by first adjusting the 
volume to 500 μl with 10 mM Tris (pH 8.0), then adding an equal volume (500 μl) of phenol 
and mixing. The mixture was centrifuged at 13,000 r.p.m for 10 mins at room temperature, 
and the upper aqueous phase was removed to a clean microfuge tube to which an equal 
volume of chloroform was added and mixed. The mixture was centrifuged as above, and the 
aqueous phase removed to another microfuge tube. A volume of 3 M NaOAc (pH 5.2) equal 
to one-tenth of the total volume of the aqueous phase was added in addition to 2.5 volumes of 
100% EtOH. DNA was precipitated overnight at -20oC, and centrifuged for 20 mins at 13,000 
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r.p.m at 4oC. The pellet was washed with 1 ml of 70% EtOH, allowed to air dry and 
resuspended in 25 μl of 10 mM Tris (pH 8.0). DNA concentration was determined and 
adjusted to 1 μg/μl using 10 mM Tris (pH 8.0) as required. 
              The linearised plasmid DNA was used as a template for the transcription of 
Digoxigenin-labelled riboprobes using T3 (anti-sense) and T7 (sense) RNA polymerase 
(Roche). Reaction constituents for DIG-labelling of riboprobes are shown below. 
 
 
 
 
 
 
 
 
Transcription reactions were incubated for two hours at 37oC, and DNA template 
digested by incubation with 20 units of DNaseI (Ambion) for 15 mins at 37oC. Probes were 
precipitated by addition of 2 μl 3 M NaOAc (pH 5.2) and 100 μl 100% EtOH, and incubated 
at -20oC overnight. RNA was pelleted by centrifugation at 13,000 r.p.m at 4oC for 20 mins, 
the pellet washed with 70% EtOH, and allowed to air dry for ten mins. The pellet was 
resuspended in 100 μl of DEPC treated H2O and divided into 10 μl aliquots, which were 
stored at -80oC. 
               Slides with paraffin embedded sections were dewaxed in two changes of xylene for 
10 mins each, and rehydrated through graded ethanols of 100% (twice), 95%, 85%, 75%, 50% 
Reagent Volume (μl) 
H2O 12  
10X Transcription Buffer  (Roche) 2  
DIG RNA Labelling mix (Roche) 2  
RNasin (Promega) 1  
RNA Polymerase (Roche) 2  
DNA 1 μl (1 μg/μl) 
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and 30% for 1 minute each. Slides were incubated in 1X saline followed by 1X PBS for 5 
mins each and incubated in 6% hydrogen peroxide (in 1X PBS) for 30 mins at room 
temperature in order to inactivate endogenous alkaline phosphatase activity. Slides were 
washed twice in 1X PBS for 5 mins each, fixed in ice cold 4% PFA (in 1X PBS) for 20 mins 
and washed twice in 1X PBS for 5 mins each. Slides were incubated for 5 mins in Proteinase 
K (Promega) (20 μg/ml Proteinase K, 50 mM Tris, 5 mM EDTA in H2O) at room 
temperature, washed in 1X PBS for 5 mins, post-fixed in 4% PFA for 5 mins and washed in 
DEPC treated H2O for 2 mins. 
 To reduce non-specific probe binding, slides were treated with acetic anhydride (0.01 
M in 0.1 M triethanolamine hydrochloride), by incubating at room temperature for 10 mins. 
Slides were washed with 1X PBS and 1X saline each for 5 minutes at room temperature. 
Slides were rehydrated through 30%, 50%, 70%, 85%, 95% and 100% (twice) EtOH 
solutions, each for one min, except for 70%, in which slides were left for five mins to prevent 
salt precipitation. Slides were air dried for 30 mins, and placed into sealable boxes lined with 
absorbent paper soaked in moisture buffer (5X SSC, 50% (v/v) formamide in DEPC H2O). 
Probe was heated at 80oC for 3 mins, and stored on ice, whilst hybridisation buffer (5X SSC, 
50% formamide, 1% SDS, 0.05 mg/ml heparin, 0.05 mg/ml calf liver tRNA in DEPC H2O) 
was thawed at 80oC. An appropriate amount of probe and hybridisation buffer were mixed 
(per slide: 1 μl probe per 100 μl hybridisation buffer), and applied to relevant slides. A piece 
of parafilm was placed on top of the probe mixture, the box sealed with electrical tape and 
incubated at 62oC overnight in a water bath. 
               Slides were incubated in pre-warmed 5X SSC at 65oC for 30 mins, and parafilm 
removed from solution using forceps. Slides were washed twice in pre-warmed solution I 
(50% formamide, 5X SSC, 1% (v/v) SDS in DEPC H2O) at 65oC for 30 mins each, and then 
washed three times in solution II (0.5 M NaCl, 0.01 Tris (pH 7.5), 0.1% Tween 20 in DEPC 
H2O) at room temperature for 10 mins each. Slides were treated with RNase (0.02 mg/ml in 
solution II) to digest unhybridised probe, by incubation at 37oC for 45 mins, followed by a 
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final 10 mins was in solution II at room temperature. Slides were washed twice at 65oC in 
solution III (50% formamide, 5X SSC in DEPC H2O) for 30 mins each. Slides were washed 
twice in PBT (0.1% Tween 20 in 1X PBS) for 10 mins each and pre-blocked in 10% heat-
inactivated sheep serum in PBT for three hours, covered with a piece of parafilm as before. 
Anti-digoxigenin alkaline phosphatase conjugated antibody (Roche) was pre-absorbed for 
three hours at 4oC in 1% heat inactivated sheep serum in PBT containing 6 mg/ml dried, 
homogenised wild type placenta. Parafilm was removed from slides by washing in PBT for 5 
mins, and the pre-absorbed antibody diluted to a final concentration of 1:2000 in 1% sheep 
serum in PBT. Antibody solution (100 μl) was applied to each slide, covered with a piece of 
parafilm, and incubated overnight at 4oC. 
                    Parafilm was removed from slides by washing in PBT for 5 mins, followed by a 
further two five min washes in PBT, and a subsequent three washes for 30 mins in PBT. 
Slides were preconditioned in three washes of NTMT (0.1 M NaCl, 0.1 M Tris (pH 9.5), 0.05 
M MgCl2, 0.1% Tween 20) containing 2 mM Levamisole (Sigma) for 5 mins each. BM 
Purple substrate (Roche) was applied directly onto each slide to completely cover sections. 
Slides were sealed in a dark box and incubated at room temperature until signal of the desired 
intensity developed (around 24 hours). Slides were washed in PBT for 10 mins, dH2O for 30 
minutes, and counterstained in Eosin Y Solution (Sigma) for up to 10 secs. Excess eosin was 
washed in running tap water and slides air dried for 30 mins. Slides were cleared briefly in 
xylene, air dried and mounted in DPX mounting medium (Sigma). 
                 Slides were imaged at 40X magnification under standard light field conditions and 
counting of Cdkn1c positive cells was performed. Four images per section were counted for 
positive staining and nuclear count, in six samples from the same in situ hybridisation. 
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Immunofluorescence 
                Immunofluorescence was performed on cryosectioned 7 µm thick P7 BL6 iBAT, 
which were prepared as already described. Upon completion of sectioning, slides were air 
dried for 30 mins to aid adhesion of the section. Lines were drawn around section using Dako 
pen (Dako). Samples were blocked in blocking buffer (5 % goat serum (Dako), 5 % donkey 
serum (Dako), 0.1 % Fraction V B.S.A (Sigma) in 1X PBS (Gibco)) for 45 minutes at room 
temperature. Blocking buffer was removed after time and sections were incubated with 
primary antibody (see antibody table) in blocking buffer for 3 hours at room temperature. 
Samples were washed 3 X 5 mins in 1 X PBS before incubation with secondary antibody in 
blocking buffer. Incubation was for one hour at 4°C in the dark. Following incubation, 
samples were washed 3 X 5 mins in 1 X PBS. 
           In order to label the nucleus for images, 4',6-diamidino-2-phenylindole (DAPI) 
staining was performed immediately following the washes. A 300 ηm working solution of 
DAPI was made from a 14.28 mM DAPI stock. 1 µl stock solution was mixed with 47.6 ml 
Mcllvaine’s buffer (0.02 M Citric Acid, 0.16 M Na2HPO4). This working solution was used 
for up to two weeks when kept in the dark at 4 °C. Sections were incubated with DAPI 
working solution for 30 seconds before washing 3 X 5 mins in 1 X PBS. Slides were mounted 
using Fluoromount aqueous media (Sigma) and photographed with the confocal microscope.  
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Transmission Electron Microscopy (TEM) 
               TEM was performed to produce high resolution images of single white adipocytes 
from 5D3 and wild type P7 rWAT. rWAT was dissected from P7 pups into cold 1 X PBS and 
immediately sent for fixation. Fixation, sectioning and microscopy was performed by Dr. 
Anthony Hann (Cardiff University) using a TEM 208 electron microscope (Phillips).   
 
     
RNA extraction + cDNA generation 
                   Analysis of gene expression was determined by qPCR analysis of cDNA, 
prepared from RNA within tissues. RNA extraction was performed via EZ-RNA Total RNA 
Isolation Kit (Geneflow), as per manufacturer’s specifications with some modifications. Still 
frozen samples were partially lysed in 0.5ml Denaturing Solution with a pestle (Sigma 
Aldrich). Once broken up into smaller parts, samples were briefly sonicated using BioRuptor 
(Diagenode) until total lysis of cells had occurred. Homogenates were then stored for 5 
minutes at room temperature prior to the addition of 0.5ml Extraction Solution. Tubes were 
vigorously shaken for 15-30 seconds, before a ten minute incubation at room temperature and 
centrifugation at 13,000 r.p.m for 15 mins at 4ºC. 
           Once separated, the upper aqueous phase was transferred to a fresh 1.5ml non-stick 
tube containing 0.5ml Isopropanol. Once mixed, samples were incubated at room temperature 
for a further 1 minute before centrifugation at 13,000 r.p.m for 10 mins at 4ºC to pellet RNA. 
Supernatant was poured off and 1ml 75% EtOH added. Tubes were inverted until RNA pellet 
was dislodged so as to ensure complete washing. Re-pelleting was achieved through further 
centrifugation at 13,000 r.p.m for 10 mins at 4ºC. Once all ethanol residue had been 
completely removed, pellet was re-dissolved in 10-30 μl 10 mM Tris.HCl pH 8, depending on 
pellet size. 
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           Reverse transcription of 2 μg RNA was performed by first mixing 1 μl 0.5 μg/μl 
random hexamers (Promega) with RNA and volume made up to 11 μl with DEPC H20. 
Samples were incubated at 70ºC for 10 mins, before returning to ice. 8 μl of RT master mix (4 
μl 5X first strand synthesis buffer, 0.5 μl RNasin, 1μl 10 mM dNTP’s (all Promega) and 2.5μl 
DEPC H20) was mixed and each sample was returned to heat block at 37ºC. After a two 
minute wait that ensured samples were at block temperature, 1 μl M-MLV Reverse 
Transcriptase (Promega) was added and complete mixing was ensured through pipetting up 
and down. After one hour incubation, heat block was increased to 70ºC for 15 mins.  
             Once completed, samples were returned to ice and diluted with 100 μl 10 mM 
Tris.HCl pH8. For every sample reverse transcribed, a negative was also performed, that 
underwent identical procedure except M-MLV was not added. These negatives acted as a 
control for DNA content. In order to test for this, after reverse transcription, 1 μl diluted 
sample underwent PCR, as already mentioned using β-Actin primers. PCR products were run 
out on a 1.5% agarose gel, and upon confirmation that no bands were present, negative 
samples were binned.  
 
 
gDNA extraction   
             gDNA was extracted from adipose tissue for two separate reasons. Firstly, changes in 
mitochondrial copy number were quantified via RT-PCR of mitochondrial and nuclear 
gDNA. In addition, gDNA was required for bisulphite treatment and sequencing, in order to 
analyse methylation status of the somatic DMR of Cdkn1c.  
              For total lysis of tissue, adipose pads were incubate in lysis buffer (100 mM Tris.HCl 
(pH 7.8), 50 mM EDTA, 0.2% SDS, 200 mM NaCl and 100 ug/ml proteinase K) at 55ºC 
overnight with rocking. Following morning, samples were briefly shaken before an equal 
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volume of phenol was added. A 10 minute incubation period was interspersed with frequent 
mixing of tubes, followed by 5 minutes of rest, and then another 10 mins of mixing. Upon 
completion, centrifugation at 13,000 r.p.m for 10 mins followed. Aqueous phase was 
transferred to a fresh tube containing an equal volume of chloroform, where the mixing 
procedure as for phenol was repeated. Samples were centrifuged again and aqueous phase 
transferred to a fresh tube containing 20 μl 3 M NaOAc (pH 6) and 0.5ml EtOH to precipitate 
DNA. 
                  When sufficient DNA was present, the pellet could be fished out with a clean 
pipette tip and transferred to another tube directly. The pellet was rinsed in 70% EtOH, 
centrifuged at 13,000 r.p.m for 10 mins and ethanol was removed. Once fully dry, the DNA 
was re-suspended in 50-100 μl TE pH8, aided by heating to 55ºC for 10-30 mins. In the event 
that insufficient DNA precipitated to form an easily identifiable pellet, DNA was spun down 
for one minute in a micro centrifuge. Supernatant was removed and the pellet was washed in 
70% EtOH and re-suspended in TE pH 8, as before. However due to the required spinning 
down of the pellet, RNA treatment was now needed to be performed on these samples. 
                   RNase A (Roche) at a final concentration of 50mg/ml was added and samples 
were kept at 37ºC for 30 mins. Equal volumes of phenol and chloroform were added upon 
completion of incubation period, with mixing performed as previously described. Following 
centrifugation at 13,000 r.p.m for 10 mins, aqueous phase was transferred to a fresh tube 
containing an equal volume of chloroform and the process repeated. After this final 
centrifugation, DNA was precipitated by transfer of upper aqueous phase to a fresh tube 
containing 20 μl 3 M NaOAc (pH 5.2) and 2 volumes 96% EtOH. DNA was spun down for 1 
min in a microcentrifuge and once supernatant was removed, washed in 0.5ml 70% EtOH, 
followed by a further spin down for 1 min. Upon removal of all traces of ethanol, DNA was 
resuspended in 50 μl 10mM Tris.HCl pH 8 as before and analysed by spectrophotography and 
run out on a 0.75% agarose gel to ensure integrity.  
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QPCR 
            For the analysis of relative gene expression and mitochondrial count, qPCR analysis 
was performed on cDNA and gDNA respectively, using a Chromo4 Continuous Fluorescence 
Detector mounted on a PTC 200 Thermocycler (MJ Research). In order to generate 
significant data, a minimum of 4+4 experimental subjects were used. Triplicate wells were 
utilised for each sample read, and every gene was analysed a minimum of four times. Primer 
design was performed in the same way as was performed during in situ hybridisation, 
however in this instance, primer pairs were designed to amplify products around 300 bp. PCR 
master mix was set up per well as follows: 
Reagent Volume (μl) 
TrueStart 10X Buffer  1.5 
MgCl2 1.2 
dNTP’s (25 mM) 0.6 
Primers F + R (25 μM) 0.3 
TrueStart Taq (Fermentas) 0.1 
SybrGreen 0.12 
ddH20 to 15 
DNA (50ηg) 5 
 
 
 Thermocycler conditions were:  95°C for 15 mins, followed by 35 cycles of 95°C for 30 secs, 
60°C for 30 secs, 72°C for 30 secs and an anti primer-dimer step performed at between 75°C 
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to 82°C for 30 secs. The anti-primer dimer step was performed to denature potential primer 
dimers, which may contribute to the measured fluorescence. The temperature of this step was 
set at least two degrees below the pre-determined melting temperature of the PCR product, to 
prevent denaturation of the specific product. Melting curve analysis was performed between 
70°C and 95°C, at 0.5°C intervals. Fluorescence and melting curves were analysed using 
Opticon 3 software. Melting curves were examined to detect non-specific amplification or the 
presence of primer-dimers, evidenced by multiple peaks. A threshold fluorescence level was 
set in the early exponential phase for each assay. The point at which the fluorescence for each 
amplicon passed through this level was the cycle threshold (CT), and was used to quantify 
relative transcript abundance using the 2-ΔΔCT method 182, compared to β-Actin expression 
level for each sample.  
 
Bisulphite treatment and Sequencing of gDNA 
                 For the purposes of studying the methylation status of the Cdkn1c somatic DMR, 
bisulphite treatment and sequencing of gDNA from different environmental scenarios was 
performed. After extraction of gDNA, as performed in a previous section, all treatment and 
sequencing of DNA was performed at Tohoku University in the laboratory of Professor 
Takahiro Arima. 
                 gDNA was bisulphite treated by EZ DNA Methylation Kit (Zymo Research) in line 
with manufacturers protocol. Briefly, 2μg DNA was denatured for 15 mins at 42ºC before 
overnight treatment with 100μl CT Conversion Reagent at 50ºC. The following morning, 
samples were cooled to 4ºC before mixing with M-Binding Buffer in the provided spin 
columns. Centrifugation at 13,000 r.p.m for 30 secs was followed by addition of 100 μl M-
Wash buffer. Samples were re-centrifuged, after which 200 μl M-desulphonation Buffer was 
added to columns and a 15 mins incubation period followed. 
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             Columns were centrifuged again to remove desulphonation buffer, which was 
followed by 2X 200 μl M-Wash Buffer additions, as before. Finally DNA was eluted into a 
fresh 1.5 ml tube by addition of M-Elution Buffer and centrifuged at 13,000 r.p.m for one 
min. DNA was immediately used in PCR amplification, due to the fragile nature of bisulphite 
treated DNA. In order to ensure maximum possible product generation, and due to the fragile 
nature of the DNA, a hemi-nested PCR was employed. PCR master mix was set up per well 
as follows for both PCR reactions, with the only difference being primers:  
 
 
 
PCR cycle for the round 1 was as follows: 1. 94ºC 5 mins, 2. 94ºC 2 mins, 3. 55ºC 2 mins, 4. 
72ºC 3 mins, repeat steps 2-4 5 times, 5. 94ºC 1 min, 6. 60ºC 1 min, 7. 72ºC 1 min, repeat 
steps 5-7 35 times, 8. 72ºC 10 mins. PCR products were analysed on a 1.8% agarose gel to 
Reagent Volume (μl) 
10X EpiTaq Buffer  2 
MgCl2 (25 mM) 2 
dNTP’s (10 mM) 2.4 
Primers F + R (10 μM) 2 
Takara HS EpiTaq (Takara Inc) 0.1 
ddH20 to 20 
BiSulphite treated DNA  2 
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ensure reaction had successfully amplified correct product, with an untreated gDNA sample 
control and a water negative used with each reaction set.  
                  For the nested PCR, as already stated, mastermix was identical to the primary 
round. 1μl of first round PCR was added to 20 μl mastermix, containing the hemi-nested 
primer set. PCR cycle was as follows: 1. 94ºC 5 mins, 2. 94ºC 1 min, 3. 60ºC 1 min, 4. 72ºC 1 
min, repeat steps 2-4 35 times, 5. 72ºC 30 mins. PCR results were separated on a 1.8% 
agarose gel and expected DNA product was cut out using a clean scalpel, and transferred to a 
clean 1.5ml tube. DNA clean up was performed using QIAquick Gel Extraction Kit (Qiagen), 
as per manufacturers specifications. 
               Upon completion DNA product was inserted into pGEM-T Easy vector and JM 109 
cells as already described. Cells were plated on LB/Carbenicillin/IPTG/X-Gal plates and 
grown up overnight at 37 °C. 24 white colonies per sample were picked the following 
morning using clean pipette tips and transferred to PCR tubes. DNA was amplified using 
illustra TempliPhi Amplification Kit (GE Healthcare) as per manufacturer’s instructions, for 6 
hours at 37 °C.  Upon completion, samples were diluted with 16 µl ddH20 and 2µl was 
transferred to new 96 well plates. PCR was performed using a primer for the T7 promoter as 
follows:  
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Thermocycler conditions were:  96°C for 2 mins, followed by 25 cycles of 96°C for 10 secs, 
50°C for 5 secs, 55°C for 2 mins. 
              Once completed, 10 µl ddH20, 2 µl 125mM EDTA and 2 µl 3M NaOAc was added 
to each PCR product. Then 50 µl 100% EtOH was added and plates were centrifuged at 
14,000 r.p.m for 15 mins at 20°C. Liquid was poured off and 50 µl 70 % EtOH was added. 
Plates were centrifuged at 14,000 r.p.m for 5 mins at 20 °C. Liquid was poured off and air 
dried for at least 10 mins. 10 µl HiDi formamide (Takara) was added to samples and plates 
were heated at 96 °C for 2 mins. Plates were then sequenced using ABI Prism 3130xl Genetic 
Analyzer (Applied Biosystems)  
 
 
 
 
Reagent Volume (μl) 
H20 4 
BigDye® Terminator v3.1 5X Sequencing 
Buffer (Applied BioSciences) 
2 
BigDye® Terminator v3.1Premix dye 
(Applied BioSciences) 
1 
T7 Primer (10 μM) 1 
DNA 2 
 64
Western blotting 
                  Western blotting was performed to analyze any changes in the expression of four 
key proteins; Cdkn1c, phospho C/ebpβ and total, Prdm16 and Ucp-1. Samples were 
completely homogenised in 2X SDS sample buffer (0.125M Tris.HCl pH 6.8, 20 % glycerol, 
2.5 % (w/v) sodium dodecyl sulfate (SDS), 0.005% bromophenol blue, Complete protease 
inhibitors (Roche)) and centrifuged at 13,000 r.p.m for 10 mins at 4°C. Lysates were removed 
to clean tubes, leaving behind the floating fat cake, and boiled at 96°C for 10 mins. Levels of 
total proteins in each sample were estimated prior to analysis, using a commercial kit 
(BioRad) based on the Bradford protein assay 183 and measuring absorbance at 590 ηm using 
a multi-well plate reader (BioTek).              
             30 µg samples were separated by SDS-PAGE using resolving gels of various 
acrylamide concentrations (8-14 %) and a 6 % stacking gel cast into BioRad plates and 
moulds.  
 
 
Resolving gel 
 
Acrylamide/bis-acrylamide (Sigma) 8-14 % 
Tris-HCl pH 8.8   384 mM 
SDS                                                     0.1 % 
Ammonium persulphate (APS)      0.1 % 
Tetramethylethylenediamine   0.1 % 
(TEMED)     
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Stacking gel 
 
Acrylamide/bis-acrylamide  6 % 
Tris-HCl pH 6.8   136 mM 
SDS     0.1 % 
APS     0.1 % 
TEMED    0.1 % 
 
 
               Loaded proteins, along with 5 μl protein ladder (10-250 kDa, PageRuler, Fermentas) 
were separated at 200 V using a Tris-glycine SDS-PAGE running buffer and 
electrophoretically transferred to polyvinylidene difluoride (PVDF) using wet transfer system 
(BioRad) at 50 V for 2 hours at room temperature, with Tris-glycine Methanol transfer buffer 
(20% methanol, 0.05 M Tris.HCl pH 8.8, 0.384 M Glycine (Sigma)).  
             Subsequent membranes were blocked in 5% non-fat dry milk (Marvel) in Tris-
buffered saline with 0.1% Tween-20 (TBS-T) for one hour, followed by incubation with 
specific primary antibodies and appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibodies (1:3000, Amersham), both diluted in 5% non-fat dry milk in TBS-T. 
Primary antibodies were incubated overnight at 4°C, while secondary antibodies were 
incubated for two hours at room temperature. Membranes were washed for 20 minutes in 
TBS-T after both primary and secondary antibody incubation. All antibodies used in Western 
blotting experiments are listed below. EZ-ECL Chemiluminescence Detection Kit (Geneflow) 
and ECL plus reagents (Amersham) were used for detection of protein bands. Membranes 
were exposed to X-ray film (Fuji). Exposure times for each Western were as follows: 
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Cdkn1c- 1 min 
Prdm16- BAT 5 min WAT 15 min 
C/EBP β Total + Phospho- 3 min 
UCP1- BAT 10 secs, WAT 3 min 
Β-Actin- 10 secs 
 
Antibodies 
 
Target Type/Clone Source Technique  Dilution 
Cdkn1c Rabbit polyclonal Sigma Western (1 : 1000) 
Cdkn1c Goat polyclonal Santa Cruz F-IHC (1 : 100) 
Prdm16 Rabbit polyclonal Sigma 
 
Western/  
F-IHC 
(1:1000) 
(1:50) 
C/EBPβ Rabbit polyclonal Santa Cruz Western (1:250) 
C/EBPβ Thr 288 Rabbit polyclonal Santa Cruz Western (1:250) 
UCP-1 Rabbit polyclonal Abcam Western (1:3000) 
β-Actin Mouse monoclonal Sigma Western (1:3000) 
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Primers 
 
Gene Primer Sequence 
BAC genotyping Forward GGGCACCAATAACTGCCTTA 
  Reverse GCGTGTTACGGTGAAAACCT 
Cdkn1c KO 
genotyping Forward CGTTCCACAGGCCGAGTGC 
  
WT 
Reverse GCTGCGGAGGTACACGTCG     
  
KO 
Reverse GCGAGGATCTCGTCGTGAC 
Cdkn1c  Forward AGAGAACTGCGCAGGAGAAC 
  Reverse TCTGGCCGTTAGCCTCTAAA  
UCP-1 Forward GGCAAAAACAGAAGGATTGC 
  Reverse TAAGCCGGCTGAGATCTTGT 
PGC-1A Forward TCATCACCTACCGTTACACCTG 
  Reverse CAAGCTTCTCTGAGCTTCCTTC 
Prdm16 Forward CAGCACGGTGAAGCCATTC    
  Reverse GCGTGCATCCGCTTGTG  
Elovl3 Forward CTGTTGCTCATCGTTGTTGG   
  Reverse ATCTGACTACGGCGTCATCC 
Fsp-27 Forward GACCCAACAGCTGGTGTCTAA      
  Reverse ATTGTGCCATCTTCCTCCAG 
Perilipin Forward CACTCTCTGGCCATGTGGAT 
  Reverse AGAGGCTGCCAGGTTGTG 
aP2 Forward TCACCTGGAAGACAGCTCCT 
  Reverse AATCCCCATTTACGCTGATG 
Cyt C Forward TCCATCAGGGTATCCTCTCC 
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  Reverse GGAGGCAACCATAAGACTGG 
Cox II Forward AATTGCTCTCCCCTCTCTACG 
  Reverse GTAGCTTCAGTATCATTGGTGC 
MyoD Forward CGCCACTCCGGGACATAG 
  Reverse GAAGTCGTCTGCTGTCTCAAAGG 
Myf 5 Forward  CAGCCCCACCTCCAACTG              
  Reverse GGGACCAGACAGGGCTGTTA 
pRb Forward AAGCAGCCTCAGCCTTCCATA   
  Reverse TGCCATACATAGAGCACATC 
PPARγ Forward  CCCTGGCAAAGCATTTGTAT          
  Reverse GAAACTGGCACCCTTGAAAA 
C/EBPβ Forward CAAGCTGAGCGACGAGTACA 
  Reverse AGCTGCTCCACCTTCTTCTG 
C/EBPα Forward CGCTGGTGATCAAACAAGAG 
  Reverse CGATCTGGAACTGCAAGTGG 
Cidea Forward TGGAAAAGGGACAGAAATGG 
  Reverse TCTCGTACATCGTGGCTTTG 
β-Actin Forward CCTGTATGCCTCTGGTCGTA 
  Reverse CCATCTCCTGCTCGAAGTCT 
RIP140 Forward TGCTGGCCACAAAGAGGAA 
  Reverse ACAGTGGGACCATTGCTTTGA 
PPARα Forward ACGATGCTGTCCTCCTTGATG 
  Reverse CGCGTGTGATAAAGCCATTG 
Cdkn1c (bisulphite) Forward TGG GTG TAG AGG GTG GAT TTA GTT 
  Reverse CCC ACA AAA ACC CTA CCC CC 
  Nested 
GTA TTG TTA GGA TTA GGA TTT AGT TGG 
TAG TAG TAG 
T7 promoter Forward TAA TAC GAC TCA CTA TAG GG 
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Statistical Analysis 
           Student’s t-test was performed on cell counting, weights of mice and organs, glucose 
tolerance testing, insulin tolerance testing, core body temperatures, feeding studies and 
bisulphite sequencing of Cdkn1c sDMR. Mann Whitney test was performed for fold changes 
for QPCR analysis. SPSS software (IBM) was used for all tests.  
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Chapter 3: Characterising the effect of altered 
Cdkn1c dosage on brown adipogenesis 
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Imprinted expression of Cdkn1c in brown adipose tissue 
 
                      Prior to this investigation, there was no published data to suggest a direct role for 
Cdkn1c in adipogenesis. Most research had focused instead on the putative role of Cdkn1c in BWS, 
and as a regulator of embryonic growth and placental development 101; 103; 184; 185; 186. Cdkn1c is highly 
expressed during embryogenesis in a subset of cells as they exit differentiation but becomes 
progressively down-regulated in the majority of tissues late in embryogenesis 90; 91. In the adult, few 
sites of Cdkn1c expression have been reported including some glomerular podocytes of the adult 
kidney, early spermatocytes and the adrenal cortex 90; 91. Cdkn1c was most recently suggested to play 
a role in self-renewal of adult lung stem cells 187 and the quiescence and maintenance of adult 
hematopoietic stem cells 188.  
 
 
Cdkn1c expression in iBAT 
 
              At the start of the study, adipose depots from postnatal mice were examined in order to 
determine firstly whether Cdkn1c was expression in these depots and secondly to ask whether 
imprinted expression was maintained. An AvaI restriction fragment length polymorphism (RFLP) had 
previously been identified within the Cdkn1c transcript between Mus mus domesticus strains (D) and 
the wild type strain Mus mus spretus (S) 21. Adipose tissue from post-natal day 90 (P90) animals was 
generated by crossing a BL6 female (D) with a hybrid male carrying the spretus region of mouse 
distal chromosome 7 (BL6Spretus7, S). Genomic DNA and RNA was isolated, cDNA was prepared and 
then primers were used to amplify a 381 base pair region spanning the polymorphism from both the 
genomic and the cDNA samples. The PCR products were purified, and then subjected to AvaI 
digestion and run out on a 2% agarose gel.   
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               A product was amplified from both the interscapular brown adipose tissue (iBAT) and 
retroperitoneal white adipose tissue (rWAT) at P90. 5 µl of the cDNA template was required to 
generate a band visible on the agarose gel as opposed to the 1 µl usually used to amplify Cdkn1c from 
placental or embryonic samples suggesting a lower level of expression. On digestion with AvaI, two 
bands were observed with the genomic DNA template but only a single band was present in the 
cDNA amplifications (Fig 3.1). This demonstrated that imprinting of Cdkn1c was maintained at least 
until 3 months in both brown and white adipose tissue.   
   
 
Figure 3.1 RFLP analysis of Cdkn1c in rWAT and iBAT. PCR products amplified from genomic DNA and 
cDNA isolated from adipose tissue from a C57BL/6 x C57BL/6Spretus7 cross were subjected to Ava I digestion, 
allowing assignment of parental alleles. This work demonstrated that Cdkn1c was expressed and imprinted 
within cells contained with the rWAT and iBAT depots until at least 3 months of age. Performed by Dr. R John. 
 
           The maintenance of imprinted expression of Cdkn1c within adipose depots suggested the 
possibility that Cdkn1c may play a role in brown adipogenesis and that the regulated dosage of 
Cdkn1c might have a functional significance.  
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Investigating the consequences of loss of Cdkn1c expression in iBAT 
 
                 To investigate the molecular and cellular consequences of loss of function of 
Cdkn1c in iBAT, heterozygous female Cdkn1c+m/-p mice were mated with wild type males to 
generate litters of Cdkn1c-m/+p (knockout) and wild type mice. On the BL6 genetic 
background, loss of function of Cdkn1c results in neonatal lethality in >90% cases 103. As part 
of a separate project, the Elledge mutation (Cdkn1ctm1Sje) had been bred into the 129 genetic 
background for +8 generation. On this 129 background, a similar lethality was observed 104; 
107.  The few live Cdkn1c-m/+p pups recovered on the day of birth were cold to touch and grey 
in appearance.  
            iBAT pads are observable as early as embryonic day (E) 15.5 of embryogenesis, although the 
lineage is believed to begin formation significantly earlier 144; 150.  Initial examination of undissected 
iBAT from Cdkn1c-m/+p and wild type mice at E18.5 revealed the altered appearance of the Cdkn1c-
m/+p iBAT (Fig 3.2). The dark nature of the iBAT, clearly seen in the wild type image and attributed to 
the huge numbers of mitochondria in these cells coupled with their relatively low lipid content and the 
vascular nature of the tissue, was not observed in the Cdkn1c-m/+p iBAT where almost none of the 
darker tissue was apparent. Instead the tissue more closely resembled white adipose tissue.  
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Figure 3.2 Whole body images of E18.5 wild type and Cdkn1c-m/+p 129 mice. The interscapular brown adipose 
tissue (iBAT) has been highlighted on both images. The wild type iBAT can be seen as two individual pads with 
a darkish appearance surrounded by ring of lighter appearing tissue. In contrast, the Cdkn1c-m/+p pads were less 
distinct and lighter in appearance.  
 
    
              Fat pads from this litter of E18.5 Cdkn1c-m/+p embryos were dissected and subjected to H+E 
(Fig 3.3) and Oil Red O (Fig 3.4) staining. In the wild type section the dark brown colour that 
distinguishes iBAT from surrounding tissue was clearly apparent at the cellular level. Small pockets 
of lipid were observed in individual cells. In contrast, the iBAT in Cdkn1c-m/+p sections appeared 
poorly differentiated with an unusual morphology, including larger areas of lipid stores. In contrast to 
wild type adipocytes, which were seen to be highly uniform in nature across the fat pad, cells within 
the Cdkn1c-m/+p iBAT displayed a high degree of heterogeneity.  
  
     
iBAT
 WT  Cdkn1c
‐m/+p 
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Figure 3.3 H+E stained E18.5 wild type and Cdkn1c-m/+p iBAT sections at 40X magnification, photographed 
under standard light field conditions. Wild type adipocytes have a darker appearance and possess small lipid 
depots whereas Cdkn1c-m/+p adipocytes are lighter in appearance with large lipid stores.  
 
                      Wild type adipocytes appeared consistent in size and shape across the population 
whereas Cdkn1c-m/+p adipocytes appeared larger and less uniform (Fig 3.3). To quantitate this feature, 
cell diameter and cell number were analyzed using Image J software (Table 1). Cdkn1c-m/+p (31.17 ± 
1.1 μm P=1.188*10-6 N=6) adipocytes were found to be statistically significantly larger than the wild 
type cells (28.88 ± 0.84 μm N=13) but no difference in cell number per image was observed between 
the two groups (92.8 ± 10.86 P=0.65) (88.57 ± 8.83) (Table 1).   
 
Table 1 Diameter and cell count of Cdkn1c-m/+p E18.5 iBAT, performed in ImageJ software. Loss of expression 
of Cdkn1c was found to increase diameter of cells, compared to wild type, while cell number counted per image 
was unaffected. Statistical analysis was performed by Student’s t-test. Images covered 22,592 µm2. Area of 
image: 80,000 µm2. 
WT  Cdkn1c‐m/+p 
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Loss of Cdkn1c expression results in elevated lipid content in iBAT 
             
                  To verify the areas with a white appearance were lipid stores, Oil Red O staining was 
performed on cryo-embedded sections (Fig 3.4). Large areas of the Cdkn1c-m/+p adipocytes stained 
positive for lipid whereas wild type brown adipocytes displayed litter staining. Though it would 
appear all cells were lipid positive in the wild type, the intensity of the red colour suggested that the 
total lipid content was comparatively low to the Cdkn1c-m/+p iBAT.    
  
 
 
 Figure 3.4 Oil Red O stained E18.5 WT (a) and Cdkn1c-m/+p (b) iBAT sections at 40X magnification under 
standard light field conditions. Wild type adipocytes displayed limited staining of lipid positive cells. In 
contrast, Cdkn1c-m/+p brown adipose tissue displayed widespread staining with a deep intensity.  
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Critical pathways are disrupted in Cdkn1c-m/+p iBAT           
               Histological results so far obtained highlighted a disruption in the normal morphology of the 
iBAT in Cdkn1c-m/+p. It had previously been noted that Cdkn1c-m/+p pups when born were cold to 
touch and grey in appearance. Therefore QPCR analysis of genes involved in the thermogenic 
programme was performed to determine if defective thermogenesis had occurred (Fig 3.5). Ucp-1, 
Cidea and Elovl3, markers of mitochondrial uncoupling, were all found to be reduced in expression. 
PGC-1α, was in contrast, found to be elevated in Cdkn1c-m/+p iBAT.  
 
 
Figure 3.5 QPCR analysis of Cdkn1c-m/+p E18.5 iBAT cDNA. Selected thermogenic program genes were found 
to reduced in the absence of Cdkn1c. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Mann Whitney test. * P< 0.05. ** P< 0.01. N=4+4 
 
                In light of the reduced expression of genes associated with thermogenesis and the 
widespread accumulation of lipid deposits in the Cdkn1c-m/+p iBAT, QPCR analysis of genes 
associated with lipid accumulation was next performed (Fig 3.6). Fsp-27, Perilipin and aP2 were all 
found to be down-regulated. The expression level of these genes would further suggest that the large 
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lipid depots observed in the adipocytes were not representing a trans-differentiation event towards the 
white adipose phenotype, and merely that correct differentiation of the brown adipocytes had not 
occurred.  
              Two genes involved in mitochondrial function, Cytochrome C 189; 190 and Cox 2 191 both 
displayed significant down-regulation at the cDNA level (Fig 3.7). Cytochrome C is transcribed from 
the nuclear genome and can be used as a measure of activity, while Cox II is transcribed from the 
mitochondrial genome and therefore serves better as a marker of mitochondrion count. Since it was 
possible that transcription may have been repressed from the mitochondrial genome, as opposed to a 
reduced organelle population, QPCR analysis was performed on genomic DNA of the iBAT from 
wild type and Cdkn1c-m/+p. The total levels of Cox 2 mitochondrial DNA when compared to the 
nuclear DNA of Rip140 and β-Actin was 62.75 ± 0.99 % the wild type level (P = 0.029) (Fig 3.7). 
 
 
Figure 3.6 QPCR analysis of Cdkn1c-m/+p E18.5 iBAT cDNA. Lipid accumulation and mitochondrial genes were 
found to be down-regulated in the absence of Cdkn1c. Error bars represent standard error of fold changes. 
Statistical analysis was performed by Mann Whitney test. * P< 0.05. N=4+4 
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Figure 3.7 QPCR analysis of Cdkn1c-m/+p E18.5 iBAT genomic DNA. Amplification of Cox 2 from the 
mitochondrial genome was compared to nuclear gDNA content, highlighting a reduction of mitochondrial 
population in the absence of Cdkn1c. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Mann Whitney test. * P< 0.05. N= 4+4. 
 
             Brown adipose tissue in the absence of Cdkn1c had been shown to be poorly differentiated 
and displayed reduced expression of genes associated with the thermogenesis. A similar phenotype, 
that of poor iBAT differentiation, has been reported in association with loss of function of Prdm16, a 
brown fat determinant 154; 157; 158 and C/ebpβ, one of the earliest transcription factors whose expression 
is elevated in adipogenesis 148; 192; 193. Analysis of these two genes and other selected adipogenic 
markers was therefore performed to gain insight into the mechanism by which differentiation was 
being inhibited (Fig 3.8).  
              The mRNA levels of Prdm16 were unaltered in the iBAT whereas expression of C/ebpβ was 
reduced. Knockout models of C/ebpβ produced mice lacking fully functional brown adipose tissue 148, 
sharing key features with the histology of Cdkn1c-m/+p iBAT (Fig 3.2). However, the analysis of the 
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expression level of downstream targets of C/ebpβ in the Cdkn1c-m/+p model was not consistent with 
loss of expression of C/ebpβ as the primary defect 148. C/ebpα is found directly downstream of, and is 
promoted by C/ebpβ in the brown adipogenic pathway 192. Were loss of expression of C/ebpβ the 
primary cause of the phenotype observed in the Cdkn1c-m/+p iBAT, reduced expression of C/ebpα 
would also be expected. Instead a modest increase in expression of the gene was observed. It should 
be noted however that previous studies have shown that the gene was dispensable in classic 
interscapular brown adipose differentiation, instead performing critical roles in the formation of white 
adipose tissue 194, and therefore the change in expression level was unlikely to account for any of the 
phenotypes observed. PPARα, a transcription factor key to brown adipogenesis, was however 
significantly down-regulated. PPARα has been demonstrated to act as a cold-inducible gene, 
increasing thermogenesis as required 195; 196. The reduced expression that is seen in Cdkn1c-m/+p iBAT 
provides further evidence of a failure to differentiate correctly.     
               pRb, PPARγ and Rip140 displayed only modest changes in expression level. Due to the 
extremity of the phenotype observed, it was unlikely that such modest changes in these adipogenic 
regulators would account for such changes.             
 
Figure 3.8 QPCR analysis of Cdkn1c-m/+p E18.5 iBAT cDNA. Adipogenic and brown adipogenic regulators 
provided a diverse pattern of expression. Error bars represent standard error of fold changes. Statistical analysis 
was performed by Mann Whitney test. * P< 0.05. N=4+4. 
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                  In certain mouse models where a failure of the brown adipose tissue to form was observed, 
QPCR analysis of the tissue often found an elevation of skeletal muscle markers 154; 197. This 
phenomenon was suggested to represent a shared progenitor between myogenic lineage of skeletal 
muscle and brown adipose tissue 154; 157. Two skeletal muscle markers, Myf5 and MyoD were analyzed 
via QPCR to determine if the Cdkn1c-m/+p iBAT possessed skeletal muscle characteristics. Both Myf5 
and MyoD were found to be significantly elevated (Fig 3.9). Combined with other genes analyzed, the 
presence of skeletal muscle markers clearly demonstrated a failure to differentiate in the iBAT of 
Cdkn1c-m/+p mice. 
 
 
 
Figure 3.9 QPCR analysis of Cdkn1c-m/+p E18.5 iBAT cDNA. Skeletal muscle markers Myf5 and MyoD were 
both found to be elevated. Error bars represent standard error of fold changes. Statistical analysis was performed 
by Mann Whitney test. ** P< 0.01. N=4+4. 
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Reduced C/EBPβ and Prdm16 disrupts non-shivering thermogenesis 
 
                  In addition to the QPCR analysis, Western blotting was performed to ascertain whether the 
qPCR data was representative of alterations in protein levels. Western analysis for Ucp-1 was 
performed on E18.5 wild type and Cdkn1c-m/+p iBAT (Figure 3.10). Ucp-1 was readily apparent in the 
wild type samples and barely detectable in the Cdkn1c-m/+p samples. 
             
    
 
Figure 3.10 Western Blot for Ucp-1 protein in Cdkn1c-m/+p E18.5 iBAT lysates. Ucp-1 was barely detectable in 
the absence of Cdkn1c expression. Lanes were normalised for protein amount through β-Actin blot.  
 
 
               Loss of Ucp-1 represented the end point in the failure for correct differentiation of Cdkn1c-
m/+p iBAT. As opposed to a direct interaction of Cdkn1c with the Ucp-1 gene, the QPCR analysis 
suggested an upstream disruption to many of the key brown adipocyte transcription factors. The 
importance of the Prdm16-C/ebpβ complex to the acquirement of the brown adipose phenotype has 
previously been shown 156, and given the already discussed reduced expression of C/ebpβ cDNA (Fig 
3.8), focus turned towards analysing the protein levels of these two transcription factors. Prdm16 
cDNA levels were unaltered in Cdkn1c-m/+p iBAT whereas C/ebpβ levels were 50% wild type (Fig 
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3.8). By Western blotting, Prdm16 protein was greatly reduced in iBAT whereas the C/ebpβ staining 
was consistent with the QPCR data (Fig 3.11).  
 
 
Figure 3.11 Western blotting for Prdm16 and C/ebpβ proteins in Cdkn1c-m/+p E18.5 iBAT lysates. Reduced 
detection of Prdm16 and total C/ebpβ protein was observed in knockout samples. This also correlated to an 
absence of the phosphorylated form of C/ebpβ. Sample amounts were normalised through β- Actin control.  
 
  
                      While a role in modifying the phosphorylation state of C/ebpβ had not previously been 
described for Cdkn1c, Cdkn1c encodes and cyclin dependant kinase inhibitor. It was possible 
therefore, that loss of function of Cdkn1c resulted in an increase in the phosphorylated form of 
C/ebpβ, which has a tendency to self dimerise and promote the white adipogenesis pathway 198, over 
the non phosphorylated form which is proposed to dimerise with Prdm16 to promote the brown 
pathways 156. Levels of the Threonine-217 phosphorylated form of C/ebpβ were therefore analysed 
through Western blotting. Threonine-217 phosphorylation is a secondary phosphorylation event that 
allows C/ebpβ homodimers to form, activating the protein as a transcription factor 198. As can be seen 
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(Fig 3.11), the phospho-protein was undetectable in the Cdkn1c knockout samples. The lack of 
phospho-C/ebpβ in Cdkn1c-m/+p iBAT suggests that Cdkn1c did not play a role in inhibiting 
phosphorylation of C/ebpβ.  
                In summary, this analysis indicated a requirement for Cdkn1c in brown adipogenesis and 
also suggested that Cdkn1c might play role in regulating brown fat development either through 
C/ebpβ or Prdm16. 
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Investigating the consequences of elevated Cdkn1c expression 
 
               The BAC transgenic models were used to investigate the functional consequences of loss of 
imprinting of Cdkn1c in iBAT. Previously mice carrying a BAC transgene spanning the Cdkn1c locus 
were shown to express Cdkn1c from this transgene in a subset of tissues where Cdkn1c is normally 
expressed  106. Two version of the BAC transgene were used to generated transgenic mice, on a pure 
BL6 background. In one version, the transgenic BAC was unmodified and lines were generated with 
one, two or more copies of the transgene. In the second version, the transgene was initially modified 
such that the transgenic Cdkn1c expression was replaced by a β-galactosidase reporter.  The lines 
with the unmodified transgene were experimental lines in which Cdkn1c was elevated whereas the 
lines carrying the modified version constituted both a reporter line but also a control for the 
experimental lines, containing the same DNA fragment but without elevation of Cdkn1c 107. 
                 As a first step, adipose depots from the reporter line 10-15 were subject to LacZ staining. 
Discrete patches of blue cells were apparent (Fig 3.12a) suggesting expression of Cdkn1c from the 
transgene in adipose tissue. To ask whether the experimental transgenic lines carrying an unmodified 
version of this transgene elevated expression of Cdkn1c in adipose tissue, adipose depots were 
isolated from P7 mice from line 5D3 which was known to carry a single copy of the BAC transgene 
spanning Cdkn1c and line 5A4 which was known to carry two copies 107. As a control, depots were 
also isolated from the lacZ reporter line 10-15 which was known to carry three copies of the modified 
BAC transgene. QPCR analysis demonstrated elevated Cdkn1c in both 5D3 and 5A4 iBAT and 
expression was at wild type levels in 10-15 iBAT (Fig 3.12b). Western blotting was used to 
demonstrate that Cdkn1c protein was also elevated (Fig 3.13). Increased signal of the protein 
correlated to the changes seen in the QPCR analysis (Fig 3.12b). This analysis demonstrated that the 
transgenic lines could be employed to study the effect of over-expression of Cdkn1c in the iBAT.  
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Figure 3.12 a) LacZ staining of iBAT depots from wild type and 10-15 mice. b) QPCR analysis of Cdkn1c 
expression in transgenic P7 iBAT. 5D3 (light green) and 5A4 (dark green) were both found to over-express 
Cdkn1c compared to wild type, while 10-15 (blue) did not. Error bars represent standard error of fold changes. 
Statistical analysis was performed by Mann Whitney test. * P<0.05, ** P<0.01. N=4+4. 
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Figure 3.13 Western blot for Cdkn1c in 5D3 and wild type (WT) P7 iBAT lysates. The presence of the BAC in 
5D3 was confirmed to result in over-expression of Cdkn1c. Sample amounts were normalised through β- Actin 
control.  
        
 
Effect of Cdkn1c over-expression in iBAT 
           
                   To begin the characterisation of the consequences of over-expressing Cdkn1c in iBAT, the 
weights of P7 iBAT from line 5D3 and line 5A4 were obtained. As a percentage of total body weight, 
both 5D3 and 5A4 iBAT depots was found to be significantly heavier than wild type iBAT depots 
(Fig 3.14).  
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Figure 3.14 Weight of iBAT pad taken from P7 pups, presented as a percentage of total body weight. Both 5D3 
and 5A4 pads constituted a significantly larger portion of total body weight than wild type mice. * P≥0.05. ** 
P≥0.01. Statistical analysis was performed by Students t-test. Error bars represent standard error. N=20+18+8 
 
                      In order to further explore the consequences of increased Cdkn1c dosage on iBAT, pads 
were fixed, sectioned and subjected to histological analysis. H+E staining was performed on both 
Cdkn1c over-expressing lines, in addition to wild type and 10-15 controls (Fig 3.15). The tissue in all 
genotypes was constituted by multi-locular classic brown adipocytes. No detectable differences could 
be seen between the 10-15 and wild type sections. 5D3 and 5A4 sections appeared generally darker in 
colour as compared to wild type, most noticeably so in the 5A4 image. In addition, images of 5D3 and 
5A4 iBAT appeared to contain more cells in a given area. To confirm this observation, cell counting 
was performed on the H+E images. Both 5D3 and 5A4 iBAT were found to contain significantly 
more cells than wild type (Fig 3.16). 
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Figure 3.15 H+E of transgenic P7 iBAT sections at 20X magnification, photographed under standard light field 
conditions. 5D3 and 5A4 brown adipocytes appeared more numerous and the tissue appeared darker in colour 
than wild type or 10-15 sections, which were not discernible from one another. Scale bar represents 50 μm 
 
 
Figure 3.16 Cell counting performed on H+E images of P7 iBAT. Both 5D3 and 5A4 iBAT were found to 
possess significantly more cells per image than wild type tissue. ** P≥0.01. Statistical analysis was performed 
by Students t-test. Error bars represent standard error. N: 8+8+8. Area of image: 160,000 µm2. 
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                      In summary, upon completion of these initial observations, Cdkn1c expression was 
shown to be elevated in iBAT from the experimental lines and this increased dosage was associated 
with a larger brown adipose deposit.  Furthermore, the results were consistent with increased 
cellularity, as opposed to an increase in the amount of lipid stored.  
 
 
Cellular expression of Cdkn1c in iBAT 
     
             In situ hybridisation was performed on paraffin embedded sections from P7 wild type and 
5D3 iBAT (Fig 3.17). The expression pattern found was consistent with the LacZ staining (Fig 3.12a), 
where only a sub-set of cells were positive for expression. Cell counting of wild type images 
demonstrated that less than 5% of cells within the wild type tissue were found to be Cdkn1c positive 
(Fig 3.18). Both 5D3 and 5A4 sections were found to possess a greater percentage of Cdkn1c positive 
cells, although only 5A4 achieved significance (Fig 3.18).  
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Figure 3.17 In situ hybridisation for Cdkn1c of 5D3 P7 iBAT sections, photographed under standard light field 
conditions. Expression of Cdkn1c was detected in a sub-population of cells within the tissue. Scale bars 
represent 200 μm (4X) and 100 μm (10X) 
 
 
 
Figure 3.18 Counting of Cdkn1c positive cells within P7 iBAT from In situ hybridisation. Less than 1% of cells 
were found to express Cdkn1c. Error bar represents standard error. N=6+6+6. 
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QPCR analysis of Cdkn1c over-expressing iBAT 
 
               cDNA was generated from iBAT and QPCR analysis was performed on genes associated 
with brown adipogenesis (Fig 3.19). While Ucp-1 and Cidea were not significantly increased in 5D3 
iBAT at this time point, PGC-1α and Elovl3 were. All four genes were found to be further elevated in 
line 5A4, indicating a dosage dependent phenotype. The results of the 5A4 analysis, together with a 
lack of amplification of the thermogenic programme in the 10-15 reporter line, excluded the 
possibility of a phenotype having arisen as a result of an insertion event. It should be noted at this 
stage that while Cdkn1c was only found to be expressed within a subset of cells in the interscapular 
brown adipose tissue, the four genes analyzed, that were involved in the thermogenic programme, 
would be uniformly expressed throughout the tissue, and therefore the cell number differences already 
described would not affect these results (Fig 3.16). 
 
 
Figure 3.19 QPCR analysis of transgenic P7 iBAT. 5D3 and 5A4 were shown to possess an enhanced 
thermogenic program, which was not the case for 10-15. Amplification of thermogenic genes occurred in a 
dosage dependent manner. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Mann Whitney test. * P< 0.05. ** P< 0.01. N=4+4+4+4 
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                     Beyond the examination of genes associated with the thermogenic programme, key 
regulators of lipid storage and mitochondrial content were analysed (Fig 3.20). Expression of Fsp-27 
was reduced in 5D3 and 5A4 iBAT whereas expression of aP2 was increased. Perilipin expression 
was also elevated in 5D3 and 5A4 lines. Given the known role of Perilipin in lipolysis and lipid 
mobilisation, to provide the fuel for heat generation 163; 199; 200, this elevation in expression was 
consistent with an enhanced thermogenic programme. 
                  H+E staining of iBAT sections (Fig 3.15) had previously revealed a darker brown colour 
in the transgenic mice which might reflect increased mitochondrial content. Cox II levels were 
increased in both 5D3 and 5A4 mice, with no changes in Cytochrome C levels in either line. 
Cytochrome C is encoded by the nuclear genome while Cox 2 is transcribed off the mitochondrial 
genome. To ascertain whether these changes in gene expression related to a change in mitochondrial 
copy number, gDNA QPCR analysis of iBAT pads was performed (Fig 3.21). The increased 
amplification of Cox 2 observed from 5D3 and 5A4 iBAT gDNA corroborated the changes that were 
seen in the cDNA analysis.        
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Figure 3.20 QPCR analysis of transgenic P7 iBAT cDNA. 5D3 and 5A4 were shown to possess an enhanced 
mitochondrial program. Large induction of Perilipin was believed to relate to increased lipid turnover within the 
adipocytes. Limited amplification of lipid accumulation and mitochondrial genes was observed. Error bars 
represent standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P< 0.05. ** 
P< 0.01. N= 4+4+4 
 
 
Figure 3.21 QPCR analysis of transgenic P7 iBAT gDNA. Total cellular Cox 2 content, compared to nuclear 
gDNA, was increased in 5D3 and 5A4. Error bars represent standard error of fold changes. Statistical analysis 
was performed by Mann Whitney test. * P< 0.05. N= 4+4+4 
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              All experiments so far performed suggested that the increased dosage of Cdkn1c enhanced 
brown adipogenesis. Further investigation into the expression levels of key adipogenic regulators was 
performed in order to gain insight into the mechanism by which this process was occurring (Fig 3.22). 
Neither pRb nor PPARγ were altered in the 5D3 or 5A4 iBAT. However both C/ebpβ and Prdm16 
displayed increased expression in 5D3 and 5A4 iBAT. These two genes have been shown to be 
critical to the formation of brown adipose tissue, and were also demonstrated to be binding partners in 
brown adipogenesis 156. Further to these genes C/ebpα, a downstream family member of C/ebpβ, was 
also found to be elevated in both 5D3 and 5A4 iBAT. Finally, the nuclear co-repressor Rip140 was 
found to be modestly elevated in 5D3 and 5A4 iBAT. 
 
Figure 3.22 QPCR analysis of transgenic P7 iBAT cDNA. 5D3 and 5A4 displayed modest amplification of 
certain adipogenic regulators. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Mann Whitney test.  * P< 0.05. N= 4+4+4 
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Cdkn1c functions with Prdm16 and C/EBPβ in iBAT 
       
                  As a result of the previously described roles of Prdm16 and C/ebpβ in brown adipogenesis 
156 the dosage dependent increases in these two genes that were found in 5D3 and 5A4 iBAT were 
further explored at the protein level. Analysis of 5D3 iBAT was performed through Western blotting 
of Prdm16 and C/ebpβ proteins (Fig 3.23), in order to corroborate the changes that were observed at 
the mRNA level (Fig 3.22). Prdm16 Western indicated increased levels of the protein in 5D3 iBAT, 
when compared to wild type. Further Western blotting including 5A4 iBAT demonstrated a Cdkn1c 
dosage related increase in Prdm16 protein (Fig 3.24). Total C/ebpβ protein levels were comparable to 
wild type. The fold change observed for the mRNA was comparatively modest (1.28 ± 0.049), and 
therefore the Western blot may have been insufficiently sensitive to detect this difference. In reference 
to the phosphorylated form of C/ebpβ, unaltered levels in the 5D3 iBAT from wild type again 
suggested that Cdkn1c does not play a role in regulating the phosphorylation state of C/ebpβ.  
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Figure 3.23 Western blotting for Prdm16 and C/ebpβ proteins in 5D3 P7 iBAT lysates. Levels of 
phosphorylated and total C/ebpβ were not seen to be altered in transgenic samples from wild type. Prdm16 
protein content was increased in 5D3. The blot produced a double band that had not previously been reported. 
The nature of this band has not yet been elucidated. Sample amounts were normalised through β- Actin control.  
 
 
                           
 
 Figure 3.24 Western blot for Prdm16 protein in P7 iBAT lysates. Prdm16 content was increased in a dosage 
dependent manner in transgenic iBAT.  Sample amounts were normalised through β-Actin control.  
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Co-localisation of Cdkn1c and Prdm16 proteins in iBAT 
 
                  The qPCR analysis and Western analysis of Cdkn1c-m/+p and BAC transgenic iBAT 
suggested a potential relationship between Cdkn1c and Prdm16. Fluorescent immunohistochemistry 
(Fig 3.25) was performed on P7 wild type iBAT to explore this relationship further. Cdkn1c 
expression seen by in situ (Fig 3.17), was detected in only a sub-set of cells. However, there appeared 
to be two separate populations that expressed Cdkn1c. The main population, that expressed the gene at 
low levels, and a much rarer cell that expressed the gene very highly (data not shown). By 
immunofluorescence, this very rare single cell was observed, highlighted by white arrows, that was 
found to fluoresce for Cdkn1c and Prdm16 expression more highly than surrounding cells. A high 
magnification image of this cell (Fig 3.25) confirmed overlapping expression of the two proteins, and 
this expression was found to be nuclear. This cell type that displayed overlapping nuclear expression 
of Cdkn1c and Prdm16 was also found to be BrdU label-retaining in a long term study (Fig. 3.26). 
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Figure 3.25 Fluorescent Immunohistochemistry of Wild type P7 iBAT for Cdkn1c and Prdm16 expression with 
the tissue. Elevated Cdkn1c expression was observed in a subset of cells while Prdm16 expression was observed 
throughout the tissue. A single cell was found to display overlapping Cdkn1c and Prdm16 expression 
(highlighted by arrows) at high levels.  
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Figure 3.26 Fluorescent immunohistochemistry of wild type P56 iBAT. High magnification image of the single 
cell which displayed over-lapping expression of both Cdkn1c and Prdm16, and was found to be BrdU label-
retaining. Other cells were not found to be BrdU positive. 
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Discussion 
 
Cdkn1c was shown to expressed and imprinted in a small population of cells within post natal 
iBAT. Using both loss-of-function and gain-in-expression models, a critical and dosage-related 
function for Cdkn1c in brown adipogenesis was identified.  
In the loss-of-expression model, an almost complete absence of Ucp-1 protein suggested that 
the tissue was largely thermogenically inactive (Fig 3.10). A lack of thermogenesis would account for 
the increased lipid content of Cdkn1c deficient iBAT (Fig 3.4). Without the uncoupling of the electron 
transport chain, use of lipid energy stores would have been reduced, resulting in the observed build 
up. Due to the neonatal lethality and other developmental abnormalities associated with loss-of-
function of Cdkn1c, it was not possible to determine whether the alterations in iBAT would result in a 
lower body temperature but this seems a likely conclusion. Such work will require the development of 
a conditional Cdkn1c allele and suitable cre-expressing lines. 
              In terms of the mechanism for loss of iBAT in Cdkn1c-m/+p pups, there was an association 
between Cdkn1c dosage and C/ebpβ expression, both at the mRNA and protein level. The phenotype 
of the Cdkn1c loss-of-expression iBAT could be attributed to loss of C/ebpβ expression (Fig 3.8, 
3.11) which has been shown to result in a failure in iBAT differentiation 148. Mirroring this effect, 
increased Cdkn1c expression in the 5D3 and 5A4 lines resulted in enhanced C/ebpβ expression at the 
mRNA level (Fig 3.22). The increase in mRNA was not apparent at the protein level although 
Western blotting is not a sufficiently sensitive a method for detecting such subtle changes in 
expression (Fig 3.23). In addition to directly or indirectly regulating C/ebpβ transcription, Cdkn1c 
might have been involved in regulating phosphorylation state of C/ebpβ since a similar function has 
already been assigned to p27KIP1 201. This CDKi protein family member was found to maintain the un-
phosphorylated state of C/ebpβ, thereby preventing protein di-merisation and G1/S phase progression. 
Cdkn1c could also have been anticipated to play a similar role. However, this was found not to be the 
case. While deficiency of the Cdkn1c would be predicted to result in hyper-phosphorylation of 
C/ebpβ, instead. Cdkn1c-m/+p iBAT, lysates were essentially devoid of detectable phosphorylated 
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C/ebpβ (Fig 3.11). It was essential to bear in mind that the total pool of protein was also shown to be 
reduced, thereby limiting the available target to be phosphorylated (Figure 3.11). With this in mind 
though, there remained still a sizable target population, and had Cdkn1c been negatively regulating 
the phosphorylation events, it would certainly have been expected that at least some of the population 
would be found in this phosphorylated state. In addition, in the reciprocal scenario, elevated Cdkn1c 
would be predicted to result in hypo-phosphorylation of C/ebpβ, Such a change in the 
phosphorylation state of C/ebpβ in 5D3 iBAT was not apparent (Fig 3.23). These data suggest that it 
is unlikely that Cdkn1c regulates the phosphorylation of C/ebpβ in iBAT.  
  Loss of Cdkn1c in iBAT also showed striking phenotypic similarities to loss of expression of 
the brown fat determinant, Prdm16 154. Furthermore, the immuno-fluorescence (Fig 3.25-26) 
demonstrated co-localisation of Cdkn1c and Prdm16 to the nucleus of a discrete population of iBAT 
cells which could indicate an interaction. Prdm16 mRNA expression was not disrupted as a 
consequence of the loss of Cdkn1c in iBAT and Prdm16 mRNA was only slightly higher in response 
to elevated Cdkn1c expression (Fig 3.8, 3.22). However, detectable differences in Prdm16 protein 
content were observed in both models. Western blot Cdkn1c-m/+p iBAT lysates detected reduced 
Prdm16 protein (Fig 3.11), while 5D3 and 5A4 iBAT was shown to exhibit elevated Prdm16 content 
(Fig 3.23-24). This disparity between Prdm16 mRNA and Prdm16 protein in the models was 
consistent with a role for Cdkn1c in the post-transcriptional stabilisation of Prdm16. A previous study 
has shown that Cdkn1c direct binds to and stabilises MyoD protein promoting the development of 
skeletal muscle 100; 202. A similar function could be suggested for Cdkn1c in the formation of brown 
adipose tissue through the stabilisation of Prdm16. Both skeletal muscle and brown adipose share a 
myogenic lineage, and the data generated would now implicate Cdkn1c as contributing to the 
formation of both tissue types. Expression of MyoD protein results in skeletal muscle formation, 
while Prdm16 protein will produce brown adipose tissue, and both proteins can therefore be termed 
“molecular switches” towards their respective cell type. Cdkn1c on the other hand, does not appear to 
function as a switch in this molecular determination since it seems to act in both lineages. Instead, 
certainly from the brown adipose perspective, the gene appears to function as an augmenter of an 
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already established cell fate (Fig 3.26). This theory is supported by the 5D3 and 5A4 iBAT, where an 
enhancement of the brown adipogenic phenotype was observed.             
 
Figure 3.26 Possible role of Cdkn1c in determining myogenic lineage cell fate. Cdkn1c acts to stabilise both 
MyoD and Prdm16, providing an augmentation of both the skeletal muscle and brown adipogenic pathways. 
 
            The in situ hybridisation of Cdkn1c expression within the iBAT displayed expression in only a 
subset of cells (Fig 3.17). This population of cells was expanded under the increased Cdkn1c dose in 
iBAT (Fig 3.18). Although not investigated further in this thesis, this population may represent a pre-
cursor cell. The immunofluorescence of the iBAT (Fig 3.24-25) demonstrated a very rare cell type 
that was expressing Cdkn1c and Prdm16, which was a label-retaining cell. This was in addition to the 
in situ data that highlighted a greater population of cells that was Cdkn1c positive, at much lower 
levels. Thus our preliminary data suggest that Cdkn1c marks two populations of cells within the 
brown adipose tissue, those that are Cdkn1c-only positive, and a much rarer population that co-
express Cdkn1c and Prdm16, which may represent the brown adipose stem cell. This subject will be 
discussed in greater detail in the final discussion.   
                   This work identified a key role for Cdkn1c in the classic brown adipose lineage most 
likely through regulation of Prdm16. Brown adipose tissue is also present within white adipose 
depots. This non-classical lineage is thought to arise from a different precursor to iBAT which does 
not express Myf5 and the role of Cdkn1c in this lineage is explored in the next chapter.  
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Chapter 4: Cdkn1c in white adipogenesis 
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Cdkn1c expression in white adipose tissue 
                The previous chapter focused exclusively on Cdkn1c expression within the classic 
interscapular brown adipose depot. In the absence of expression of Cdkn1c, cells were poorly 
differentiated and were found to be lacking in the thermogenic programme. Use of the 
Cdkn1c over-expression lines demonstrated that elevated expression enhanced the 
thermogenic programme in a dosage dependent manner. Work has suggested that populations 
of brown adipocytes are found contained with the white adipose depots (reviewed 125). It is 
believed that this cell type may represent a different lineage to those cells within the iBAT. 
While iBAT cells are found to be Myf5+ 154, brown adipocytes found in the white adipose 
depots are believed to be Myf5- 156 (reviewed 193). The next focus point was to determine if 
Cdkn1c had a role in regulating the brown adipocytes found within white adipose tissue. 
                     Cdkn1c expression within the white adipose tissue was not known upon 
commencement of these studies. RFLP analysis had demonstrated a detectable level of 
Cdkn1c in the rWAT depot and that the gene was imprinted (Fig 3.1). In situ hybridisation 
was performed on P7 wild type rWAT. Expression of Cdkn1c was confirmed in the rWAT, 
however and as had been the case for the iBAT, expression was only detected in a sub-set of 
cells (Fig 4.1). The 10-15 reporter line was again utilised to ask whether Cdkn1c was 
expressed from the transgene. Expression was only detected in a sub-set of cells (Fig 4.2), 
consistent with the in situ image.  
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Figure 4.1 In situ hybridisation for Cdkn1c of wild type P7 rWAT sections, photographed under 
standard light field conditions. Only a sub-population of cells within the tissue were found to express 
Cdkn1c. Scale bar represented 50 μm. 
 
 
Figure 4.2 LacZ staining of whole 10-15 reporter line P7 rWAT, photographed under standard light 
field conditions. Positive blue staining represented a sub-population within the adipose tissue of cells 
expressing Cdkn1c. Surrounding white adipocytes were not found to be expressing the gene. No 
staining was observed in wild type adipose pads. 
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                  Expression of Cdkn1c, both endogenously and from the transgene, had now been 
confirmed in the rWAT depot through in situ hybridisation and lacZ staining (Fig 4.1-2). 
QPCR analysis was performed to ask whether or not the experimental transgenic lines 5D3 
and 5A4 over-expressed Cdkn1c which would therefore allow the study of the consequences 
of increased Cdkn1c expression in this white adipose depot. As can be seen below (Fig 4.3), 
over-expression of Cdkn1c was found in both the 5D3 and 5A4 lines at a similar level to the 
over-expression observed in iBAT. Critically, no increase in Cdkn1c expression was observed 
in the 10-15 rWAT. Western blotting for Cdkn1c was used to demonstrate that there was 
increased Cdkn1c protein, with increased signal in 5D3 lysates as compared to wild type (Fig 
4.4).   
 
Figure 4.3 qPCR analysis of Cdkn1c expression in transgenic p.7 rWAT cDNA. 5D3 and 5A4 were 
both found to over-express Cdkn1c compared to wild type, while 10-15 did not. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P<0.05, ** 
P<0.01. N=4+4+4+4. 
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Figure 4.4 Western blot for Cdkn1c in 5D3 P7 rWAT lysates. Elevated detection of the protein was 
found in 5D3 males and females, compared to wild type littermates. Sample amounts were normalised 
through β-Actin control.  
 
 
Increased Cdkn1c alters normal white adipose tissue 
              Upon confirmation that the transgenic lines could be employed to study the 
consequences of Cdkn1c over-expression in a white adipose tissue depot, rWAT pads from 
the transgenic lines were subjected to sectioning and H+E staining. Both wild type and 10-15 
sections were populated primarily by uni-locular white adipocytes with few regions with a 
BAT-like appearance. In contrast 5D3 and 5A4 rWAT sections, although also containing uni-
locular cells, were found to contain more extensive areas of multi-locular cells (Fig 4.5). 
Under higher magnification, these cells were found to more closely resemble brown 
adipocytes (Fig 4.6).  
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Figure 4.5 H+E staining of transgenic P7 rWAT sections, photographed under standard light 
microscopy. Wild type and 10-15 sections revealed a uniform tissue comprised of unilocular white 
adipocytes. 5D3 and 5A4 sections meanwhile presented with both unilocular and multi-locular 
adipocytes. Scale bar represented 50 μm.  
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Figure 4.6 High magnification image of 5D3 multi-locular white adipocytes. Almost all cells within the 
field of view were found to be multi-locular. Wild type and 10-15 samples did not present with such 
cells. Scale bar represents 50 μm. 
 
                 To shed further light on the observed differences, transmission electron microscopy 
was performed on sections from P7 rWAT. This technique allowed resolution of the cells at 
far higher magnification, clearly displaying any morphological discrepancies.  Seen below are 
adipocytes from wild type and 5D3 P7 rWAT (Fig 4.7). In the wild type image, the membrane 
of two separate cells can be seen bordering one another. A thin segment of cytosolic region 
could be observed within each membrane; however the huge majority of the cell volume was 
occupied by the white unilocular lipid droplet. Near the bottom right of the image, the 
flattened nucleus of the upper adipocyte could be seen. From the 5D3 image, the multi-locular 
nature of the lipid stores was clearly resolved, confirming observations from the H+E images 
under light microscopy. A far larger cytosolic region could also be seen. 
        Contained within this cytosolic space is the mitochondrial population, seen as the dark 
organelles. While mitochondria were apparent within both wild type and 5D3 adipocytes (Fig 
4.7), they were more abundant in 5D3 adipocytes and this was observed in different sections 
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from different experimental animals where clusters of these abundant mitochondria was 
observed.  
  
 
Figure 4.7 TEM images of wild type (left) and 5D3 (right) p.7 white adipocytes from the 
retroperitoneal adipose pad, imaged at 4000X magnification. Unilocular white adipocytes were 
observed in the wild type rWAT, while 5D3 adipocytes were found to be multi-locular. Performed by 
Dr. Anthony Hann. 
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Induction of thermogenic genes 
 
                 In the previous experimental chapter, over-expression of Cdkn1c resulted in an 
amplification of the brown adipocyte gene program including increase Ucp-1 expression. The 
increased prevalence of brown-adipocyte-like cells in 5D3 rWAT alongside the multi-locular 
cells and increased mitochondrial content (Fig 4.7) suggested Cdkn1c functioned to drive the 
accumulation of brown adipose in the white adipose depot. To determine whether such an 
event had taken place, QPCR analysis of thermogenic genes was performed on P7 rWAT 
obtained from females for the different transgenic lines. Elevated Ucp-1 expression was 
detected in 5D3 (10-fold) rWAT, which was further elevated in 5A4 (23-fold). PGC-1α, 
Cidea and Elovl3 were also expressed more highly in transgenic rWAT than in wild type. 
Crucially 10-15 rWAT was not found to possess elevated levels of any of the genes analyzed 
(Fig 4.8). QPCR analysis was performed on subcutaneous white adipose tissue (Fig 4.8- 
purple) and 5D3 males (supplemental data), where increased expression of the thermogenic 
programme genes was also present.  
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Figure 4.8 QPCR analysis of female transgenic P7 rWAT cDNA. 5D3, 5A4 and 5D3 subcutaneous 
(purple) were shown to possess an enhanced thermogenic program, which was not the case for 10-15. 
Amplification of thermogenic genes occurred in a dosage dependent manner. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P< 0.05. ** 
P< 0.01. N=4+4+4+4 
 
   Disruption of adipogenic genes             
 
                     Increased dosage of Cdkn1c was found to be associated with increased 
expression of genes associated with brown adipocytes and an active thermogenic programme, 
in both iBAT and now rWAT. Further to this, the histology performed on 5D3 rWAT 
identified regions of cells within the pad that were multi-locular with increased mitochondria 
(Fig 4.5-7). With this in mind, QPCR analysis of lipid accumulation and mitochondrial genes 
was performed. All three of Fsp-27, Perilipin and aP2 were found to have reduced expression 
levels in 5D3 rWAT. In addition, Cytochrome C and Cox 2 were both found to be elevated. 
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This was consistent with the TEM images that appeared to show an increased mitochondrial 
population in 5D3 white adipocytes.  
 
 
Figure 4.9 QPCR analysis of adipogenic regulators and lipid accumulation genes within 5D3 P7 rWAT 
cDNA. Lower expression of all three lipid accumulation genes measured was observed. Adipogenic 
regulators, with the exception of PPARγ whose expression was reduced, were found to possess 
elevated expression levels. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Mann Whitney test. * P< 0.05. ** P< 0.01. N=4+4 
 
       
                  Next QPCR of adipogenic regulators was performed (Fig 4.10). pRb expression 
was unchanged, however PPARγ was found to be significantly down-regulated. This change 
was consistent with the reduced expression level of the lipid accumulation genes observed at 
the same time-point (Fig 4.9), as PPARγ represents the master adipogenic regulator 203; 204. 
C/ebpα displayed a modest increase in expression. Brown adipogenic regulators C/ebpβ, 
Prdm16, Rip140 and PPARα were all found to be significantly up-regulated in 5D3 P7 rWAT. 
These increases were largely consistent with a brown adipocyte phenotype.  
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Figure 4.10 QPCR analysis of brown adipogenic and mitochondrial markers, in 5D3 P7 rWAT cDNA. 
Both sets of genes were found to be increased, compared to wild type levels. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P< 0.05. ** 
P< 0.01. N=4+4 
 
 
Cdkn1c acts through C/ebpβ and Prdm16 
 
                     Due to the amplification of the thermogenic programme, and as had been the 
case for the iBAT studies, exploration of C/ebpβ (Fig 4.11) and Prdm16 (Fig 4.12) protein 
levels was performed. Total C/ebpβ levels in the 5D3 rWAT were consistent with the QPCR 
data (Fig 4.10). Levels of phosphorylated protein were unchanged from those in the wild type 
(Fig 4.11). 
                  Prdm16 has previously been shown to not be detectable at the protein level 
through Western blotting in mouse visceral adipose tissue 205. This was confirmed in P7 wild 
type rWAT (Fig 4.12), in both male and female depots. In addition, Western blotting for Ucp-
1 was performed, with no detectable protein in the male sample, while trace amounts were 
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observed in the female white adipose tissue (Fig 4.12). 5D3 male and female mice differ from 
the wild type, in that both Prdm16 and Ucp-1 proteins were detectable in male and female 
rWAT.      
 
 
 
Figure 4.11 Western blotting for C/ebpβ protein in 5D3 p.7 rWAT lysates. Levels of phosphorylated 
C/ebpβ were not seen to be altered in transgenic samples from wild type. Greater detection of total 
C/ebpβ however were observed in the tissue Sample amounts were normalised through β-Actin control.  
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Figure 4.12 Western blot for Prdm16 and Ucp-1 proteins in 5D3 P7 rWAT lysates. Prdm16 and Ucp-1 
protein were detected in both male and female 5D3 samples, and were largely absent from the wild 
type lanes, although trace amounts of Ucp-1 were found in the female wild type sample. Sample 
amounts were normalised through β-Actin control.  
 
                  Results presented thus far implicated a role for Cdkn1c in the enhancement of a 
brown adipose phenotype in both the classic brown depot and also within the white adipose 
tissue. However, the BAC transgene drives expression of Cdkn1c at other sites including the 
hypothalamus, the adrenal gland, the pancreas and the pituitary gland 106, all known to play a 
role in regulating metabolism. As a result, ex vivo studies were performed in order to ask 
whether the amplification of the brown adipose gene program was due to the intrinsic action 
of Cdkn1c within adipose or due to expression elsewhere. Mouse embryonic fibroblasts 
(MEFs) from E12.5 embryos when exposed to a cocktail of hormones are forced to 
differentiate down the adipocyte lineage, towards a white adipose phenotype (reviewed 133).  
Thus by examining MEFs from the transgenic lines, the results obtained could be exclusively 
attributed to altered dosage of Cdkn1c in the adipocytes. In addition, this technique presented 
the opportunity to study the consequences of loss of expression of Cdkn1c on adipocyte 
differentiation in vitro. 
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Ex-vivo: Mouse Embryonic Fibroblast (MEF) culture to adipocytes 
 
                   As a means of determining whether the phenotype was intrinsic to adipose, MEFs 
were isolated from wild type, 5D3, Cdkn1c-m/+p and 5D3/ Cdkn1c-m/+p (double transgenic = 
'rescue’) E12.5 embryos obtained by crossing a 5D3 male with a Cdkn1c+m/-p male, and 
subjected to the differentiation protocol. After 8 days being subjected to differentiation media, 
cells were fixed and stained with Oil Red O. As can be observed below, all genotypes studied 
underwent differentiation to adipose-like cell, demonstrated by the accumulation of lipid in 
each sample (Fig 4.13).  
         
 
Figure 4.13 Oil Red O stained day 8 MEF induced-adipocytes. MEFs from wild type, 5D3, Cdkn1c 
knockout and Rescue all differentiated into mature adipocytes. Undifferentiated MEFs appeared blue 
from haematoxylin staining.   
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            Further light microscopic analysis of the MEFs was performed through the use of 
confocal microscopy. Day 8 culture plates were stained using Rhodamine-123 (Sigma), a 
mitochondrial stain, with individual mitochondria were seen as a lighter green colour 
compared to the darker green non-specific binding. HCS CellMask Red (Invitrogen), a cell 
membrane stain, and Hoechst 33342 (Invitrogen) were also used. In all three genotypes 
studied, unstained lipid globules (black) were observed in the cytosol. Regarding 
mitochondrial staining, no marked differences were observed between the wild type and 
Cdkn1c-m/+p images in mitochondrial staining whereas there appeared to contain more 
mitochondria in 5D3 MEFs. Higher magnification images of the 5D3 MEFs confirmed that 
the signal of Rhodamine-123 was associated with mitochondria (Fig 4.14). These 
mitochondria were so large that, in some cases, the two sides of the mitochondrial membrane 
surrounding the matrix were observable. It was not possible to find similar large Rhodamine-
123 staining organelles in the wild type or the Cdkn1c+m/-p cells. This suggested that 
mitochondria were both more frequent and much larger in 5D3 cells. This was consistent with 
the observations made by EM (Fig 4.7).  
 120
 
Figure 4.14 Confocal microscopy of day 8 MEF- induced adipocytes. Individual adipocytes were 
imaged in wild type, 5D3 and Cdkn1c-m/+p cultures. Lipid droplets were not stained and so appear 
black. Mitochondrial population (Rhodamine-123, Sigma) was stained green and detectable in all 
genotypes. Higher magnification imaging of mitochondria within 5D3 adipocytes enabled the 
resolution of the mitochondrial matrix, which was not possible in the other genotypes. Nuclei can be 
seen in blue (Hoechst 33342, Invitrogen) while cell membrane was stained red (HCS CellMask Red, 
Invitrogen). 
 
            Next QPCR analysis of differentiating MEFs was performed. By including the 
‘rescue’ genotype in which both the single copy transgene and a targeted deletion of the 
endogenous maternal allele were present, any changes in 5D3 adipocyte gene expression 
could be attributed to endogenous Cdkn1c expression by comparing data from these ‘rescue’ 
MEFs with the single transgenic MEFs and wild type MEFs. Expression of Cdkn1c was 
examined in these samples, and also in wild type and 5A4 differentiated MEFs. 5D3 MEFs 
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over-expressed Cdkn1c at day 8 of differentiation at levels similar to that observed in vivo 
(1.33-fold wild type ± 0.14 P=0.029). 
               An expression profile for Cdkn1c during the eight days of differentiation was 
generated for wild type MEFs. Cdkn1c was rapidly induced upon differentiation, with day 2 
and day 4 represent peak expression levels, both around forty five-fold higher than the day 0 
levels. Expression was decreased by day 8 but was still significantly higher than in confluent, 
undifferentiated MEFs (Fig 4.15).  
 
Figure 4.15 Expression profile of Cdkn1c during wild type MEF differentiation. Fold changes were 
determined with respect to expression level at day 0. Error bars represent standard error of fold 
changes. N=4+4+4+4 
 
              Analysis of the expression of the four key genes associated with brown adipogenesis 
was performed. As seen in the graph, Ucp-1 levels in 5D3 MEFs at day 8 were elevated 
compared to those of wild type. PGC-1α, Cidea and Elovl3 were also elevated. A dosage 
dependent phenotype, as previously noted in vivo (Fig 4.8), was also found in 5A4 MEFs at 
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day 8. When the ‘rescue’ MEFS (red) were analysed, gene expression was similar to wild 
type thus assigning these changes to elevated Cdkn1c and excluding a role for other genes on 
the BAC or a site of integration effect (Fig 4.16). Cdkn1c-m/+p MEFs, although demonstrating 
a varied range of expression for thermogenic genes, were not found to possess increased Ucp-
1 mRNA levels.  
 
      
Figure 4.16 QPCR analysis of thermogenic program genes in transgenic day 8 differentiated MEFs. 
Genes were elevated in a dosage dependent manner in 5D3 and 5A4 MEFs, while Cdkn1c+m/-p samples 
displayed reduced expression of some genes. This was rescued by the presence of the BAC (red). Error 
bars represent standard error of fold changes. Statistical analysis was performed by Mann Whitney test. 
* P< 0.05. ** P< 0.01. N=4+4+4+4 
 
                   The induction of the thermogenic gene programme in the presence of excess 
Cdkn1c was confirmed in MEFs through Western blotting. Ucp-1 was detectable in 5D3 
MEFs, but not in wild type (Fig 4.19). The level of amplification of the four genes analysed 
by QPCR was consistent with those seen in vivo (Fig 4.8). Next, QPCR analysis of lipid 
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accumulation and mitochondrial genes was performed on 5D3 and Cdkn1c-m/+p day 8 MEFs. 
These genes had been studied in vivo, and therefore it was important to confirm if an over-
lapping pattern of expression was observed. Both 5D3 and Cdkn1c-m/+p MEFs displayed 
significant down-regulation of lipid accumulation genes. For 5D3 MEFs, this pattern of 
expression was similar to that observed in vivo data for these three genes (Fig 4.9). 
Meanwhile increased expression of mitochondrial genes was detected in 5D3 MEFs, while 
decreased expression was found in Cdkn1c-m/+p MEFs (Fig 4.17). 
 
 
Figure 4.17 QPCR analysis of lipid accumulation and mitochondrial genes in transgenic day 8 
differentiated MEFs. Expression of lipid accumulation genes was impaired in both 5D3 and Cdkn1c-
m/+p MEFs. 5D3 mitochondrial genes were elevated, while Cdkn1c-m/+p were reduced in expression 
level. Error bars represent standard error of fold changes. Statistical analysis was performed by Mann 
Whitney test. * P< 0.05. N=4+4 
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              To complete the QPCR analysis of these MEFs, adipogenic regulators were studied, 
with the same genes targeted as was done for in vivo. 5D3 MEFs displayed significant down-
regulation of the adipogenic regulators PPARу and C/ebpα, but not pRb. The brown 
adipogenic regulators C/ebpβ and Prdm16 were both elevated. In contrast, Cdkn1c-m/+p MEFs 
were not found to possess altered expression of pRb, C/ebpβ or Prdm16. However PPARу 
was down-regulated while C/ebpα was elevated (Fig 4.18).  
 
 
Figure 4.18 QPCR analysis of adipogenic and brown adipogenic genes in transgenic day 8 
differentiated MEFs. Restricted expression of 5D3 adipogenic genes was found, while brown 
adipogenic genes were elevated. No amplification of brown adipogenic genes was detected in 
Cdkn1c+m/-p MEFs, while correct expression of adipogenic genes was disrupted. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P< 0.05. 
N=4+4 
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Figure 4.19 Western blotting of Ucp-1 in differentiating MEF plates. Protein could be detected at low 
levels in 5D3 samples, where it was not seen in wild type. Sample amounts were normalised through β-
Actin control.  
        
                Regarding an in vivo versus ex vivo comparison, the  data set of fold changes were 
graphed together to provide a direct comparison (Figure 4.20), with 5D3 in vivo represented 
by the greens columns 5D3 ex vivo represented by the blue columns, 5D3 P7 iBAT 
represented by brown columns and Cdkn1c-m/+p iBAT represented by yellow columns. The 
fold changes represent original comparisons to the respective wild type data, and were 
otherwise unchanged. Statistical analysis was not performed as the groups are distinct from 
one another.  A relatively high degree of similarity was seen between the 5D3 iBAT, rWAT 
and MEF expression levels was observed, while little obvious pattern was observed in the 
Cdkn1c-m/+p iBAT.  
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Figure 4.20 Comparison of 5D3 day 8 differentiating MEFs (blue), 5D3 P7 rWAT (green), 5D3 P7 
iBAT (brown) and Cdkn1c-m/+p iBAT (yellow) expression of adipogenic genes. Expression levels 
represent expression; in comparison to their respective wild type. Error bars represent standard error of 
calculated fold changes. No statistical analysis was performed. 
 
 
 
                A final experiment for the 5D3 MEF culture was performed to explore the 
inducibility of the system, with regards to Ucp-1. Adipocytes differentiated from MEFs have 
previously been shown to be sensitive to retinoic acid, and upon treatment, express Ucp-1 206 
because retinoic acid is a positive regulator of Ucp-1 gene transcription 207; 208. QPCR 
analysis of the Retinoic Acid (RAR’s) and Retinoic X (RXR’s) receptors at day 8 of 
differentiation had shown a significant increase in all six receptors in 5D3 adipocytes (Fig 
4.21). D8 differentiated MEFs were therefore subjected to 0.1 µM retinoic acid treatment for 
48 hours, before cells were harvested. Western blot analysis of these time points clearly 
showed induction of Ucp-1 in both wild type and 5D3 MEFs, as was expected. 5D3 MEFs 
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however, displayed a greater signal of the protein than the wild type cells after 48hr treatment 
(Fig 4.22). 
 
Figure 4.21 Relative expression levels of Retinoic Acid (RAR) and Retinoid X (RXR) receptors in 5D3 
day 8 differentiating MEFs. All were found to be significantly up regulated at this time. Error bars 
represent standard error of calculated fold changes. Statistical analysis was performed by Mann 
Whitney test. * P< 0.05. N=4+4  
 
Figure 4.22 Western blot of Ucp-1 expression in day 8 MEFs subjected to 0.1μM Retinoic acid 
treatment for the given time periods. Ucp-1 was found to be induced in both genotypes, with a stronger 
detection at all time points in 5D3 samples.  Sample amounts were normalised through β-Actin control.  
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Discussion 
                    The ex vivo system for differentiating MEFs into adipocytes was extremely 
important for these studies, as they presented a system for studying the intrinsic effects of 
altering Cdkn1c dosage during adipogenesis. 5D3 MEFs at day 8 of differentiation were 
found to display a phenotype similar to that seen in vivo in rWAT (Fig 4.21), including 
detectable induction of Ucp-1 protein (Fig 4.19). In vivo Western blot analysis showed 
increased Prdm16 protein in response the elevated Cdkn1c dose, which was consistent with 
the induction of thermogenic genes. Although similar downstream changes in gene expression 
were apparent in the differentiated MEFs, Prdm16 protein was not detectable by Western 
(data not shown). Ucp-1 protein was only weakly detectable in D8 5D3 MEFs in contrast to 
the high level in 5D3 rWAT. It was seemed likely that the Western blot was insufficiently 
sensitive to detect Prdm16 protein.   
            The gene expression changes observed in the in vivo studies were similar to those 
obtained utilising 5D3 and 5A4 MEFs. While this work does not exclude a contribution of 
other sites of transgenic expression to the in vivo phenotypes described in chapter 3 and this 
chapter, this work did identify an intrinsic role for Cdkn1c in inducing brown adipogenesis. It 
should be noted however that although this protocol drives differentiation towards a white 
adipocyte phenotype, fibroblasts are a Myf5+ cell type. Normal white adipocytes are Myf5- 156, 
while brown adipocytes are Myf5+ 205, highlighting the limitations of this technique. Given the 
results presented in the previous chapter, where loss of Cdkn1c expression was shown to 
heavily impair the formation of brown adipocytes, the poor differentiation of MEFs in the 
absence of Cdkn1c cannot conclusively be stated as exclusively a white adipocyte phenotype. 
                    The in vivo data demonstrated a role for Cdkn1c within the white adipose depot. 
As had been the case in the iBAT, there was over-expression of genes in the 5D3 and 5A4 
lines and an increase in Prdm16 protein consistent with augmentation of the thermogenic 
programme (Fig 4.8). Prdm16 has also previously been shown to suppress the white adipocyte 
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phenotype, through binding partners CtBP1 and 2 155, consistent with the data generated for 
5D3 and 5A4 white adipose tissue, where expression of lipid accumulation genes and 
adipogenic markers were altered (Fig 4.9-10). Therefore it is possible that Cdkn1c may 
exclusively function in brown adipocytes purely by augmenting Prdm16 levels, thereby 
enhancing the brown adipocyte phenotype. However, Cdkn1c is a multifunctional protein and 
alterations in the timing of cell cycle exit, for example, may also account for some of the 
changes observed. 
               The MEF system also allowed insight into the consequences of loss of expression of 
Cdkn1c on adipogenesis. Although the Cdkn1c-m/+p MEFs did differentiate (Fig 4.13-14), the 
appearance of the cells, coupled with the QPCR data (Fig 4.16-18) suggested that this did not 
occur as normal and that adipogenesis was impaired. Reduced PPARу (Fig 4.18) expression 
could account for the impaired adipogenesis.  
               Prdm16 and Cdkn1c were found in the previous chapter to be co-expressed in the 
nucleus of a rare cell type within iBAT. In addition, Cdkn1c was also found to mark a 
separate population of cells, which did not co-express Prdm16 (Fig 3.24-25). Comparable 
immuno-histochemistry was not performed in the white adipocytes. However, the in situ 
hybridisation for Cdkn1c (Fig 4.1) also produced a restricted pattern of expression, as seen in 
iBAT (Fig 3.17). This sub-population of cells could be the iBAT progenitor population. The 
question arising from the rWAT in situ therefore is if Cdkn1c is marking the same population. 
It is now believed that populations of brown adipocyte-like cells exist within the white 
adipose depots (reviewed 125). Given the expression pattern seen in the rWAT and the data in 
this chapter showing an increase in brown adipose-like cells within rWAT, it is possible that 
Cdkn1c may be marking an iBAT progenitor population in WAT. One intriguing possibility is 
that, in addition to role in driving accumulation of Prdm16 protein and thus attenuating the 
brown fat gene program, elevated Cdkn1c also increases the number of iBAT progenitors in 
both iBAT, accounting for the increase mass and cellularity of this tissue, and in rWAT 
accounting for the presence of patches of BAT-like cells within the rWAT depot and 
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increased expression of the iBAT markers. Future studies using the transgenic models will be 
useful in testing this hypothesis.  
                 An increase in thermogenically active brown adipose is associated with obesity 
resistance 164; 209; 210; 211. Given that both the 5D3 and the 5A4 mice showed indications of 
increased brown fat, the next step was to ask whether these mice were resistant to either age-
induced or diet induced obesity. 
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Chapter 5: Consequences of over-expression of 
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Weight gain in Cdkn1c BAC transgenic mice. 
 
            The experiments described in Chapters 3 and 4 identified Cdkn1c as a novel regulator 
of both the classic brown adipose lineage and the non classic adipose lineage found within 
white adipose deposits. The data obtained was consistent with Cdkn1c enhancing the brown-
phenotype in both lineages at least in part through the stabilisation of Prdm16 protein. The 
interscapular brown adipose pad was found to be greater in mass with a higher cellularity in 
response to elevated Cdkn1c, alongside an enhanced thermogenic programme, while white 
adipose depots were found to contain a greater proportion of brown-like adipose. An 
increased proportion of thermogenically active brown adipose would be predicted to provide 
protection against obesity. In this chapter, an investigation of weight gain and glucose 
management was made in the context of both aging and a high fat diet in the over expression 
models. 
 
Fat pad mass in Cdkn1c BAC transgenic mice at 10 weeks of age maintained on a 
standard chow diet 
                             For the analysis, cohorts of mice from line 5D3 and line 5A4 were 
generated and maintained on a standard chow diet for 10 weeks. In previous work, transgenic 
mice from both these lines displayed a degree of post natal growth restriction on a mixed 
129/BL6 genetic background 107. Similar results were obtained when the weights of male and 
female transgenic mice was compared with wild type littermates on the ‘pure’ (>8 
generations) BL6 background (Table 2). 5D3 males were approximately 14% lighter than 
wild type males while 5A4 males were 18% lighter. 5D3 females were 14% lighter than wild 
type females and 5A4 females were 20% lighter.  
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 Table 2 Total body weights of 10 week old mice, housed under standard conditions. Statistical analysis 
was performed by Student’s t-test. 
  
             On dissection of the 10 week old female mice, the weights of the kidney and iBAT 
were found to be a similar proportion of total body weight for both lines, although 5D3 
kidneys were found to be significantly lighter than wild type. A comparable pattern was 
observed in the male transgenic lines (Fig 5.1). Results at P7 had demonstrated 5D3 and 5A4 
mice to possess significantly larger iBAT than wild type (Fig 3.14), a result that was not 
replicated at 10 weeks of age (Fig 5.1 (b)). H+E staining of 10 weeks brown adipose depots 
revealed a lower lipid burden in 5D3 female iBAT (Fig 5.2) which could account for the 
reduced overall mass of the iBAT at 10 weeks. 
                 On examination of the weight of the white adipose depots, female 5D3 mice had an 
overall reduction in total visceral weights of 37.1 % (± 4.38 %). Although statistically only 
the mesenteric white adipose depot was found to be significantly lighter in 5D3 females, all 
the other depots weighed showed a reduction in weight. In the case of line 5A4, the combined 
visceral adipose depots were 48.4 % (± 8.44 %) lighter than wild type and the reduction in 
weights of each depot with respect to wild type was significant, suggesting a dosage 
dependent reduction in white fat mass. Similarly 5D3 and 5A4 males were found to possess 
comparably lighter visceral adipose depots than wild type (Fig 5.1(a)). In contrast to the 
visceral depots, the subcutaneous white adipose tissue was not found to be significantly 
lighter in 5D3 or 5A4 females compared to wild type. A modest restriction was observed in 
Male  WT 5D3 5A4 
 Weight (g) 30.601 26.400 25.160 
 St. Error 0.510 1.04 0.340 
 P. Value  4.6*10-3 1.6*10-5 
 N 8 8 6
Female     
 Weight (g) 23.250 20.450 18.570 
 St. Error 0.350 0.390 0.750 
 P. Value  1.8*10-3 1*10-5 
 N 8 7 7
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5A4 males compared to wild type, but not in 5D3.                            
         
 
 
 
 
 
(a) 
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Figure 5.1 (a: males) (b: females): Wet weight of adipose pads at 10 weeks of age, presented as a 
percentage of total body weight. Reduced weight of white adipose pads were observed in both the 5D3 
and 5A4 lines in both males and females. Brown adipose tissue and kidney weights were not found to 
be altered in either 5D3 or 5A4. Statistical analysis was performed by Student’s t-test. * P<0.05. ** 
P<0.01 N=9+9+8 (for each gender) 
                                                   
 
Figure 5.2 H+E staining of 10 week old 5D3 (right) and wild type (left) iBAT. 5D3 iBAT appeared 
darker in colour. Scale bar represents 100µm.  
 
(b) 
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     Induction of thermogenic genes         
 
                In the previous experimental chapters, increased dosage of Cdkn1c had been shown 
to enhance the brown adipogenesis. In particular, the effect of this change in dosage was the 
induction of the mitochondrial uncoupling thermogenic gene programme. At P7, Ucp-1 
mRNA was found to be expressed 10-fold higher in 5D3 female rWAT than wild type and 
Ucp-1 protein was readily detectable by Western blot (Fig 4.8, 4.12). To ask whether the 
induction of the thermogenic gene program identified at P7 was maintained into adulthood, 
QPCR was performed on cDNA prepared from rWAT isolated from 10 week old transgenic 
and wild type females from line 5D3. Firstly, QPCR was used to confirm that elevation in 
Cdkn1c expression was maintained until at least 10 weeks (Fig 5.4). Ucp-1 , PGC-1α, Cidea 
and Elovl 3 were all found to be more highly expressed in the 10 week old transgenic 
samples, and the degree of difference was greater than seen at P7 (Fig 4.8). QPCR analysis of 
the same key thermogenic genes was also performed on males (Table 3). An even greater 
increase in the expression of Ucp-1 was found in 5D3 male mice. The other remaining 
thermogenic genes analysed, PGC-1α, Cidea and Elovl3, were also elevated in 5D3 males.  In 
addition to the thermogenic genes, QPCR analysis was performed for C/ebpβ and Prdm16 in 
female rWAT from line 5D3. Both C/ebpβ and Prdm16 were found to be elevated in the 
presence of higher Cdkn1c dose (Fig 5.4).   
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Figure 5.3 QPCR analysis of selected thermogenic program genes in 5D3 female 10 week rWAT. All 
genes analysed were found to be highly induced in the presence of excess Cdkn1c.  Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. ** P<0.01. 
N=4+4. 
 
 
 
Table 3 Fold changes in male 5D3 10 week retroperitoneal white adipose tissue of thermogenic 
program genes. Large induction of thermogenic program had also occurred in male 5D3 mice, as was 
seen in females. Error bars represent standard error of fold changes. Statistical analysis was performed 
by Mann Whitney test. N=4+4. 
 
Gene  Cdkn1c Ucp-1 PGC-1α Cidea Elovl3 
Av. Fold Change 1.47 159.79 2.17 6.00 45.30 
St.Error  0.08 7.62 0.30 0.68 8.97 
P.value  0.029 0.008 0.008 0.008 0.008 
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Figure 5.4 QPCR analysis of selected brown adipogenic genes in 5D3 female 10 week rWAT. Excess 
Cdkn1c increased the expression of both C/ebpβ and Prdm16.  Error bars represent standard error of 
fold changes. Statistical analysis was performed by Mann Whitney test. ** P<0.01. N=4+4. 
 
Elevated core body temperature. 
 
               Increased thermogenesis would be predicted to result in an elevation in body 
temperature as a consequence of greater heat production. Therefore a measurement of rectal 
temperatures of the 10 week old male and female mice was performed. In addition, mice were 
subjected to a cold challenge after baseline temperature measurement, which involved 
subjecting the mice to 4ºC environment for a 30 minute period and then obtaining a 
measurement of body temperature.  
             5D3 males were found to be significantly hotter both pre- and post- cold challenge 
than wild type (Fig 5.5). Data for 5A4 males was not obtained. Both 5D3 and 5A4 female 
mice were hotter under standard conditions that wild type. After the cold challenge, 5D3 and 
5A4 were hotter than wild type but this did not reach statistical significance (Fig 5.6). 
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Figure 5.5 Rectal temperature of 5D3 male 10 week old mice, under standard conditions and after a 30 
minute cold challenge. 5D3 mice were found to be significantly hotter than wild type litter mates, pre- 
and post- cold challenge. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Student’s t-test.  * P<0.05, ** P<0.01. N=8+6. 
 
Figure 5.6 Rectal temperature of female 10 week old mice, under standard conditions and cold 
challenge. 5D3 and 5A4 mice were found to be significantly hotter than wild type litter mates under 
standard conditions. However, after being subjected to cold challenge, there was not a statistically 
significant difference. Error bars represent standard error of fold changes. Statistical analysis was 
performed by Student’s t-test.  ** P<0.01. N=7+6+5. 
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Fat pad mass in Cdkn1c BAC transgenic mice at one year of age maintained on a 
standard chow diet 
 
                In order to study the long term consequences of elevated Cdkn1c expression of 
weight gain, 5D3 and 5A4 mice were housed in cohorts containing not more than four 
individuals, with both wild type and transgenic animals, for one year maintained on a 
standard chow diet. Mice were weighted monthly. At six months and one year of age, mice 
were subjected to glucose and insulin tolerance testing and at 12 months mice were sacrificed 
to obtain fat pad data. 
             At 10 weeks of age, mice over-expressing Cdkn1c were reduced in total body weights 
(Table 2). At 6 months of age 5D3 and 5A4 male mice were found to weigh significantly less 
than wild type. This difference was maintained through to one year of age (Fig 5.7). In total 
wild type male mice increased in total body weight by 19.04 % (± 5.57 %) between six and 
twelve months while 5D3 male mice increased by 8.70 % (± 2.09 %) and 5A4 increased in 
weight by 4.03 % (± 1.26 %). Female 5D3 mice were lighter than wild type at 6 months but 
this difference was not found to be significant. 5A4 female mice were significantly lighter at 
this time-point (Figure 5.8). This pattern was maintained to 1 year of age, where 5D3 and 5A4 
females were lighter than wild type. The lack of significance for the 5D3 females likely 
reflects the relatively higher standard deviation and the small number of animals (N=5). 
Consequently obtaining data for additional animals at this time point will be important in 
future work. 
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Figure 5.7 Monthly weights of male transgenic groups in 1 year ageing cohort. 5D3 and 5A4 mice were 
found to be significantly lighter at all time-points. Error bars represent standard error of fold changes. 
Statistical analysis was performed by Student’s t-test. * P<0.05, ** P<0.01 N=5+5+4. 
 
Figure 5.8 Monthly weights of female transgenic groups in 1 year ageing cohort. 5A4, but not 5D3 
mice were found to be significantly lighter at all time points. Error bars represent standard error of fold 
changes. Statistical analysis was performed by Student’s t-test. * P<0.05, ** P<0.01 N=6+5+5. 
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Glucose and Insulin tolerance 
                 
                    Increased fat mass has linked to irregularities in the management of glucose 212.  
In order to ascertain whether the reduction in fat mass in the transgenic models had any 
consequences for glucose metabolism at the whole body level, glucose and insulin tolerance 
testing were performed at 6 months and 1 year of age. At 6 months of age, there was no 
significant alterations in the handling of glucose after an IP glucose challenge in male 5D3 
mice or 5A4 (Fig 5.9). Female 5D3 and 5A4 mice displayed an improved response at the 
thirty minute mark post injection from wild type (Figure 5.10).  
 
Figure 5.9 10 mM/ kg Glucose tolerance testing of transgenic male groups at 6 months of age. No 
differences between transgenic groups were detected. Error bars represent standard error. Statistical 
analysis was performed by Student’s t-test. N=5+5+4 
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Figure 5.10 10 mM/ kg Glucose tolerance testing of transgenic female groups at 6 months of age. 5D3 
and 5A4 mice had a significantly reduced elevation in blood glucose level 30 minutes after injection. 
No further differences were detected. Error bars represent standard error. Statistical analysis was 
performed by Student’s t-test. ** P<0.01   N=6+5+5 
  
               At one year of age, both 5D3 and 5A4 mice showed significantly improved 
responses at ninety minutes to wild type (Figure 5.11). These significantly improved 
responses were maintained through to the tests conclusion at one hundred and twenty minutes 
respectively. 5A4 male mice also presented with a more measured initial peak compared to 
wild type mice, thirty minutes after glucose injection. 5D3 mice at this time point were found 
to possess a similar peak to wild type.  
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Figure 5.11 10 mM/ kg Glucose tolerance testing of transgenic male groups at 1 year of age. 5D3 and 
5A4 mice were found to possess a significantly improved response to glucose challenge. Error bars 
represent standard error. Statistical analysis was performed by Student’s t-test. * P<0.05 N=5+5+4 
                  
                 Female 5D3 and 5A4 mice also displayed a significantly improved glucose 
tolerance response at 1 year (Fig 5.12). Unlike the male mice, both 5D3 and 5A4 females 
were found to possess an improved response compared to wild type mice at all time points 
measured. Thirty minutes after glucose injection, both 5D3 and 5A4 presented with a hugely 
reduced initial response, compared to wild type. Thus while the wild type mice showed a 
slower clearance of the IP glucose challenge as they aged, both the 5D3 and 5A4 males and 
females appeared to resist this age induced glucose intolerance. 
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Figure 5.12 10 mM/ kg Glucose tolerance testing of transgenic female groups at 1 year of age. 5D3 and 
5A4 mice were found to possess a significantly improved response to glucose challenge. Error bars 
represent standard error. Statistical analysis was performed by Student’s t-test. * P<0.05 N= 6+5+5 
                 
 
                   Insulin tolerance testing (ITT) was also performed at 6 months and 12 months. 
During the initial ITT of 6 month old 5A4 mice, a very rapid and large decrease in blood 
glucose was observed in response to the insulin injection and the mice appeared to be losing 
consciousness. It was consequently necessary to remove them from the test and administer 
glucose injection due to the risks associated with hypoglycaemia. As a result, no data at six 
months of age was generated for the 5A4 mice. For the male 5D3 mice, fifteen minutes post-
injection they were found to possess an improved response to insulin challenge as compared 
to wild type. This improved response was apparent at each time point measured till the end of 
the test (Fig 5.13). 5D3 females did not display a significantly improved response to wild type 
(Fig 5.14).  
                  At 1 year of age, the ITT was performed under the same experimental conditions. 
This time data was obtained from both the 5D3 and the 5A4 cohorts. Fifteen minutes post-
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injection 5D3 and 5A4 males were both found to be more sensitive to insulin challenge than 
wild type (Fig 5.15). This improved response was retained throughout the test in both 
transgenic lines. In 1 year old females, 5D3 and 5A4 also were found to be more sensitive to 
insulin challenge than wild type. This improved response was retained at the thirty minute 
post-injection time point in both 5D3 and 5A4, but thereafter lost (Fig 5.16). 
                               
 
Figure 5.13 0.75U Insulin Tolerance Testing for transgenic male groups at 6 months of age. 5D3 mice 
possessed a significantly improved response to insulin challenge. Error bars represent standard error. 
Statistical analysis was performed by Student’s t-test. * P<0.05 N=5+5 
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Figure 5.14 0.75U Insulin Tolerance Testing for transgenic female groups at 6 months of age. No 
difference was detected between wild type and 5D3 mice. Error bars represent standard error. 
Statistical analysis was performed by Student’s t-test. N= 6+5 
 
 
Figure 5.15 0.75U Insulin Tolerance Testing for transgenic male groups at 1 year of age. Both 5D3 and 
5A4 mice possessed a significantly improved response to wild type at all time points after injection. 
Error bars represent standard error. Statistical analysis was performed by Student’s t-test. * P<0.05 
N=5+5+4 
148 
 
 
Figure 5.16 0.75U Insulin Tolerance Testing for transgenic female groups at 1 year of age. Both 5D3 
and 5A4 mice possessed a significantly improved response to wild type at 15 and 30 minute time 
points.  Error bars represent standard error. Statistical analysis was performed by Student’s t-test. * 
P<0.05 N= 6+5+ 
 
 
 
Adipose weights 
 
                     Upon completion of glucose and insulin tolerance testing, mice were dissected 
and organs harvested for weights. Transgenic males and females from both lines showed a 
similar proportion in weight of kidney and liver as wild types (Fig 5.17-18). Visceral adipose 
depots taken were found to weigh significantly less in 5D3 (42.98 % ± 7.81 %) and 5A4 
(71.50 % ± 7.43 %) females than wild type. At this stage in life, all visceral adipose depots 
when taken individually were lighter in both 5D3 and 5A4 females than wild type. In addition 
the inguinal subcutaneous white adipose depot was found to be lighter in 5D3 females than 
wild type. iBAT was significantly lighter in 5D3 females than wild type (Fig 5.18). Male 5D3 
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(44.43 % ± 5.58) and 5A4 (76.26 % ± 4.11) mice largely shared this pattern to wild type 
mice, with reduced visceral and subcutaneous white adipose depots (Fig 5.17). 
 
 
Figure 5.17 Wet weight of transgenic male adipose pads at 1 year of age, presented as a percentage of 
total body weight. Significantly reduced white adipose pads were observed in both the 5D3 and 5A4 
lines in both males and females. Brown adipose tissue and kidney content were not found to be affected 
under any of the conditions. Statistical analysis was performed by Student’s t-test. * P<0.05. ** P<0.01 
*** P<0.001. N=5+5+4 
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Figure 5.18 Wet weight of transgenic female adipose pads at 1 year of age, presented as a percentage 
of total body weight. Significantly reduced white adipose pads were observed in both the 5D3 and 5A4 
lines in both males and females. Kidney content was not found to be affected under any of the 
conditions. Statistical analysis was performed by Student’s t-test. * P<0.05. ** P<0.01 *** P<0.001. 
N=6+5+5 
 
 
Examination of fat pad mass in Cdkn1c BAC transgenic mice in response to a 
high fat diet 
 
                  Given the apparent protection against age-induced obesity provided by elevated 
Cdkn1c, it was interesting to determine whether elevated Cdkn1c provided any protection 
against obesity induced by a high fat diet. Wild type BL6 mice subject to a high fat diet 
rapidly gain weight as a consequence of increase fat deposition and develop both glucose 
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intolerance and insulin resistance 142. A cohort of 10 week old female mice initially bred and 
maintained on a standard chow diet that delivers 18% of calories from fat were switched for a 
12 week period to the high fat diet where 45% of calories come from fat. One week into the 
high fat diet, a measurement was made of food consumption on the high fat diet for a two 
week period. No differences were observed in the amount of food consumed between the 5D3 
and wild type female mice (Fig 5.19). 
 
 
Figure 5.19 Feeding study for singly housed transgenic animals subjected to high fat diet study. 
Consumption was measured over a 2 week period, after an initial one week period post diet change. No 
difference was observed between 5D3 and wild type. Statistical analysis was performed by Student’s t-
test. N= 6+6. 
 
              From week 0 through week 12 of the high fat diet, 5D3 female mice total body 
weights were obtained. 5D3 female were found to be highly significantly lighter than wild 
types throughout (Fig 5.20). While wild type mice gained 9.85 g (± 1.04 g) over the duration 
of the diet whereas 5D3 mice gained 2.48 g (± 0.73 g). By the end of the study, wild type 
females were 50% heavier than 5D3 females.  
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 Figure 5.20 Weekly weights of 5D3 female cohort subjected to high fat diet. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Student’s t-test. ** P<0.01, *** 
P<0.001 N=9+9 
 
              Glucose and insulin tolerance testing were performed to observe the different 
groups’ response to these respective challenges after the high fat diet challenge. Both wild 
type and 5D3 mice achieved similar peak blood glucose readings with no significant 
difference between the two groups. However 5D3 mice were found to clear glucose from 
sixty minutes to the end of the test. At one hundred and twenty minutes, 5D3 mice had 
significantly lower blood glucose than wild type (Fig 5.21). 
                           Upon administration of insulin, 5D3 mice were found to be more sensitive to 
insulin challenge than wild type mice, at all time points measured (Fig 5.22). After forty-five 
minutes, the time point at which maximum decrease in blood glucose was determined, 5D3 
mice had a greater response to insulin challenge than wild type. 
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Figure 5.21 10 mM/ kg Glucose tolerance testing of 5D3 female cohort subjected to high fat diet. 5D3 
mice were found to clear glucose challenge more rapidly than wild type. Error bars represent standard 
error. Statistical analysis was performed by Student’s t-test. * P<0.05, ** P<0.01   N=9+9 
     
Figure 5.22 0.75 U Insulin tolerance testing of 5D3 female cohort subjected to high fat diet. 5D3 mice 
displayed a significantly improved response to insulin challenge than wild type. Error bars represent 
standard error. Statistical analysis was performed by Student’s t-test. * P<0.05, ** P<0.01. N=9+9. 
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             In addition to ITT and GTT after the HFD, an assessment of rectal temperature was 
made. While increased dietary lipids will elevate Ucp-1 expression throughout the adipose 
organ and thereby increase mitochondrial uncoupling, this potential increase in body heat can 
be counter-acted as energy expenditure is reduced in BL6 mice under these conditions 213. At 
10 weeks of age 5D3 and 5A4 mice were significantly hotter than wild type (Fig 5.6). After 
12 weeks of high fat diet 5D3 subjects were found to be significantly warmer than wild type 
mice (Fig 5.23). 
 
 
 
Figure 5.23 Rectal temperature of 5D3 female cohort subjected to high fat diet, under otherwise 
standard conditions. 5D3 mice were found to be significantly hotter than wild type, at rest. Error bars 
represent standard error of fold changes. Statistical analysis was performed by Student’s t-test.  ** 
P<0.01. N=9+9. 
 
               Mice were culled and dissected and organ weights were obtained. There was no 
significant difference in the weight of the kidney and liver as a proportion of total body 
weight between 5D3 and wild type. All adipose depots dissected were found to be 
significantly lighter in 5D3 mice (Fig 5.24), including visceral white adipose depots found to 
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be 62.70 % (± 6.74 %) lighter than wild type. 
 
 
Figure 5.24 Wet weight of 5D3 female cohort adipose pads subjected to high fat diet, presented as a 
percentage of total body weight. Significantly reduced white adipose pads were observed in both 5D3 
females. Kidney and liver displayed no difference between groups. Statistical analysis was performed 
by Student’s t-test. * P<0.05. ** P<0.01 *** P<0.001 N=9+9 
 
                   As a percentage of total body weight, there was no significant difference in the 
weight of the liver between wild type and 5D3 mice after the high fat diet (Fig 5.24). When 
weights were compared without taking into account total body weight, the wild type livers 
were significantly heavier (wild type 1.016 g ± 0.064 versus 5D3 mice 0.692 g ± 0.037; 
P=0.001). H+E images of these livers showed substantial lipid deposition in the wild type 
liver which was less apparent in the 5D3 livers (Fig 5.25). Similarly, while the wild type 
white and brown adipose depots appeared to have larger cells indicating increased lipid 
stores, this was not the case for the 5D3 depots.  
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Figure 5.25 H+E staining of 5D3 rWAT, iBAT and liver sections, from cohort subjected to high fat 
diet, photographed under standard light field conditions. The appearance of the wild type sections 
suggests a greater lipid load as compared to 5D3 tissues. Scale bar represents 50 μm. 
 
          QPCR was used to examine the expression of key markers of non shivering 
thermogenesis. PGC-1α, Ucp-1, Cidea and Elovl3 were all found to be elevated in 5D3 
rWAT after high fat diet (Fig 5.26). 
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iBAT 
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157 
 
 
Figure 5.26 QPCR analysis of selected thermogenic program genes in 5D3 female high fat diet rWAT. 
All genes analysed were found to be elevated in 5D3 rWAT.  Error bars represent standard error of fold 
changes. Statistical analysis was performed by Mann Whitney test. ** P<0.01. N=4+4. 
 
 
 
 
Fat pad mass in Cdkn1c BAC transgenic mice on the 129 genetic background in 
response to a high fat diet 
           
           Work presented in the results so far examined BAC transgenic mice maintained on a 
‘pure’ BL6 background. Prior to breeding of the lines onto this genetic background, 
provisional work that had identified a potential lean phenotype in line 5D3 when this line was 
studied on a mixed 129:BL6 background (Fig 1.15). It was not possible to study 5D3 or 5A4 
transgenic mice on a pure 129 background as this was known to be a non viable combination 
107. BL6 is the strain of mice commonly used in metabolic studies due to the propensity of this 
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strain to gain weight and develop metabolic irregularities on a HFD 142. In contrast, the 129 
strain has been shown to be relatively resistant to the adverse consequences of a HFD 214. In 
order to compare the relative “fat-fighting” effect of Cdkn1c on the two genetic backgrounds, 
a cohort of 5D3 and 5A4 mice and their wild type litter mates, was generated on a 75% 
129/25% BL6 background and on a standard chow diet. A 10 weeks of age, these mice were 
switched to a high fat diet and weekly weights were recorded. Both 5D3 (1.8 g ± 0.66 g; 
P=0.03) and 5A4 (0.17 g ± 1.05 g; P=0.001) mice gained less weight than wild type (5.68 g ± 
1.47 g). After 8 weeks under the dietary change 5D3 and 5A4 mice weighed significantly less 
than wild type mice (Fig 5.27).  
 
 
Figure 5.27 Weekly weights of 75% 129 transgenic female cohorts subjected to high fat diet. Both 5D3 
and 5A4 mice were significantly lighter than wild type. Error bars represent standard error of fold 
changes. Statistical analysis was performed by Student’s t-test. * P<0.05, ** P<0.01 *** P<0.001 
N=8+7+6 
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            As was the case for the BL6 cohort, glucose and insulin tolerance testing was 
performed upon completion of the high fat diet. In glucose tolerance testing, no difference 
was observed between 5D3, 5A4 or wild type, 30 minutes after injection. Similar responses 
were achieved for all groups, through to one hundred and twenty (Fig 5.28). Insulin tolerance 
testing also returned highly similar plots for all three genetic groups forty five minute 
readings, where maximum insulin induced drop in blood glucose had been achieved. No 
differences were found between any of the groups, with the exception of a higher 5A4 
measuring at one hour (Fig 5.29).                
 
Figure 5.28 10 mM/ kg Glucose tolerance testing of 75% 129: 25% BL6 transgenic 5D3 and 5A4 
females subjected to high fat diet. No differences in response to glucose challenge were detected in 
5D3 or 5A4 mice, to wild type. Error bars represent standard error. Statistical analysis was performed 
by Student’s t-test. N=8+7+6 
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Figure 5.29 0.75U Insulin tolerance testing of 75% 129 transgenic female cohort subjected to high fat 
diet. Response to insulin challenge was highly similar in 5D3, 5A4 and wild type mice. Error bars 
represent standard error. Statistical analysis was performed by Student’s t-test. N=8+7+6. 
              Mice were culled after the tolerance testing and dissected to determine adipose pad 
weights (Fig 5.30). The reductions in weight seen were similar to that observed when 5D3 
was studied on the BL6 background (Fig 5.24). All three visceral white adipose and the 
inguinal subcutaneous white adipose depots were found to be lighter in both 5D3 and 5A4 
mice than wild type. No differences were detected between groups in iBAT or kidney weights 
(Fig 5.30).  
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Figure 5.30 Wet weight of 75% 129:25% BL6 female adipose pads after high fat diet, presented as a 
percentage of total body weight. Significantly reduced white adipose pads were observed in both 5D3 
and 5A4 females compared to wild type. Kidney and iBAT content was not found to be altered. 
Statistical analysis was performed by Student’s t-test. * P<0.05. ** P<0.01. N=8+7+6 
 
 
Discussion 
                      The Spiegelman group had previously reported that ectopic expression of 
Prdm16 from the aP2 promoter resulted in a lean phenotype, due to an induction of the 
mitochondrial uncoupling programme 205. They also noted that, although near equal levels of 
Prdm16 mRNA were detected in inguinal and epididymal adipose depots, the protein was 
detectable by Western in only the inguinal white adipose tissue. It was this discrepancy that 
prompted them to theorise that as yet unknown factor(s) were present to suppress the pooling 
of Prdm16 in the visceral white adipose depots, where mitochondrial uncoupling is not 
anticipated. 
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                Work in the previous two chapters suggested Cdkn1c as a novel regulator of 
adipogenesis through regulating the accumulation of Prdm16 protein in the adipose tissue. 
5D3 females were found to contain the protein in their rWAT (Fig 4.12), which was not 
detectable by Western in wild type mice. In addition, Prdm16 accumulation was found to be 
greater in transgenic iBAT, in a dosage dependent manner (Fig 3.24). An accumulation of 
Prdm16 would account for the induction of the thermogenic programme in the transgenic 
white adipocyte depots alongside detectable levels of Ucp-1 protein (Fig 4.12). Consistent 
with increased thermogenesis, even as early as 10 weeks on a standard chow diet, there was a 
clear reduction in the weight of the visceral adipose depots in the single copy BAC transgenic 
line, with a further reduction apparent in the two copy transgenic line (Fig 5.1). This dosage 
phenotype correlated with the dosage dependent increase in Prdm16 accumulation (Fig 3.24).  
             The relative differences in adipose weight between wild type and the experimental 
lines were found to increase as mice aged (Fig 5.17-18). The profile of weight gain suggested 
that, rather than losing weight as they aged, the transgenic mice failed to gain weight like 
their wild type counterparts. Similarly, the transgenic mice also appeared to resist aged 
induced glucose intolerance and insulin resistance (Fig 5.9-16).  
                  In addition to resisting age-induced weight gain, both 5D3 and 5A4 mice 
demonstrated an extreme resistance to diet-induced obesity (Fig 5.20-30). There were reduced 
lipid stores in the white adipose depots and also within iBAT and the liver of 5D3 females, 
compared to wild type (Fig 5.25). A single extra copy of the Cdkn1c gene was sufficient to 
confer almost total resistance to the effects of the high fat diet. This is in contrast to many 
other “anti-obesity” genes, where effects are seen after highly ectopic over-expression from 
the aP2 promoter, or potentially dangerous deletions such as pRb haploinsufficiency 205; 209; 215; 
216. These results highlight Cdkn1c as a potential obesity therapy, which will be discussed in 
more detail later. 
                The final experimental chapter will focus on Cdkn1c expression in different adipose 
depots and between young and aging mice.  
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Chapter 6: Cdkn1c expression in adipose tissue 
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          In the previous chapter Cdkn1c was found to protect against both age- and diet-
induced obesity, in a dosage dependent manner consistent with a role for Cdkn1c in 
promoting the formation of thermogenically active brown adipose as suggested by the results 
in chapters 3 and 4. In light of these functions, a final enquiry that this project posed was to 
explore whether variations in the relative expression levels of Cdkn1c occurred in across the 
different adipose deposits and whether the expression level varied either as mice aged or in 
response to specific diets.  
 
Cdkn1c expression across different depots 
 
                 In order to determine whether the level of Cdkn1c varied between the different 
adipose subtypes, four separate adipose depots were isolated at P7: retroperitoneal, 
subcutaneous, mesenteric (mWAT) and iBAT. mWAT is a visceral white adipose depot and 
was chosen as it represents a visceral adipose depot with less brown adipocyte content that 
rWAT 125. In a recently published work, Prdm16 content had been shown to vary across 
adipose depots, at levels that correlated to an increased brown adipose characteristic 205. 
Initially it was determined by QPCR that mWAT expressed Cdkn1c at the lowest level as 
compared to the other depots. In rWAT and scWAT Cdkn1c was expressed at nearly 8-fold 
higher level than in mWAT while iBAT displayed the highest level of Cdkn1c expression at 
approximately 16-fold more than in mWAT (Fig 6.1).  
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Figure 6.1 QPCR analysis of Cdkn1c expression in C57/Bl6 adipose deposits at P7, compared to the 
mesenteric adipose depot. rWAT (purple) and scWAT (pink) were found to possess similar expression 
levels, whilst expression in the iBAT (brown) was highest. 
 
 
Cdkn1c expression in adipose as mice age  
 
 In order to determine whether the level of Cdkn1c varied as mice aged, the same four adipose 
depots were isolated from mice aged one year. The expression of Cdkn1c in these older 
adipose depots was compared by QPCR to those from P7. In mWAT and iBAT there was a 
small but significant increase in expression between the two time-points. In contrast, 
expression of Cdkn1c in rWAT and scWAT was very much reduced at one year as compared 
to P7 (Fig 6.2). 
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Figure 6.2 QPCR analysis of Cdkn1c expression in C57/Bl6 adipose deposits, comparing P7 (black) 
expression, to 1 year (red). Both mesenteric and iBAT were modestly increased, while rWAT and 
scWAT demonstrated significant down-regulation. Error bars represent standard error of fold changes. 
Statistical analysis was performed by Mann Whitney test. * P< 0.05. ** P< 0.01. N=4+4 
                
          There are two interpretations of these findings. Firstly the reduced expression in 
retroperitoneal and subcutaneous WAT might indicate a progressive silencing of the locus. 
Alternatively, there may be fewer cells expressing Cdkn1c relative the total mass of the 
depots.  
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Cdkn1c sDMR and Lit1 gDMR in adipose as mice age  
 
                          It has previously been mentioned that Cdkn1c imprinted expression is 
regulated by differential methylation of the Lit1 gDMR, and the Cdkn1c sDMR 22; 65; 217; 218; 219; 
220. 
                      To explore whether changes in the methylation of these DMR’s could account 
for the reduced expression patterns observed, gDNA was isolated from the four depots at P7 
and at one year. This DNA was subjected to bi-sulphite treatment, PCR amplified and PCR 
clones were sequenced. Methylation of the Cdkn1c sDMR was found to be slightly reduced in 
iBAT at one year (22.92 % of CpG’s methylated ± 1.13 P = 0.00019) as compared to P7 
iBAT (37.24 % ± 0.68) (Fig 6.3).  Similarly, a slight reduction in methylation was observed in 
rWAT (1 year 22.78 % ± 2.08 versus P7 32.51 % ± 0.87; P = 0.006) (Fig 6.4). A decrease in 
the percentage of methylated CpG’s in Lit1 gDMR in iBAT was also observed at one year 
(25.60 % ± 7.73 P=0.11) and P7 (46.83 % ± 10.28) (Fig 6.5), however this did not achieve 
significance. This was again replicated in the rWAT (1 year 29.43 % ± 2.01 versus P7 37.85 
% ± 4.90; P = 0.12). 
 
Figure 6.3 Example of sequencing results of Cdkn1c sDMR, from wild type female iBAT gDNA after 
bisulphite treatment. Filled circles represent methylated CpG’s, while empty circles represent 
unmethylated. The area analysed contained 50 CpG’s and was located just upstream of the predicted 
transcription start site.  
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Figure 6.4 Example of Sequencing results of Cdkn1c sDMR, from wild type female rWAT gDNA after 
bisulphite treatment. Filled circles represent methylated CpG’s, while empty circles represent 
unmethylated. 
 
 
Figure 6.5 Example of sequencing results of Lit1 gDMR, from wild type female iBAT gDNA after 
bisulphite treatment. Filled circles represent methylated CpG’s, while empty circles represent 
unmethylated. 
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Figure 6.6 Example of sequencing results Lit1 gDMR, from wild type female rWAT gDNA after 
bisulphite treatment. Filled circles represent methylated CpG’s, while empty circles represent 
unmethylated. 
  
These minor changes in methylation showed that increased DNA methylation during aging 
was not consistent with the shutting down of the Cdkn1c locus during aging by DNA 
methylation.  
 
 
Cdkn1c expression in adipose in response to maternal conditions  
 
                 A previous study had noted that maternal exposure to low protein diet resulted in 
elevated Cdkn1c expression in the brain of her offspring in three of four regions studied and 
there was also reduced methylation of Cdkn1c sDMR 221. Since this study was performed on 
only one tissue, the brain, and since both expression and methylation were examined only in 
adult mice, it was important to determine whether this phenomenon was restricted to the brain 
and whether this occurred in younger animals. Pregnant 129 females were fed a low protein 
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diet during gestation from the day of the discernable plug until term. A second cohort of mice 
was set up at the same time but mothers were maintained on a standard chow diet. Pups were 
harvested at P7 and QPCR analysis was performed on iBAT. In iBAT of pups that had been 
exposed to the low protein diet, Cdkn1c expression was found to be significantly up-regulated 
as compared to standard chow pups (Fig 6.7). Although this up-regulation was more subtle 
that reported by Vucetic in the adult brain 221, it was significant (P = 0.011). Bi-sulphite 
sequencing of the Cdkn1c sDMR was also performed. A reduction in methylation was 
observed in the low protein samples (LP 10.19 % ± 2.31 % versus St chow 23.2 % ± 3.01 %; 
P = 0.05) (Fig 6.8).  
 
 
 
Figure 6.7 QPCR analysis of Cdkn1c expression in P7 iBAT, after maternal exposure to low protein 
diet, during pregnancy. Cdkn1c was found to be significantly up-regulated. Error bars represent 
standard error of fold changes. Statistical analysis was performed by Mann Whitney test. * P< 0.05. ** 
P< 0.01. N=4+4 
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Figure 6.8 High throughput sequencing of Cdkn1c sDMR, from P7 iBAT bisulphite treated gDNA, 
after maternal exposure to low protein diet. Loss of sDMR methylation arose. Filled circles represent 
methylated CpG’s, while empty circles represent unmethylated. 
 
 
 
 
Discussion 
            
                 Cdkn1c expression was found to vary both across the different adipose depots, in 
response to aging and also in response to maternal diet. At P7, highest expression was 
observed in iBAT with subcutaneous and retroperitoneal WAT showing medium levels and 
mesenteric the lowest. Cdkn1c is expressed on a small subset of cells within iBAT and rWAT 
(Fig 3.17, 3.25, 4.1). Given the co-localisation of Cdkn1c with the brown fat determinant 
Prdm16 in some of these cells (Fig 3.25-26) and the low frequency of label retaining cell in 
the iBAT 35, it is tempting to speculate that Cdkn1c marks the brown adipose stem cells in 
both iBAT and rWAT and that the level of expression reflects the number of cells present in 
the different depots rather that the absolute level of expression of Cdkn1c per cell. There was 
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not time to pursue this idea but further experiments are in progress to ask whether the Cdkn1c 
+ve cell is a label retaining cell.  
              Expression of Cdkn1c was much lower in one year old rWAT and scWAT than in P7 
depots but this was not reflected in an increase in DNA methylation (Fig 6.2). A small 
increase in expression of Cdkn1c was observed in iBAT and mesenteric WAT. Again little 
change was observed in DNA methylation. More work is required to determine the 
mechanism by which Cdkn1c is down regulated by 9-fold in r and scWAT but one intriguing 
possibility is that this reduced expression reflects an age-related loss of the cells expressing 
Cdkn1c which may be brown adipose stem cells. Such a loss of stem cell could account for 
the loss in brown fat capacity and tendency towards adiposity seen in aging animals. Again, 
further work is required to explore this hypothesis.  
        While the methylation pattern of the sDMR appeared to change very little in response to 
aging, the experiments involving exposure to low protein diet demonstrated that there was 
epigenetic flexibility at the Cdkn1c locus (Fig 6.7). Timing of the exposure to low protein diet 
occurs prior to the time-point at which methylation of the sDMR is detectable between E8.5 
and E9.5, and after monoallelic expression has been established  23. In this short study, the 
temporal changes in methylation were not assessed. There remain four main possibilities. 
Firstly, that mono-allelic expression of Cdkn1c is not established under conditions of low 
protein diet possibly due to a failure in signalling from the IC. Secondly, monoallelic 
expression of Cdkn1c is established but the secondary DNA methylation event does not occur 
and consequently the imprinted expression of Cdkn1c is not locked down – similar to that 
seen in the Dnmt1 KO experiments 220; 222. Thirdly, it may be that both mono-allelic 
expression and differential DNA methylation are established but that this is not maintained. 
Finally, imprinted status may have been retained and the increase in expression of Cdkn1c 
results from an increase in transcription from the maternally inherited allele.              
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               The low protein diet altered DNA methylation and expression of Cdkn1c while 
aging, albeit over a relatively short time of 12 months, altered expression in some depots but 
not all and the changes in DNA methylation were not consistent for a role for DNA 
methylation in inducing progressive silencing of the locus.  This could be interpreted to mean 
that the Cdkn1c imprint is relative responsive during embryogenesis but less responsive after 
birth.  
               Finally, in response to the low protein diet, Cdkn1c expression was elevated in the 
iBAT (Fig 6.7). The level of over-expression in these low protein iBAT was similar to the 
over-expression levels in 5D3 iBAT (Fig 3.12). This is quite an important finding since it is 
usually presumed that such small changes in genes expressi on (less than 2-fold) would have a 
negligible effect on any process. However, our transgenic work demonstrates a very great 
effect on brown adipogenesis at this level of over-express. The consequence of elevated 
expression in response to the low protein diet may have a similar consequence – to increase 
iBAT. 
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Chapter 7: Discussion 
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                      This study has used four separate mouse lines to gain insight into a role for Cdkn1c in 
adipogenesis. Prior to this study, an adipogenic phenotype had not been characterised in Cdkn1c-m/+p 
offspring. The results presented in Chapter 3 have therefore highlighted a new feature of these mice. 
This may prove to be important in future studies, regarding loss of expression of Cdkn1c.  
                  The studies using the transgenic lines provided validity to the use of BAC transgenic lines in 
adipose tissue biology. A single copy of a BAC transgene was sufficient to produce phenotypes in all 
adipose tissue studied, and was able to protect against diet and age-induced obesity. The double copy 
line added to this by displaying a dosage dependent phenotype. Over-expression of a gene at the levels 
employed in these studies provides biological relevance given the imprinted nature of Cdkn1c. 
 
Cdkn1c in adipogenesis 
  
              The work in chapters 3-5 identified Cdkn1c as a novel regulator of brown adipogenesis. 
Cdkn1c was expressed in only a subset of cells within the BAT and WAT adipose depots. In situ 
hybridisation demonstrated that less than one percent of the cells at P7 were Cdkn1c positive. Further to 
this, there was over-lapping nuclear expression of Cdkn1c and Prdm16 in a rarer subset of Cdkn1c-
positive cells in iBAT, detected by immunofluorescence. This co-localisation alongside the very low 
frequency of this double positive cell was very intriguing. Long term studies demonstrated this cell to be 
BrdU label retaining). One hypothesis is that the co-expressing cell represents the brown adipose stem 
cell, while Cdkn1c-only cells are brown pre-adipocytes. There was insufficient time to look for Cdkn1c 
and Prdm16 co-localisation in WAT but it is interesting to speculate that the Cdkn1c positive cells 
within rWAT are also brown fat stem cells. The ability to label these putative stem cells with a LacZ 
marker (reporter line) would provide another important tool in enhancing the understanding of brown 
adipogenesis. 
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Mechanism for action 
             Altering the dose of Cdkn1c resulted in alterations in two key molecules involved in promoting 
brown adipogenesis, C/ebpβ and Prdm16. Expression of the mRNA for C/ebpβ was altered in response 
to different doses of Cdkn1c while for Prdm16, it was the protein level that was changed. Although the 
mechanism by which Cdkn1c induced these changes was not investigated, the changes observed in 
C/ebpβ and Prdm16 were consistent with Cdkn1c promoting the formation the C/ebpβ: Prdm16 complex 
which would result in the downstream enhancement of the thermogenic gene programme. This work 
suggested that Cdkn1c acts to modulate an existing brown adipose program rather than acting as a 
brown fat determinant although further work is required. 
      One very striking discovery made during this work was identifying the relationship between Cdkn1c 
and Prdm16. Altering the dosage of Cdkn1c was not largely found to affect Prdm16 mRNA levels. 
Instead, Cdkn1c dosage correlated with Prdm16 protein. The higher the dose of Cdkn1c, the more 
Prdm16 protein was found. In contrast, the lower the dose (KO), the less protein was found. The 
suggested a post-transcriptional role for Cdkn1c in the maintenance of Prdm16 protein. The mechanism 
for this regulation was not resolved. However, Prdm16 is a 140kDa protein with multiple potential 
phosphorylation and ubiquitination sites and recent work has shown Prdm16 protein stability is 
enhanced through the administration of PPARу agonists which correlated with an inhibition of 
ubiquitination 124. This recent data suggests that the Prdm16 protein undergoes posttranslational 
modification and degradation. By blocking phosphorylation of PPARγ, Prdm16 half-life can be 
lengthened. Maintaining PPARγ in this hypo-phosphorylated state would be consistent with already 
identified functions of Cdkn1c 87; 88, and is therefore a potential future experimental pathway to explore 
if this is the case.  
            Cdkn1c has been shown to directly bind to and stabilise the MyoD protein enhancing the 
skeletal muscle phenotype 100. It is interesting to speculate that Cdkn1c may function in both skeletal 
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muscle and brown adipose tissue by directly binding MyoD or Prdm16 respectively, and stabilising 
these proteins to further enhance the predetermined cell fate. 
 
Loss of expression of Cdkn1c           
                 The consequences of loss of expression of Cdkn1c in white adipose tissue in vivo in adults 
were not studied due to the difficulties in obtaining Cdkn1c-deficient animal after birth. However, 
through the ex vivo system of differentiating MEF’s to adipocytes (Fig 4.13-18), it was determined that a 
loss of Cdkn1c did not promote white adipogenesis. Rather it seemed that Cdkn1c was required for both 
white and brown adipogenesis.  Given the role the Cdkn1c plays in both cell cycle regulation and also 
directing differentiation, it will not be straightforward to dissect apart the roles that Cdkn1c plays in both 
white and brown adipogenesis. Both in vitro systems such as 3T3-L1 cells and also a conditional 
Cdkn1c knockout model would be helpful to dissect apart mechanisms and to study loss of expression 
phenotypes in the adult.  
 
           Although not fully explored here, it might be possible to generate a model in which Cdkn1c 
expression is lower than wild type but not completely absent. Low protein diet during pregnancy results 
in increased expression of Cdkn1c in the iBAT and brain 221. It has not currently been confirmed, but 
this increase in expression is likely attributable to a release of silencing of the paternally inherited copy 
of the Cdkn1c gene. If this were to be the case, maternal low protein exposure during pregnancy may be 
sufficient to rescue the lethality associated with Cdkn1c-m/+p mutation, by partially reactivating the 
silenced copy of the gene. This would allow the study of the consequences of reduced expression of 
Cdkn1c in brown and white adipose tissue and also the whole organism level. 
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Flexibility of Cdkn1c in iBAT. 
           
              Data in chapter 6 suggested that the Cdkn1c imprint is responsive to environmental cues 
during embryogenesis. Although much work is still required, this flexibility has important implications. 
Cdkn1c is already known to regulate birth weight 107. In this thesis, a role for Cdkn1c in enhancing 
thermogenesis has been identified.  This means that Cdkn1c has the ability to regulated both birth weight 
and thermogenesis. Sub-optimal conditions during pregnancy are widely known to result in growth 
restriction 223; 224; 225. A consequence of growth restriction is an increased surface to body ratio, which 
leads to greater heat loss. As a result, greater demand is placed on heat generation, to ensure body 
temperature is maintained. It was found during these studies that low protein diet was sufficient to 
increase expression of Cdkn1c in the iBAT. Cdkn1c, due to its’ role in brown adipogenesis, may 
therefore function in accommodating these changes. By possessing flexibility in the expression level of 
Cdkn1c, iBAT capacity could potentially be modulated to allow for increased demands, as a result of a 
sub-optimal pregnancy.   
 
 
Imprinting of Cdkn1c 
 
          The imprinted nature of Cdkn1c adds an extra element of intrigue to the phenotypes seen. 
5D3/5A4 iBAT essentially model the consequence of loss of imprinting of Cdkn1c. Increased Ucp-1 
protein and iBAT mass suggests a greater heat generating capacity than a wild type pad. Wild type 
newborn mice are able to survive early life before the development of fur through their ability to 
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produce heat through both shivering and non-shivering thermogenesis. Non-shivering thermogenesis has 
often been referred to as a highly efficient form of heat generation, when compared to shivering. 
However, due to the inability of the subject to freely switch Ucp-1 function on and off, that it is possible 
to do when shivering, non shivering thermogenesis is essentially fixed during development. If not 
required, excess energy will simply be radiated out of the body at the expense of the individual through 
lost lipid stores.  
              Imprinting of Cdkn1c involved a decrease from two active copies to one active copy. Our data 
suggest that such a change in active copies would result in lower Cdkn1c expression and a reduction in 
active iBAT, in other words, less thermogenesis at birth. Previous work performed in the lab identified 
Cdkn1c as a dosage dependent growth restrictor. Elevated Cdkn1c was linked to lower birth weight and 
loss of Cdkn1c was linked to fetal overgrowth 104; 107. Cdkn1c expression therefore modulates both birth 
weight and iBAT mass. Heat production is of far greater importance to new born mice than at any other 
time in their lives, due to their high surface area to volume ratio, and low level of fur covering. The 
presence of their littermates and parents helps maintain body warmth, due to huddling, and combined 
non-shivering thermogenesis. As the mouse ages, greater covering of hair, higher motility and the 
development of subcutaneous white fat reduce the comparative amount of non shivering thermogenesis 
required to maintain body temperature. Under Allan and Bergman’s rules, smaller pups have a higher 
degree of heat loss due to a high surface area to volume ratio, and more so more heat generation is 
required to maintain body temperature as compared to larger pups 226 (Fig 7.1). Since a larger pup 
requires less thermogenesis to maintain body temperature, linking of birth weight to thermogenesis via 
Cdkn1c would provide a distinct advantage. Essentially when Cdkn1c acquired imprinted status, birth 
weight was increased and thermogenesis decreased such that energy acquired from suckling would all 
go toward supporting growth rather than keeping warm, providing a distinct advantage. In the event of a 
sub-optimal pregnancy however, the ability to increase Cdkn1c dosage in the iBAT is retained through 
flexibility of the sDMR. 
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Figure 7.1 Effect of imprinting Cdkn1c on body size and thermogenic requirements. Mono-allelic expression of 
Cdkn1c results in larger offspring that loose less heat.           
 
Cdkn1c and obesity               
                  In addition to the brown adipose depots, Cdkn1c was expressed from the transgenes at other 
sites with relevance to obesity including the hypothalamus, the adrenal gland and the pituitary (John 
2001) which may contribute to the obesity resistance observed in the 5D3 and 5A4 models. The action 
of Cdkn1c at these sites requires further investigation. Nonetheless, the changes observed in both brown 
and white adipose depots, in particular the increase in Prdm16 protein, suggest that the resistance to age- 
and diet-induced obesity is in part directed by elevated Cdkn1c in these depots. Consequently CDKN1C 
may be a target for obesity therapy in humans.                  
               It currently remains to be seen whether the human gene functions in adipose tissue to regulate 
the accumulation of PRDM16 and enhance thermogenesis. However, observations from Silver-Russell 
patients suggest that it might. Three observed symptoms of the disease are a striking lack of 
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subcutaneous adipose tissue, night sweats and hypoglycaemia (recently reviewed 227; 228). These three 
symptoms are consistent with excessive thermogenesis and also consistent with the phenotype observed 
in 5D3/5A4 mice. Further work will be required to conclusively demonstrate if such a role for CDKN1C 
in adipogenesis is present in humans. Were the function to be conserved between species however, the 
potential of CDKN1C providing a novel therapy is extremely appealing. Due to the imprinted nature of 
the gene, we all possess an extra copy of the gene that is currently unused, the paternally inherited 
silenced copy. Given the results presented in this chapter, where a single extra copy of Cdkn1c from a 
BAC transgene was sufficient to provide the phenotype, it is possible to speculate that activation of the 
paternally inherited allele may be enough to provide a buffer towards age and diet-induced obesity.  
                One final point of interest regarding weight regulation comes from a prediction that Prdm16 is 
imprinted, in both mice and humans 229; 230. As a result of the potential relationship between Cdkn1c and 
Prdm16 in adipose, and the prediction that it is the maternal allele of Prdm16 that is silenced, this could 
represent a synergy between imprinted genes. Further work will be required, first of all to confirm if the 
gene is in fact imprinted.   
 
Brown adipose tissue and the Parental Conflict Hypothesis. 
                The divergence of eutherians and marsupials represents the expansion of the brown adipose 
pathway, with only limited mitochondrial uncoupling detected in marsupials, and none in monotremes 
137; 231; 232; 233. It is interesting to speculate that these marsupial brown adipose cells are more closely 
related to the Myf5- population of BAT seen in white adipose depots of rodents, as opposed to the Myf5+ 
iBAT lineage. Regardless of the origins, it appears that thermogenically active brown fat likely was 
present in the common ancestor of marsupials and eutherians at the time of an expansion of the 
imprinting system, so we also see an expansion in the biological significance of brown adipose tissue.  
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                The mechanisms that have given rise to the differences between eutherian and marsupial 
brown adipose tissue have not been elucidated. However, the so far established roles of imprinted genes 
in adipose tissue are largely consistent with this tissue being a site of parental conflict, including Pref-1 
234; 235 and Necdin 38; 159; 236.  
                         David Haig predicted in his theory of Kinship that maternally expressed imprinted 
transcripts would promote brown adipogenesis 173; 237; 238. Cdkn1c, a maternally expressed imprinted 
gene would therefore fit within this hypothesis, with respect to the adipose tissue. Pref-1 and Necdin, 
which are paternally expressed imprinted genes, inhibit adipogenesis, and therefore also fit within this 
framework. Previous work has shown Cdkn1c, and other members of the IC2 imprinted cluster are not 
be imprinted in marsupials 34; 36. We can therefore speculate that the imprinting of Cdkn1c, and 
potentially other imprinted genes, may have been influenced by conflict caused by the brown adipose 
lineage. It is particularly interesting that Cdkn1c also regulates embryonic growth and thus weight at 
birth 180. One can imagine that when Cdkn1c became mono-allelically expressed, this resulted in larger 
mammals with a lower surface area and also less brown fat thus energy normally required for 
thermogenesis could be used to support post-natal growth. Much work still needs to be done. For 
example, although Cdkn1c is imprinted in humans and not marsupials, nothing is known about the 
epigenetic status of Cdkn1c in Afrotheria (elephants), a lineage of eutherians most distant from 
euchodroglires (human, mice).  
                  This work has explored a novel function for Cdkn1c and has demonstrated the gene to be 
involved in brown adipogenesis. The exact mechanism for its’ function remains to be discovered but the 
work has highlighted an exciting new gene in the adipose field.  
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